Document and Entity Information (USD $)	12 Months Ended
Document and Entity Information (USD $)	Dec. 31, 2014	Jun. 30, 2014	Jan. 31, 2015 Class A	Jan. 31, 2015 Class B	Jan. 31, 2015 Class C	Jan. 31, 2015 Class D
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Trading Symbol	UHS
Entity Registrant Name	UNIVERSAL HEALTH SERVICES INC
Entity Central Index Key	0000352915
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding			6,595,708	91,656,482	664,000	28,111
Entity Public Float		$ 8,700,000,000

Consolidated Statements of Income (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Net revenues before provision for doubtful accounts									$ 8,764,309	$ 8,411,038	$ 7,688,071
Less: Provision for doubtful accounts									698,983	1,127,216	726,671
Net revenues	2,107,581	2,017,758	2,019,821	1,920,166	1,800,846	1,816,369	1,834,975	1,831,632	8,065,326	7,283,822	6,961,400
Operating charges:
Salaries, wages and benefits									3,845,461	3,604,620	3,440,917
Other operating expenses									1,782,981	1,468,744	1,376,122
Supplies expense									895,693	821,089	799,621
Depreciation and amortization									375,624	337,172	302,426
Lease and rental expense									93,993	97,758	94,885
Transaction costs									0	0	5,716
Electronic health records incentive income									(27,902)	(61,024)	(30,038)
Costs related to extinguishment of debt									36,171	0	29,170
Operating Expenses, Total									7,002,021	6,268,359	6,018,819
Income from operations									1,063,305	1,015,463	942,581
Interest expense, net									133,638	146,131	178,918
Income before income taxes									929,667	869,332	763,663
Provision for income taxes									324,671	315,309	274,616
Net income	190,492	96,038	166,614	151,852	133,186	123,099	167,803	129,935	604,996	554,023	489,047
Less: Net income attributable to noncontrolling interests	17,695	13,241	14,943	13,774	8,665	8,512	15,962	10,151	59,653	43,290	45,601
Net income attributable to UHS	$ 172,797	$ 82,797	$ 151,671	$ 138,078	$ 124,521	$ 114,587	$ 151,841	$ 119,784	$ 545,343	$ 510,733	$ 443,446
Basic earnings per share attributable to UHS	$ 1.75	$ 0.84	$ 1.53	$ 1.40	$ 1.27	$ 1.17	$ 1.55	$ 1.23	$ 5.52	$ 5.21	$ 4.57
Diluted earnings per share attributable to UHS	$ 1.71	$ 0.82	$ 1.51	$ 1.38	$ 1.24	$ 1.15	$ 1.53	$ 1.21	$ 5.42	$ 5.14	$ 4.53
Weighted average number of common shares-basic									98,826	98,033	96,821
Add: Other share equivalents									1,718	1,328	890
Weighted average number of common shares and equivalents-diluted									100,544	99,361	97,711

Consolidated Statements of Comprehensive Income (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Net income	$ 190,492	$ 96,038	$ 166,614	$ 151,852	$ 133,186	$ 123,099	$ 167,803	$ 129,935	$ 604,996	$ 554,023	$ 489,047
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges									17,668	16,963	6,677
Amortization of terminated hedge									(336)	(336)	(336)
Minimum pension liability									(14,270)	14,657	4,986
Foreign currency translation adjustment									(2,431)	0	0
Other comprehensive income (loss) before tax									631	31,284	11,327
Income tax (benefit) expense related to items of other comprehensive income									1,053	11,940	4,306
Total other comprehensive income (loss), net of tax									(422)	19,344	7,021
Comprehensive income									604,574	573,367	496,068
Less: Comprehensive income attributable to noncontrolling interests									59,653	43,290	45,601
Comprehensive income attributable to UHS									$ 544,921	$ 530,077	$ 450,467

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 32,069	$ 17,238
Accounts receivable, net	1,282,735	1,116,961
Supplies	108,115	101,781
Deferred income taxes	114,565	119,903
Other current assets	77,654	76,446
Total current assets	1,615,138	1,432,329
Property and Equipment
Land	435,632	388,190
Buildings and improvements	3,948,501	3,593,055
Equipment	1,648,718	1,496,707
Property under capital lease	40,782	27,636
Property Equipment Gross	6,073,633	5,505,588
Accumulated depreciation	(2,532,341)	(2,249,733)
Property and equipment excluding construction in progress net	3,541,292	3,255,855
Construction-in-progress	138,397	186,314
Property, Plant and Equipment, Net	3,679,689	3,442,169
Other assets:
Goodwill	3,291,213	3,049,016
Deferred charges	40,319	57,881
Other	348,084	330,328
Other assets	3,679,616	3,437,225
Total assets	8,974,443	8,311,723
Current liabilities:
Current maturities of long-term debt	68,319	99,312
Accounts payable	336,447	276,911
Accrued liabilities
Compensation and related benefits	323,425	278,206
Interest	13,977	9,577
Taxes other than income	112,119	59,473
Other	327,094	329,282
Current federal and state income taxes	1,446	7,127
Total current liabilities	1,182,827	1,059,888
Other noncurrent liabilities	268,555	284,589
Long-term debt	3,210,215	3,209,762
Deferred income taxes	282,214	239,148
Commitments and contingencies (Note 8)
Redeemable noncontrolling interest	239,552	218,107
Equity:
Cumulative dividends	(255,196)	(225,531)
Retained earnings	4,015,387	3,499,337
Accumulated other comprehensive loss	(25,232)	(24,810)
Universal Health Services, Inc. common stockholders' equity	3,735,946	3,249,979
Noncontrolling interest	55,134	50,250
Total Equity	3,791,080	3,300,229
Liabilities and Equity, Total	8,974,443	8,311,723
Class A
Equity:
Common Stock	66	66
Class B
Equity:
Common Stock	914	910
Class C
Equity:
Common Stock	7	7
Class D
Equity:
Common Stock	$ 0	$ 0

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Class A
Common Stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	12,000,000	12,000,000
Common Stock, shares issued	6,595,708	6,595,708
Common Stock, shares outstanding	6,595,708	6,595,708
Class B
Common Stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	150,000,000	150,000,000
Common Stock, shares issued	91,427,258	91,021,377
Common Stock, shares outstanding	91,427,258	91,021,377
Class C
Common Stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	1,200,000	1,200,000
Common Stock, shares issued	664,000	664,000
Common Stock, shares outstanding	664,000	664,000
Class D
Common Stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	5,000,000	5,000,000
Common Stock, shares issued	29,121	29,999
Common Stock, shares outstanding	29,121	29,999

Consolidated Statements of Changes in Equity (USD $) In Thousands, unless otherwise specified	Total	Redeemable Interest	Cumulative Dividends	UHS Common Stockholders' Equity	Class A Common	Class B Common	Class C Common	Class D Common	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest
Balance at Dec. 31, 2011		$ 218,266
Balance at Dec. 31, 2011	2,347,118		(147,515)	2,296,352	66	893	7	0	2,494,076	(51,575)	50,766
Common Stock
Issued/(converted) including tax benefits from exercise of stock options	21,684			21,684		14			21,670
Repurchased	(19,154)			(19,154)		(4)			(19,150)
Restricted share-based compensation expense	2,308			2,308					2,308
Dividends paid	(58,395)		(58,395)	(58,395)
Stock option expense	20,083			20,083					20,083
Distributions to noncontrolling interests	(7,933)	(18,961)									(7,933)
Sale of minority ownership interests in majority owned businesses	(832)										(832)
Comprehensive income:
Net income	454,049			443,446					443,446		10,603
Net income		34,998
Amortization of terminated hedge (net of income tax effect of $120)	(216)			(216)						(216)
Unrealized derivative gains and losses on cash flow hedges (net of income tax effect of $6,529 in 2014, 6,390 in 2013, $2,528 in 2012)	4,149			4,149						4,149
Minimum pension liability (net of income tax effect of $5,356 in 2014, 5,670 in 2013, $1,898 in 2012)	3,088			3,088						3,088
Subtotal-comprehensive income	461,070			450,467					443,446	7,021	10,603
Subtotal-comprehensive income		34,998
Balance at Dec. 31, 2012		234,303
Balance at Dec. 31, 2012	2,765,949		(205,910)	2,713,345	66	903	7	0	2,962,433	(44,154)	52,604
Common Stock
Issued/(converted) including tax benefits from exercise of stock options	26,880			26,880		11			26,869
Repurchased	(27,201)			(27,201)		(4)			(27,197)
Restricted share-based compensation expense	664			664					664
Dividends paid	(19,621)		(19,621)	(19,621)
Stock option expense	25,835			25,835					25,835
Distributions to noncontrolling interests	(13,039)	(48,290)									(13,039)
Other	(511)										(511)
Comprehensive income:
Net income	521,929			510,733					510,733		11,196
Net income		32,094
Foreign currency translation adjustments	0
Amortization of terminated hedge (net of income tax effect of $120)	(216)			(216)						(216)
Unrealized derivative gains and losses on cash flow hedges (net of income tax effect of $6,529 in 2014, 6,390 in 2013, $2,528 in 2012)	10,573			10,573						10,573
Minimum pension liability (net of income tax effect of $5,356 in 2014, 5,670 in 2013, $1,898 in 2012)	8,987			8,987						8,987
Subtotal-comprehensive income	541,273			530,077					510,733	19,344	11,196
Subtotal-comprehensive income		32,094
Balance at Dec. 31, 2013	218,107	218,107
Balance at Dec. 31, 2013	3,300,229		225,531	3,249,979	66	910	7	0	3,499,337	24,810	50,250
Common Stock
Issued/(converted) including tax benefits from exercise of stock options	41,801			41,801		14			41,787
Repurchased	(100,749)			(100,749)		(10)			(100,739)
Restricted share-based compensation expense	491			491					491
Dividends paid	(29,665)		(29,665)	(29,665)
Stock option expense	29,168			29,168					29,168
Distributions to noncontrolling interests	(7,666)	(26,016)									(7,666)
Other	358										358
Comprehensive income:
Net income	557,535			545,343					545,343		12,192
Net income		47,461
Foreign currency translation adjustments	(2,431)			(2,431)						(2,431)
Amortization of terminated hedge (net of income tax effect of $120)	(216)			(216)						(216)
Unrealized derivative gains and losses on cash flow hedges (net of income tax effect of $6,529 in 2014, 6,390 in 2013, $2,528 in 2012)	11,139			11,139						11,139
Minimum pension liability (net of income tax effect of $5,356 in 2014, 5,670 in 2013, $1,898 in 2012)	(8,914)			(8,914)						(8,914)
Subtotal-comprehensive income	557,113			544,921					545,343	(422)	12,192
Subtotal-comprehensive income		47,461
Balance at Dec. 31, 2014	239,552	239,552
Balance at Dec. 31, 2014	$ 3,791,080		$ 255,196	$ 3,735,946	$ 66	$ 914	$ 7	$ 0	$ 4,015,387	$ 25,232	$ 55,134

Consolidated Statements of Changes in Equity (Parenthetical) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Amortization of terminated hedge, income tax effect	$ 120	$ 120	$ 120
Unrealized derivative gains and losses on cash flow hedges, income tax effect	6,529	6,390	2,528
Minimum pension liability, income tax effect	$ 5,356	$ 5,670	$ 1,898

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash Flows from Operating Activities:
Net income	$ 604,996	$ 554,023	$ 489,047
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation & amortization	375,624	337,356	308,690
Gains on sales of assets and businesses, net of losses	(7,837)	(3,114)	(27,085)
Stock based compensation expense	31,092	27,783	22,518
Costs related to extinguishment of debt	19,730	0	29,170
Changes in assets & liabilities, net of effects from acquisitions and dispositions:
Accounts receivable	(105,708)	(49,708)	(71,068)
Accrued interest	4,400	(1,197)	152
Accrued and deferred income taxes	33,920	34,861	(5,666)
Other working capital accounts	73,912	26,234	28,554
Other assets and deferred charges	13,667	8,984	30,976
Other	2,449	23,485	6,367
Accrued insurance expense, net of commercial premiums paid	59,276	(3,821)	62,660
Payments made in settlement of self-insurance claims	(69,645)	(70,645)	(75,084)
Net cash provided by operating activities	1,035,876	884,241	799,231
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(391,150)	(358,493)	(363,192)
Acquisition of property and businesses	(431,386)	(12,636)	(527,847)
Proceeds received from sales of assets and businesses	15,178	37,482	149,311
Costs incurred for purchase and implementation of electronic health records application	(13,488)	(49,811)	(54,362)
Increase in insurance subsidiary investments	(12,000)	0	0
Return of Deposit on terminated purchase agreement	0	0	6,500
Net cash provided by (used in) investing activities	(832,846)	(383,458)	(789,590)
Cash Flows from Financing Activities:
Reduction of long-term debt	(879,129)	(440,224)	(849,647)
Additional borrowings	830,000	15,761	913,500
Financing costs	(14,976)	(231)	(8,283)
Repurchase of common shares	(100,749)	(27,201)	(19,154)
Dividends paid	(29,665)	(19,621)	(58,395)
Issuance of common stock	6,863	5,708	5,435
Excess income tax benefits related to stock based compensation	33,912	20,121	16,040
Profit distributions to noncontrolling interests	(33,680)	(61,329)	(26,895)
Net cash (used in) provided by financing activities	(187,424)	(507,016)	(27,399)
Effect of exchange rate changes on cash and cash equivalents	(775)	0	0
Increase (decrease) in cash and cash equivalents	14,831	(6,233)	(17,758)
Cash and cash equivalents, beginning of period	17,238	23,471	41,229
Cash and cash equivalents, end of period	32,069	17,238	23,471
Supplemental Disclosures of Cash Flow Information:
Interest paid, including early redemption premium and original issue discount write-off in 2014	130,279	131,259	157,415
Income taxes paid, net of refunds	258,612	259,896	264,824
Noncash purchases of property and equipment	$ 35,469	$ 36,212	$ 34,896

Business and Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2014

Business and Summary of Significant Accounting Policies

1) BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Services provided by our hospitals, all of which are operated by subsidiaries of ours include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. We, through our subsidiaries, provide capital resources as well as a variety of management services to our facilities, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations.

The more significant accounting policies follow:

A) Principles of Consolidation: The consolidated financial statements include the accounts of our majority-owned subsidiaries and partnerships controlled by us or our subsidiaries as the managing general partner. All significant intercompany accounts and transactions have been eliminated.

B) Revenue Recognition: We record revenues and related receivables for health care services at the time the services are provided. Medicare and Medicaid revenues represented 36% of our net patient revenues during 2014, 38% during 2013 and 39% during 2012. Revenues from managed care entities, including health maintenance organizations and managed Medicare and Medicaid programs accounted for 50% of our net patient revenues during 2014 and 49% during each of 2013 and 2012.

We report net patient service revenue at the estimated net realizable amounts from patients and third-party payors and others for services rendered. We have agreements with third-party payors that provide for payments to us at amounts different from our established rates. Payment arrangements include prospectively determined rates per discharge, reimbursed costs, discounted charges and per diem payments. Estimates of contractual allowances under managed care plans are based upon the payment terms specified in the related contractual agreements. We closely monitor our historical collection rates, as well as changes in applicable laws, rules and regulations and contract terms, to assure that provisions are made using the most accurate information available. However, due to the complexities involved in these estimations, actual payments from payors may be different from the amounts we estimate and record.

We estimate our Medicare and Medicaid revenues using the latest available financial information, patient utilization data, government provided data and in accordance with applicable Medicare and Medicaid payment rules and regulations. The laws and regulations governing the Medicare and Medicaid programs are extremely complex and subject to interpretation and as a result, there is at least a reasonable possibility that recorded estimates will change by material amounts in the near term. Certain types of payments by the Medicare program and state Medicaid programs (e.g. Medicare Disproportionate Share Hospital, Medicare Allowable Bad Debts and Inpatient Psychiatric Services) are subject to retroactive adjustment in future periods as a result of administrative review and audit and our estimates may vary from the final settlements. Such amounts are included in accounts receivable, net, on our Consolidated Balance Sheets. The vast majority of the net revenues generated at our behavioral health facilities located in the United Kingdom are derived from government based payors. The funding of both federal Medicare and state Medicaid programs, and the government based payor programs in the United Kingdom, are subject to legislative and regulatory changes. As such, we cannot provide any assurance that future legislation and regulations, if enacted, will not have a material impact on our future government based reimbursements. Adjustments related to the final settlement of these retrospectively determined amounts did not materially impact our results in 2014, 2013 and 2012. We provide care to patients who meet certain financial or economic criteria without charge or at amounts substantially less than our established rates. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in net revenues or in accounts receivable, net. See additional disclosure below in Charity Care, Uninsured Discounts and Provision for Doubtful Accounts for our estimated uncompensated care provided and estimated cost of providing uncompensated care.

C) Charity Care, Uninsured Discounts and Provision for Doubtful Accounts: Collection of receivables from third-party payers and patients is our primary source of cash and is critical to our operating performance. Our primary collection risks relate to uninsured patients and the portion of the bill which is the patient’s responsibility, primarily co-payments and deductibles. We estimate our provisions for doubtful accounts based on general factors such as payer mix, the agings of the receivables and historical collection experience. We routinely review accounts receivable balances in conjunction with these factors and other economic conditions which might ultimately affect the collectability of the patient accounts and make adjustments to our allowances as warranted. At our acute care hospitals, third party liability accounts are pursued until all payment and adjustments are posted to the patient account. For those accounts with a patient balance after third party liability is finalized or accounts for uninsured patients, the patient receives statements and collection letters. Our hospitals establish a partial reserve for self-pay accounts in the allowance for doubtful accounts for both unbilled balances and those that have been billed and are under 90 days old. All self-pay accounts are fully reserved at 90 days from the date of discharge. Third party liability accounts are fully reserved in the allowance for doubtful accounts when the balance ages past 180 days from the date of discharge. Patients that express an inability to pay are reviewed for potential sources of financial assistance including our charity care policy. If the patient is deemed unwilling to pay, the account is written-off as bad debt and transferred to an outside collection agency for additional collection effort.

Historically, a significant portion of the patients treated throughout our portfolio of acute care hospitals are uninsured patients which, in part, has resulted from patients who are employed but do not have health insurance or who have policies with relatively high deductibles. Patients treated at our hospitals for non-elective services, who have gross income less than 400% of the federal poverty guidelines, are deemed eligible for charity care. The federal poverty guidelines are established by the federal government and are based on income and family size. Because we do not pursue collection of amounts that qualify as charity care, they are not reported in our net revenues or in our accounts receivable, net.

A portion of the accounts receivable at our acute care facilities are comprised of Medicaid accounts that are pending approval from third-party payers but we also have smaller amounts due from other miscellaneous payers such as county indigent programs in certain states. Our patient registration process includes an interview of the patient or the patient’s responsible party at the time of registration. At that time, an insurance eligibility determination is made and an insurance plan code is assigned. There are various pre-established insurance profiles in our patient accounting system which determine the expected insurance reimbursement for each patient based on the insurance plan code assigned and the services rendered. Certain patients may be classified as Medicaid pending at registration based upon a screening evaluation if we are unable to definitively determine if they are currently Medicaid eligible. When a patient is registered as Medicaid eligible or Medicaid pending, our patient accounting system records net revenues for services provided to that patient based upon the established Medicaid reimbursement rates, subject to the ultimate disposition of the patient’s Medicaid eligibility. When the patient’s ultimate eligibility is determined, reclassifications may occur which impacts the reported amounts in future periods for the provision for doubtful accounts and other accounts such as Medicaid pending. Although the patient’s ultimate eligibility determination may result in amounts being reclassified among these accounts from period to period, these reclassifications did not have a material impact on our results of operations in 2014, 2013 or 2012 since our facilities make estimates at each financial reporting period to reserve for amounts that are deemed to be uncollectible.

We also provide discounts to uninsured patients (included in “uninsured discounts” amounts below) who do not qualify for Medicaid or charity care. Because we do not pursue collection of amounts classified as uninsured discounts, they are not reported in our net revenues or in our net accounts receivable. In implementing the discount policy, we first attempt to qualify uninsured patients for governmental programs, charity care or any other discount program. If an uninsured patient does not qualify for these programs, the uninsured discount is applied. Effective January 1, 2014, in response to market conditions and other considerations, we modified our uninsured discount policy and increased the discount to 60% of gross charges from 30% previously. The increase in the uninsured discount in 2014 had no material impact on our net revenues, net income attributable to UHS or net accounts receivable, as compared to prior year periods. However, since we expect to collect only a small portion of amounts due from our uninsured patients, this change resulted in an increase in uninsured discounts and a decrease in the provision for doubtful accounts.

On a consolidated basis, we monitor our total self-pay receivables to ensure that the total allowance for doubtful accounts provides adequate coverage based on historical collection experience. Our accounts receivable are recorded net of allowance for doubtful accounts of $325 million and $395 million at December 31, 2014 and 2013, respectively.

Uncompensated care (charity care and uninsured discounts):

The following table shows the amounts recorded at our acute care hospitals for charity care and uninsured discounts, based on charges at established rates, for the years ended December 31, 2014, 2013 and 2012:


	(dollar amounts in thousands)
	2014					2013					2012
	Amount		%			Amount		%			Amount		%
Charity care	$	515,435		45	%	$	593,474		59	%	$	778,268		74	%
Uninsured discounts		620,587		55	%		405,296		41	%		267,304		26	%

Total uncompensated care	$	1,136,022		100	%	$	998,770		100	%	$	1,045,572		100	%

The provision for doubtful accounts at our acute care hospitals decreased to approximately $590 million during 2014 as compared to $1.02 billion during 2013. The decrease in the provision for doubtful accounts during 2014, as compared to 2013, was primarily due to the increase in the uninsured discount effective January 1, 2014, and reclassifications among provision for doubtful accounts and other accounts such as Medicaid pending based upon our patients’ ultimate eligibility determination, as discussed above.

The estimated cost of providing uncompensated care:

The estimated cost of providing uncompensated care, as reflected below, were based on a calculation which multiplied the percentage of operating expenses for our acute care hospitals to gross charges for those hospitals by the above-mentioned total uncompensated care amounts. The percentage of cost to gross charges is calculated based on the total operating expenses for our acute care facilities divided by gross patient service revenue for those facilities. An increase in the level of uninsured patients to our facilities and the resulting adverse trends in the provision for doubtful accounts and uncompensated care provided could have a material unfavorable impact on our future operating results.


	(amounts in thousands)
	2014		2013		2012
Estimated cost of providing charity care	$	78,475	$	95,675	$	131,890
Estimated cost of providing uninsured discounts related care		94,484		65,338		45,299

Estimated cost of providing uncompensated care	$	172,959	$	161,013	$	177,189

Our accounts receivable as of December 31, 2014 and 2013 include amounts due from Illinois of approximately $44 million and $49 million, respectively. Collection of the outstanding receivables continues to be delayed due to state budgetary and funding pressures. Approximately $23 million as of December 31, 2014 and $28 million as of December 31, 2013, of the receivables due from Illinois were outstanding in excess of 60 days, as of each respective date. In addition, our accounts receivable as of December 31, 2014 and 2013 includes approximately $102 million and $62 million due from Texas in connection with Medicaid supplemental payment programs. The $102 million due from Texas as of December 31, 2014 consists of $45 million related to uncompensated care program revenues, $33 million related to disproportionate share hospital program revenues and $24 million related to Delivery Service Reform Incentive Payment program (“DSRIP”) revenues. Approximately $24 million of cash was received in January, 2015 from Texas related to the above-mentioned DSRIP receivables outstanding as of December 31, 2014. Although the accounts receivable due from Illinois and Texas could remain outstanding for the foreseeable future, since we expect to eventually collect all amounts due to us, no related reserves have been established in our consolidated financial statements. However, we can provide no assurance that we will eventually collect all amounts due to us from Illinois and/or Texas. Failure to ultimately collect all outstanding amounts due from these states would have an adverse impact on our future consolidated results of operations and cash flows.

D) Concentration of Revenues: Our five majority owned acute care hospitals in the Las Vegas, Nevada market contributed, on a combined basis, 14% of our consolidated net revenues during each year of 2014, 2013 and 2012.

E) Accounting for Medicare and Medicaid Electronic Health Records Incentive Payments: In July 2010, the Department of Health and Human Services published final regulations implementing the health information technology provisions of the American Recovery and Reinvestment Act. The regulation defines the “meaningful use” of Electronic Health Records (“EHR”) and established the requirements for the Medicare and Medicaid EHR payment incentive programs. The implementation period for these new Medicare and Medicaid incentive payments started in federal fiscal year 2011 and can end as late as 2016 for Medicare and 2021 for the state Medicaid programs. We recognize income related to Medicare and Medicaid incentive payments using a gain contingency model that is based upon when our eligible hospitals have demonstrated “meaningful use” of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.

Medicare EHR incentive payments: Federal regulations require that Medicare EHR incentive payments be computed based on the Medicare cost report that begins in the federal fiscal period in which a hospital meets the applicable “meaningful use” requirements. Since the annual Medicare cost report periods for each of our acute care hospitals ends on December 31^st, we will recognize Medicare EHR incentive income for each hospital during the fourth quarter of the year in which the facility meets the “meaningful use” criteria and during the fourth quarter of each applicable subsequent year.

Medicaid EHR incentive payments: Medicaid EHR incentive payments are determined based upon prior period cost report information available at the time our hospitals met the “meaningful use” criteria. Therefore, the majority of the Medicaid EHR incentive income recognition occurred in the period in which the applicable hospitals were deemed to have met initial “meaningful use” criteria. Upon meeting subsequent fiscal year “meaningful use” criteria, our hospitals may become entitled to additional Medicaid EHR incentive payments which will be recognized as incentive income in future periods. Medicaid EHR incentive payments received prior to our hospitals meeting the “meaningful use” criteria were included in other current liabilities (as deferred EHR incentive income) in our consolidated balance sheet.

F) Cash and Cash Equivalents: We consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents.

G) Property and Equipment: Property and Equipment: Property and equipment are stated at cost. Expenditures for renewals and improvements are charged to the property accounts. Replacements, maintenance and repairs which do not improve or extend the life of the respective asset are expensed as incurred. We remove the cost and the related accumulated depreciation from the accounts for assets sold or retired and the resulting gains or losses are included in the results of operations. Construction-in-progress includes both construction projects and equipment not yet placed into service.

We capitalize interest expense on major construction projects while in progress. There was no capitalized interest recorded during 2014. We capitalized interest on major construction projects and the development and implementation of electronic health records applications amounting to $4.9 million during 2013 and $5.7 million during 2012.

Depreciation is provided on the straight-line method over the estimated useful lives of buildings and improvements (twenty to forty years) and equipment (three to fifteen years). Depreciation expense (excluding discontinued operations) was $314.5 million during 2014, $285.6 million during 2013 and $270.5 million during 2012.

H) Long-Lived Assets: We review our long-lived assets, including intangible assets, for impairment whenever events or circumstances indicate that the carrying value of these assets may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value of our asset based on our estimate of its undiscounted future cash flow. If the analysis indicates that the carrying value is not recoverable from future cash flows, the asset is written down to its estimated fair value and an impairment loss is recognized. Fair values are determined based on estimated future cash flows using appropriate discount rates.

I) Goodwill and Intangible Assets: Goodwill and indefinite-lived intangible assets are reviewed for impairment at the reporting unit level on an annual basis or sooner if the indicators of impairment arise. Our judgments regarding the existence of impairment indicators are based on market conditions and operational performance of each reporting unit. We have designated September 1^st as our annual impairment assessment date and performed an impairment assessment as of September 1, 2014 which indicated no impairment of goodwill or indefinite-lived intangible assets. There were also no impairments during 2013 or 2012. Future changes in the estimates used to conduct the impairment review, including profitability and market value projections, could indicate impairment in future periods potentially resulting in a write-off of a portion or all of our goodwill or indefinite-lived intangible assets.

Changes in the carrying amount of goodwill for the two years ended December 31, 2014 were as follows (in thousands):


	Acute Care Services		Behavioral Health Services			Total Consolidated
Balance, January 1, 2013	$	382,696	$	2,654,069		$	3,036,765
Adjustments to goodwill (a)		315		11,936			12,251

Balance, December 31, 2013		383,011		2,666,005			3,049,016
Goodwill acquired during the period		4,088		246,124			250,212
Adjustments to goodwill (b)		0		(8,015	)		(8,015	)

Balance, December 31, 2014	$	387,099	$	2,904,114		$	3,291,213

(a)	The increase in the Behavioral Health Services’ goodwill consists primarily of an amount that was reclassified from other assets.

(b)	The decrease in the Behavioral Health Services’ goodwill consists primarily of foreign currency translation adjustments.

J) Other Assets: Other assets consist primarily of amounts related to: (i) intangible assets acquired in connection with our acquisition of Psychiatric Solutions, Inc. (“PSI”) in November, 2010 and Ascend Health Corporation in October, 2012, consisting of Medicare licenses, certificates of need and contracts to manage the operations of behavioral health services owned by third-parties (PSI only); (ii) prepaid fees for various software and other applications used by our hospitals; (iii) costs incurred in connection with the purchase and implementation of an electronic health records application for each of our acute care facilities; (iv) required capital reserves related to our commercial insurer; (v) deposits; (vi) investments in various businesses, including Universal Health Realty Income Trust; (vii) the invested assets related to a deferred compensation plan that is held by an independent trustee in a rabbi-trust and that has a related payable included in other noncurrent liabilities; (viii) the estimated future payments related to physician-related contractual commitments, as discussed below, and; (ix) other miscellaneous assets. As of December 31, 2014 and 2013, other intangible assets, net of accumulated amortization, were approximately $98 million and $97 million, respectively.

K) Physician Guarantees and Commitments: As of December 31, 2014 and 2013, our accrued liabilities-other, and our other assets included $2 million and $3 million, respectively, of estimated future payments related to physician-related contractual commitments. The $2 million of potential future financial obligations outstanding as of December 31, 2014 are potential 2015 obligations.

L) Self-Insured/Other Insurance Risks: We provide for self-insured risks, primarily general and professional liability claims and workers’ compensation claims. Our estimated liability for self-insured professional and general liability claims is based on a number of factors including, among other things, the number of asserted claims and reported incidents, estimates of losses for these claims based on recent and historical settlement amounts, estimate of incurred but not reported claims based on historical experience, and estimates of amounts recoverable under our commercial insurance policies. All relevant information, including our own historical experience is used in estimating the expected amount of claims. While we continuously monitor these factors, our ultimate liability for professional and general liability claims could change materially from our current estimates due to inherent uncertainties involved in making this estimate. Our estimated self-insured reserves are reviewed and changed, if necessary, at each reporting date and changes are recognized currently as additional expense or as a reduction of expense. See Note 8 for discussion of adjustments to our prior year reserves for claims related to our self-insured general and professional liability and workers’ compensation liability.

In addition, we also: (i) own a commercial health insurer headquartered in Reno, Nevada, and; (ii) maintain self-insured employee benefits programs for employee healthcare and dental claims. The ultimate costs related to these programs/operations include expenses for claims incurred and paid in addition to an accrual for the estimated expenses incurred in connection with claims incurred but not yet reported. Given our significant insurance-related exposure, there can be no assurance that a sharp increase in the number and/or severity of claims asserted against us will not have a material adverse effect on our future results of operations.

M) Income Taxes: Deferred tax assets and liabilities are recognized for the amount of taxes payable or deductible in future years as a result of differences between the tax bases of assets and liabilities and their reported amounts in the financial statements. We believe that future income will enable us to realize our deferred tax assets net of recorded valuation allowances relating to state net operating loss carry-forwards.

We operate in multiple jurisdictions with varying tax laws. We are subject to audits by any of these taxing authorities. Our tax returns have been examined by the Internal Revenue Service (“IRS”) through the year ended December 31, 2006. We believe that adequate accruals have been provided for federal, foreign and state taxes. See Note 6—Income Taxes, for additional disclosure.

N) Other Noncurrent Liabilities: Other noncurrent liabilities include the long-term portion of our professional and general liability, workers’ compensation reserves, pension and deferred compensation liabilities, and a liability incurred in connection with split-dollar life insurance agreements on the lives of our chief executive officer and his wife.

O) Redeemable Noncontrolling Interests and Noncontrolling Interest: Outside owners hold noncontrolling, minority ownership interests of: (i) approximately 28% in our five acute care facilities (and one additional facility currently under construction) located in Las Vegas, Nevada; (ii) 20% in an acute care facility located in Washington, D.C.; (iii) approximately 11% in an acute care facility located in Laredo, Texas, and; (iv) 20% in a behavioral health care facility located in Philadelphia, Pennsylvania. The redeemable noncontrolling interest balances of $240 million as of December 31, 2014 and $218 million as of December 31, 2013, and the noncontrolling interest balances of $55 million as of December 31, 2014 and $50 million as of December 31, 2013, consist primarily of the third-party ownership interests in these hospitals.

In connection with five acute care facilities (and an additional facility currently under construction) located in Las Vegas, Nevada, the minority ownership interests of which are reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owners have certain “put rights” that, if exercisable, and if exercised, require us to purchase the minority member’s interests at fair market value. The put rights are exercisable upon the occurrence of: (i) certain specified financial conditions falling below established thresholds; (ii) breach of the management contract by the managing member (a subsidiary of ours), or; (iii) if the minority member’s ownership percentage is reduced to less than certain thresholds. In connection with a behavioral health care facility located in Philadelphia, Pennsylvania and acquired by us as part of the PSI acquisition, the minority ownership interest of which is also reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owner has a “put option” to put its entire ownership interest to us at any time. If exercised, the put option requires us to purchase the minority member’s interest at fair market value.

P) Accumulated Other Comprehensive Income: The accumulated other comprehensive income (“AOCI”) component of stockholders’ equity includes: net unrealized gains and losses on effective cash flow hedges, foreign currency translation adjustments and the net minimum pension liability of a non-contributory defined benefit pension plan which covers employees at one of our subsidiaries. See Note 10, “Pension Plan” for additional disclosure regarding the defined benefit pension plan.

The amounts recognized in AOCI for the two years ended December 31, 2014 were as follows (in thousands):


	Net Unrealized Gains (Losses) on Effective Cash Flow Hedges			Foreign Currency Translation Adjustment			Minimum Pension Liability			Total AOCI
Balance, January 1, 2013, net of income tax	$	(24,527	)	$	0		$	(19,627	)	$	(44,154	)
2013 activity:
Pretax amount		16,627			0			14,657			31,284
Income tax effect		(6,270	)		0			(5,670	)		(11,940	)

Change, net of income tax		10,357			0			8,987			19,344

Balance, January 1, 2014, net of income tax		(14,170	)		0			(10,640	)		(24,810	)
2014 activity:
Pretax amount		17,332			(2,431	)		(14,270	)		631
Income tax effect		(6,409	)		0			5,356			(1,053	)

Change, net of income tax		10,923			(2,431	)		(8,914	)		(422	)

Balance, December 31, 2014, net of income tax	$	(3,247	)	$	(2,431	)	$	(19,554	)	$	(25,232	)

Q) Accounting for Derivative Financial Investments and Hedging Activities: We manage our ratio of fixed to floating rate debt with the objective of achieving a mix that management believes is appropriate. To manage this risk in a cost-effective manner, we, from time to time, enter into interest rate swap agreements in which we agree to exchange various combinations of fixed and/or variable interest rates based on agreed upon notional amounts.

We account for our derivative and hedging activities using the Financial Accounting Standard Board’s (“FASB”) guidance which requires all derivative instruments, including certain derivative instruments embedded in other contracts, to be carried at fair value on the balance sheet. For derivative transactions designated as hedges, we formally document all relationships between the hedging instrument and the related hedged item, as well as its risk-management objective and strategy for undertaking each hedge transaction.

We use interest rate derivatives in our cash flow hedge transactions. Such derivatives are designed to be highly effective in offsetting changes in the cash flows related to the hedged liability. For derivative instruments designated as cash flow hedges, the ineffective portion of the change in expected cash flows of the hedged item are recognized currently in the income statement.

Derivative instruments designated in a hedge relationship to mitigate exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Fair value hedges are accounted for by recording the changes in the fair value of both the derivative instrument and the hedged item in the income statement.

For hedge transactions that do not qualify for the short-cut method, at the hedge’s inception and on a regular basis thereafter, a formal assessment is performed to determine whether changes in the fair values or cash flows of the derivative instruments have been highly effective in offsetting changes in cash flows of the hedged items and whether they are expected to be highly effective in the future.

R) Stock-Based Compensation: At December 31, 2014, we have a number of stock-based employee compensation plans. Pursuant to the FASB’s guidance, we expense the grant-date fair value of stock options and other equity-based compensation pursuant to the straight-line method over the stated vesting period of the award using the Black-Scholes option-pricing model.

The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities. The applicable FASB guidance requires that cash flows resulting from tax deductions in excess of compensation cost recognized be classified as financing cash flows.

S) Earnings per Share: Basic earnings per share are based on the weighted average number of common shares outstanding during the year. Diluted earnings per share are based on the weighted average number of common shares outstanding during the year adjusted to give effect to common stock equivalents.

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:


	Twelve Months Ended December 31,
	2014			2013			2012
Basic and diluted:
Net Income	$	604,996		$	554,023		$	489,047
Less: Net income attributable to noncontrolling interest		(59,653	)		(43,290	)		(45,601	)
Less: Net income attributable to unvested restricted share grants		(236	)		(294	)		(497	)

Net income attributable to UHS—basic and diluted	$	545,107		$	510,439		$	442,949

Basic earnings per share attributable to UHS:
Weighted average number of common shares—basic		98,826			98,033			96,821

Total basic earnings per share	$	5.52		$	5.21		$	4.57

Diluted earnings per share attributable to UHS:
Weighted average number of common shares		98,826			98,033			96,821
Net effect of dilutive stock options and grants based on the treasury stock method		1,718			1,328			890

Weighted average number of common shares and equivalents—diluted		100,544			99,361			97,711

Total diluted earnings per share	$	5.42		$	5.14		$	4.53

The “Net effect of dilutive stock options and grants based on the treasury stock method”, for all years presented above, excludes certain outstanding stock options applicable to each year since the effect would have been anti-dilutive. The excluded weighted-average stock options totaled 2,250 during 2014, 4,000 during 2013, and 2.0 million during 2012.

T) Fair Value of Financial Instruments: The fair values of our registered debt and investments are based on quoted market prices. The fair values of other long-term debt, including capital lease obligations, are estimated by discounting cash flows using period-end interest rates and market conditions for instruments with similar maturities and credit quality. The carrying amounts reported in the balance sheet for cash, accounts receivable, accounts payable, and short-term borrowings approximates their fair values due to the short-term nature of these instruments. Accordingly, these items have been excluded from the fair value disclosures included elsewhere in these notes to consolidated financial statements.

U) Use of Estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

V) Mergers and Acquisitions: The acquisition method of accounting for business combinations requires that the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective fair values with limited exceptions. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Any excess of the purchase price (consideration transferred) over the estimated fair values of net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired company are expensed as incurred. The fair value of intangible assets, including Medicare Licenses, Certificates of Need, and certain contracts, is based on significant judgments made by our management, and accordingly, for significant items we typically obtain assistance from third party valuation specialists.

W) GPO Agreement/Minority Ownership Interest: During 2013, we entered into a new group purchasing organization agreement (“GPO”) and acquired a minority interest in the GPO for a nominal amount. In connection with the completion of an initial public offering of the stock of the GPO, during the fourth quarter of 2013, we received cash proceeds for the sale of a portion of our ownership interest, which were recorded as deferred income and included in liabilities on our consolidated balance sheet as of December 31, 2014 and 2013. The deferred income is being recognized, on a pro rata basis, as a reduction to our supplies expense over the expected life of the GPO agreement. Also in connection with this GPO agreement and related minority interest ownership, we received shares of restricted stock in the GPO which vest ratably over a seven-year period, contingent upon our continued participation and minority ownership interest in the GPO. We are recognizing the fair value of this restricted stock, as a reduction to our supplies expense, in our consolidated statements of income on a pro rata basis over the vesting period.

X) Provider Taxes: We incur health-care related taxes (“Provider Taxes”) imposed by states in the form of a licensing fee, assessment or other mandatory payment which are related to: (i) healthcare items or services; (ii) the provision of, or the authority to provide, the health care items or services, or; (iii) the payment for the health care items or services. Such Provider Taxes are subject to various federal regulations that limit the scope and amount of the taxes that can be levied by states in order to secure federal matching funds as part of their respective state Medicaid programs. We derive a related Medicaid reimbursement benefit from assessed Provider Taxes in the form of Medicaid claims based payment increases and/or lump sum Medicaid supplemental payments. Under these programs, including the impact of Uncompensated Care and Upper Payment Limit programs, and the Texas Delivery System Reform Incentive program, we earned revenues of approximately $293 million during 2014, $213 million during 2013, and $176 million during 2012. These revenues were offset by assessments of $137 million during 2014, $84 million during 2013, and $93 million during 2012, resulting in a net aggregate benefit of $156 million, $130 million, and $83 million, respectively. The aggregate net benefit is earned from multiple states and therefore no particular state’s portion is individually material to our consolidated financial statements. In addition, under various disproportionate share hospital payment programs and the Nevada state plan amendment program, we earned revenues of $59 million in 2014, $54 million in 2013, and $47 million in 2012.

Y) Recent Accounting Standards:

In April 2014, the Financial Accounting Standards Board (“FASB”) updated the accounting guidance related to the definition of a discontinued operation and the related disclosures. The updated accounting guidance defines a discontinued operation as a disposal of a component or a group of components that is to be disposed of or is classified as held for sale and represents a strategic shift that has or will have a major effect on an entity’s operations and financial results. The updated guidance is applicable to us effective January 1, 2015 with early adoption permitted. We do not expect the adoption of this update to have a material impact on our consolidated financial statements.

In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers”, which provides guidance for revenue recognition. The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosures. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016. We are currently in the process of evaluating the impact of adoption of this ASU on our consolidated financial statements.

In August 2014, FASB issued ASU No. 2014-15, “Preparation of Financial Statements—Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (ASU 2014-15). Continuation of a reporting entity as a going concern is presumed as the basis for preparing financial statements unless and until the entity’s liquidation becomes imminent. Preparation of financial statements under this presumption is commonly referred to as the going concern basis of accounting. If and when an entity’s liquidation becomes imminent, financial statements should be prepared under the liquidation basis of accounting in accordance with Subtopic 205-30, “Presentation of Financial Statements—Liquidation Basis of Accounting”. Even when an entity’s liquidation is not imminent, there may be conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. In those situations, financial statements should continue to be prepared under the going concern basis of accounting, but the new criteria in ASU 2014-15 should be followed to determine whether to disclose information about the relevant conditions and events. The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We will evaluate the going concern considerations in this ASU.

Acquisitions and Divestitures

12 Months Ended

Dec. 31, 2014

Acquisitions and Divestitures

2) ACQUISITIONS AND DIVESTITURES

2015 Acquisition:

In February, 2015, we acquired the Orchard Portman House Hospital (now called Cygnet Hospital-Taunton), a 46-bed behavioral health care facility located near Taunton, United Kingdom.

Year ended December 31, 2014:

2014 Acquisitions of Assets and Businesses:

During 2014 we spent $431 million to:

•

acquire the stock of Cygnet Health Care Limited (“Cygnet”) which consists of 17 facilities located throughout the United Kingdom including 15 inpatient behavioral health hospitals and 2 nursing homes with a total of 723 beds (during the third quarter);

•

acquire and fund the required capital reserves related to Prominence Health Plan, a commercial health insurer headquartered in Reno, Nevada (during the second quarter);

•

acquire the Psychiatric Institute of Washington, a 124-bed behavioral health care facility and outpatient treatment center located in Washington, D.C. (during the second quarter);

•

acquire the operations of Palo Verde Behavioral Health, a 48-bed behavioral health facility in Tucson, Arizona (during the first quarter);

•

acquire the real property of The Bridgeway, a 103-bed behavioral health care facility located in North Little Rock, Arkansas, that was previously leased from Universal Health Realty Income Trust (during the fourth quarter);

•

acquire the previously leased real property of Cygnet Hospital-Harrow, a 44-bed behavioral health care facility located in the United Kingdom, the operations of which were acquired as part of our acquisition of Cygnet (during the fourth quarter), and;

•

acquire physician practices.

The aggregate net purchase price of the facilities was allocated to assets and liabilities based on their preliminary estimated fair values as follows:


	Amount (000s)
Working capital, net	$	(41,000	)
Property & equipment		174,000
Goodwill		250,000
Other assets		59,000
Income tax assets, net of deferred tax liabilities		4,000
Debt		(16,000	)
Other		1,000

Cash paid in 2014 for acquisitions	$	431,000

Goodwill of the facilities acquired is computed, pursuant to the residual method, by deducting the fair value of the acquired assets and liabilities from the total purchase price. The factors that contribute to the recognition of goodwill, which may also influence the purchase price, include the following for each of the acquired facilities: (i) the historical cash flows and income levels; (ii) the reputations in their respective markets; (iii) the nature of the respective operations, and; (iv) the future cash flows and income growth projections. The vast majority of the goodwill resulting from these transactions is not deductible for federal income tax purposes (see Note 6. Income Taxes).

Included in our consolidated net revenues for the year ended December 31, 2014 was an aggregate of approximately $175 million representing the net revenues generated at the Cygnet facilities, the commercial health insurer located in Reno, Nevada and the 124-bed behavioral health care facility and outpatient treatment center located in Washington, D.C., from their respective dates of acquisition through December 31, 2014. The aggregate effect of the earnings generated by these facilities since the dates of acquisition, less the cost on the borrowings utilized to finance the acquisition, was not material to our 2014 net income attributable to UHS and net income attributable to UHS per diluted share.

Assuming the acquisitions occurred on January 1, 2014, our 2014 pro forma net revenues would have been approximately $8.28 billion and our pro forma net income attributable to UHS would have been approximately $558 million, or $5.55 per diluted share. Assuming the above-mentioned acquisitions occurred on January 1, 2013, our 2013 unaudited pro forma net revenues would have been approximately $7.62 billion and our unaudited pro forma net income attributable to UHS would have been approximately $522 million and $5.25 per diluted share.

2014 Divestiture of Assets and Businesses:

During 2014 we received $15 million in connection with the divestiture of a non-operating investment (during the first quarter) and the real property of a closed behavioral health facility (during the second quarter).

Year ended December 31, 2013:

2013 Acquisitions of Assets and Businesses:

During 2013, we spent an aggregate of $13 million for the purchase of real property located in Pennsylvania, Nevada and Arizona. The aggregate net purchase price of these properties was allocated to property and equipment on our consolidated balance sheet.

2013 Divestiture of Assets and Businesses:

During 2013, we received an aggregate of $37 million in connection with the divestiture of Peak Behavioral Health Services (sold during the second quarter of 2013) and certain other assets and real property including three previously closed behavioral health care facilities. As discussed below in Discontinued Operations, we agreed to sell Peak Behavioral Health Services as part of our agreement with the Federal Trade Commission in connection with our acquisition of Ascend Health Corporation (“Ascend”) in October of 2012. The aggregate pre-tax gain on these divestitures was approximately $3 million and in included in our 2013 consolidated results of operations.

Year ended December 31, 2012:

2012 Acquisitions of Assets and Businesses:

During 2012, we spent $528 million to acquire the following assets and businesses:

•

spent $503 million to acquire nine behavioral health care facilities from Ascend in October, 2012, and;

•

spent $25 million in connection with the acquisition of physician practices and various real property.

The aggregate net purchase price of the facilities was allocated to assets and liabilities based on their estimated fair values as follows:


	Amount (000s)
Working capital, net	$	21,000
Property & equipment		60,000
Goodwill		446,000
Other assets		9,000
Income tax assets, net of deferred tax liabilities		(1,000	)
Other liabilities		(7,000	)

Cash paid in 2012 for acquisitions	$	528,000

During the period of October 10, 2012 through December 31, 2012, the facilities acquired from Ascend generated $42 million of net revenues which are included in our consolidated net revenues for the year ended December 31, 2012. The aggregate effect of the earnings generated by these facilities since the date of acquisition, less the cost on the borrowings utilized to finance the acquisition, and less the above-mentioned transaction costs, was not material to our 2012 net income attributable to UHS and net income attributable to UHS per diluted share. Assuming the acquisition of Ascend occurred on January 1, 2012, our 2012 unaudited pro forma net revenues would have been approximately $7.11 billion and our unaudited pro forma net income attributable to UHS and unaudited pro forma net income attributable to UHS per diluted share would have been $464 million and $4.74 per diluted share, respectively.

2012 Divestiture of Assets and Businesses:

During 2012, we received $149 million from the divestiture of assets and businesses, including the following:

•

received $93 million for the sale of Auburn Regional Medical Center (“Auburn”), a 159-bed acute care hospital located in Auburn, Washington (sold in October of 2012);

•

received $50 million for the sale of the Hospital San Juan Capestrano, a 108-bed acute care hospital located in Rio Piedras, Puerto Rico (sold in January of 2012 pursuant to our below-mentioned agreement with the FTC in connection with our acquisition of PSI in November, 2010), and;

•

received an aggregate of $6 million for the sale of the real property of two non-operating behavioral health facilities and our majority ownership interest in an outpatient surgery center located in Puerto Rico.

Included in our 2012 consolidated results of operations was a $26 million pre-tax gain on the divestiture of Auburn. The divestiture of San Juan Capestrano (in January, 2012) did not have a material impact on our consolidated results of operations.

Discontinued Operations

There were no material divestitures during 2014.

In connection with the receipt of antitrust clearance from the Federal Trade Commission (“FTC”) in connection with our acquisition of Ascend Health Corporation in October of 2012, we agreed to certain conditions, including the divestiture of Peak Behavioral Health Services (“Peak”), a 104-bed behavioral health care facility located in Santa Teresa, New Mexico. The divestiture of Peak was completed during the second quarter of 2013 for total cash proceeds of approximately $24 million resulting in a pre-tax gain of approximately $3 million which is included in our 2013 consolidated financial statements.

In October of 2012, we completed the divestiture of Auburn Regional Medical Center (“Auburn”), a 159-bed acute care hospital located in Auburn, Washington, for total cash proceeds of approximately $93 million. This divestiture resulted in a pre-tax gain of $26 million which was included in our 2012 consolidated financial statements.

In connection with the receipt of antitrust clearance from the FTC in connection with our acquisition of PSI in November, 2010, we agreed to divest three former PSI facilities (which were divested during 2011) as well as one of our legacy behavioral health facilities in Puerto Rico, which we divested in 2012.

The following table shows the results of operations for Auburn and Peak, on a combined basis, which were reflected as discontinued operations during our period of ownership for each of the years presented herein (amounts in thousands). Since the aggregate income from discontinued operations before income tax expense for these facilities is not material to our consolidated financial statements, it is included as a reduction to other operating expenses.


	2013			2012
Net revenues	$	7,813		$	95,226
Income (loss) from discontinued operations, before income taxes		932			(3,472	)
Gain on divestiture		3,080			26,419

Income from discontinued operations, before income tax expense		4,012			22,947
Income tax expense		(1,506	)		(8,688	)

Income from discontinued operations, net of income taxes	$	2,506		$	14,259

Financial Instruments

12 Months Ended

Dec. 31, 2014

Financial Instruments

3) FINANCIAL INSTRUMENTS

Fair Value Hedges:

During 2014, 2013 and 2012, we had no fair value hedges outstanding.

Cash Flow Hedges:

We manage our ratio of fixed and floating rate debt with the objective of achieving a mix that management believes is appropriate. To manage this risk in a cost-effective manner, we, from time to time, enter into interest rate swap agreements in which we agree to exchange various combinations of fixed and/or variable interest rates based on agreed upon notional amounts. We account for our derivative and hedging activities using the Financial Accounting Standard Board’s (“FASB”) guidance which requires all derivative instruments, including certain derivative instruments embedded in other contracts, to be carried at fair value on the balance sheet. For derivative transactions designated as hedges, we formally document all relationships between the hedging instrument and the related hedged item, as well as its risk-management objective and strategy for undertaking each hedge transaction.

Derivative instruments designated in a hedge relationship to mitigate exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Cash flow hedges are accounted for by recording the fair value of the derivative instrument on the balance sheet as either an asset or liability, with a corresponding amount recorded in accumulated other comprehensive income (“AOCI”) within shareholders’ equity. Amounts are reclassified from AOCI to the income statement in the period or periods the hedged transaction affects earnings. We use interest rate derivatives in our cash flow hedge transactions. Such derivatives are designed to be highly effective in offsetting changes in the cash flows related to the hedged liability. For derivative instruments designated as cash flow hedges, the ineffective portion of the change in expected cash flows of the hedged item are recognized currently in the income statement.

The fair value of interest rate swap agreements approximates the amount at which they could be settled, based on estimates obtained from the counterparties. We assess the effectiveness of our hedge instruments on a quarterly basis. We performed periodic assessments of the cash flow hedge instruments during 2014 and 2013 and determined the hedges to be highly effective. We also determined that any portion of the hedges deemed to be ineffective was de minimis and therefore there was no material effect on our consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose us to credit risk in the event of nonperformance. However, at December 31, 2014 and 2013, each swap agreement entered into by us was in a liability position which would require us to make the settlement payments to the counterparties. We do not anticipate nonperformance by our counterparties. We do not hold or issue derivative financial instruments for trading purposes.

During 2010, we entered into four forward starting interest rate swaps whereby we pay a fixed rate on a total notional amount of $600 million and receive three-month LIBOR. Each of the four swaps became effective in December, 2011 and will mature in May, 2015. The average fixed rate payable on these swaps is 2.38%. We also entered into six forward starting interest rate swaps in 2011 whereby we pay a fixed rate on a total notional amount of $425 million and receive three-month LIBOR. Three of these swaps with a total notional amount of $225 million became effective in March, 2011 and will mature in May, 2015. The average fixed rate payable on these swaps is 1.91%. The three remaining interest rate swaps with total notional amounts of $75 million, $25 million and $100 million became effective in December, 2011 and had corresponding fixed rates of 1.32%, 1.96% and 2.50%. The $75 million, $25 million and $100 million interest rate swaps matured in December, 2012, December, 2013 and December, 2014, respectively.

During 2011, we entered into a forward starting interest rate cap, which is now expired, on a total notional amount of $450 million from December, 2011 to December, 2012 reducing to $400 million from December, 2012 to December, 2013 whereby we paid a premium of $740,000 in exchange for the counterparty agreeing to pay the difference between 7.00% and three-month LIBOR if the three-month LIBOR rate rises above 7.00% during the term of the cap. The three-month LIBOR never reached 7.00% during the term of the cap, which expired in December, 2013, and therefore no payment was made to us.

We measure our interest rate swaps at fair value on a recurring basis. The fair value of our interest rate swaps is based primarily on quotes from banks. We consider those inputs to be “level 2” in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with derivative instruments and hedging activities. The fair value of our interest rate swaps was a liability of $6 million at December 31, 2014, all of which is included in other current liabilities. At December 31, 2013, the fair value of our interest rate swaps was a liability of $24 million, of which $19 million was included in other current liabilities and $5 million was included in other noncurrent liabilities on the accompanying balance sheet.

Long-Term Debt

12 Months Ended

Dec. 31, 2014

Long-Term Debt

4) LONG-TERM DEBT

A summary of long-term debt follows:


	December 31,
	2014			2013
	(amounts in thousands)
Long-term debt:
Notes payable and Mortgages payable (including obligations under capitalized leases of $21,600 in 2014 and $6,633 in 2013) and term loans with varying maturities through 2037; weighted average interest rates of 6.4% in 2014 and 5.9% in 2013 and 2012 (see Note 7 regarding capitalized leases)	$	41,257		$	37,553
Revolving credit and on-demand credit facility		140,500			25,500
Term Loan A, net of unamortized discount of $2,035 in 2014 and $3,340 in 2013		1,761,872			935,308
Term Loan B, net of unamortized discount of $6,473 in 2013		0			543,527
Term Loan A2		0			871,875
Revenue bonds, interest at floating rates of 0.05% at December 31, 2014 and 0.10% at December 31, 2013, with varying maturities through 2015		5,300			5,300
Accounts receivable securitization program		330,000			240,000
3.75% Senior Secured Notes due 2019, net of unamortized discount of $198 in 2014		299,802			0
4.75% Senior Secured Notes due 2022, net of unamortized discount of $204 in 2014		299,796			0
7.125% Senior Secured Notes due 2016, including unamortized net premium of $7 in 2014 and $11 in 2013		400,007			400,011
7.00% Senior Unsecured Notes due 2018		0			250,000

		3,278,534			3,309,074
Less-Amounts due within one year		(68,319	)		(99,312	)

	$	3,210,215		$	3,209,762

During the third quarter of 2014, we completed the following financing transactions:

•

On August 7, 2014, we entered into a Fourth Amendment (the “Fourth Amendment”) to our credit agreement dated as of November 15, 2010, as amended on March 15, 2011, September 21, 2012 and May 16, 2013, among UHS, as borrower, the several banks and other financial institutions from time to time parties thereto, as lenders (“Credit Agreement”). The Credit Agreement, as amended, which is scheduled to mature in August, 2019, consists of: (i) an $800 million revolving credit facility ($140 million of borrowings outstanding as of December 31, 2014), and; (ii) a $1.775 billion term loan A facility ($1.764 billion of borrowings outstanding as of December 31, 2014) which combined our previously outstanding term loan A and term loan A2 facilities which were scheduled to mature in 2016;

•

Repaid $550 million of outstanding borrowings pursuant to our previously outstanding term loan B facility which was scheduled to mature in 2016;

•

Increased the borrowing capacity on our existing accounts receivable securitization program (“Securitization”) to $360 million from $275 million, effective August 1, 2014. The Securitization, the terms of which remain the same as the previous agreement, as discussed below, is scheduled to mature in October, 2016;

•

Issued $300 million aggregate principal amount of 3.750% senior secured notes due in 2019 (see below for additional disclosure);

•

Issued $300 million aggregate principal amount of 4.750% senior secured notes due in 2022 (see below for additional disclosure);

•

Redeemed our previously outstanding $250 million, 7.00% senior unsecured notes due in 2018 on July 31, 2014 for an aggregate price equal to 104.56% of the principal amount.

In connection with these transactions, our 2014 results of operations included a $36 million pre-tax charge incurred for the costs related to the extinguishment of debt. This charge consisted of the write-off of deferred charges ($20 million) and original issue discount on the extinguished debt ($5 million) as well as the make-whole premium paid ($11 million) on the early redemption of the $250 million, 7.00% senior unsecured notes.

Borrowings under the Credit Agreement bear interest at either (1) the ABR rate which is defined as the rate per annum equal to, at our election: the greatest of (a) the lender’s prime rate, (b) the weighted average of the federal funds rate, plus 0.5% and (c) one month LIBOR rate plus 1%, in each case, plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 0.50% to 1.25% for revolving credit and term loan-A borrowings, or (2) the one, two, three or six month LIBOR rate (at our election), plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 1.50% to 2.25% for revolving credit and term loan-A borrowings. As of December 31, 2014, the applicable margins were 0.50% for ABR-based loans, 1.50% for LIBOR-based loans under the revolving credit and term loan-A facilities.

As of December 31, 2014, we had $140 million of outstanding borrowings pursuant to the terms of our $800 million revolving credit facility and we had $640 million of available borrowing capacity, net of $500,000 of outstanding borrowings pursuant to a short-term, on-demand credit facility and $20 million of outstanding letters of credit. The revolving credit facility includes a $125 million sub-limit for letters of credit. The Credit Agreement is secured by certain assets of the Company and our material subsidiaries and guaranteed by our material subsidiaries.

Pursuant to the terms of the Fourth Amendment to our Credit Agreement, term loan-A quarterly installment payments of approximately: (i) $11 million commenced during the fourth quarter of 2014 and are scheduled to continue through September, 2016, and; (ii) $22 million are scheduled from the fourth quarter of 2016 through June, 2019. Prior to commencement of the Fourth Amendment, we made scheduled principal payments of $36 million on the term loan-A and term loan A2 facilities during 2014 and $72 million during 2013.

As discussed above, on August 1, 2014, our accounts receivable securitization program (“Securitization”), with a group of conduit lenders and liquidity banks which is scheduled to mature in October, 2016, was amended to increase the borrowing capacity to $360 million from $275 million. Substantially all of the patient-related accounts receivable of our acute care hospitals (“Receivables”) serve as collateral for the outstanding borrowings. We have accounted for this Securitization as borrowings. We maintain effective control over the Receivables since, pursuant to the terms of the Securitization, the Receivables are sold from certain of our subsidiaries to special purpose entities that are wholly-owned by us. The Receivables, however, are owned by the special purpose entities, can be used only to satisfy the debts of the wholly-owned special purpose entities, and thus are not available to us except through our ownership interest in the special purpose entities. The wholly-owned special purpose entities use the Receivables to collateralize the loans obtained from the group of third-party conduit lenders and liquidity banks. The group of third-party conduit lenders and liquidity banks do not have recourse to us beyond the assets of the wholly-owned special purpose entities that securitize the loans. At December 31, 2014, we had $330 million of outstanding borrowings and $30 million of additional capacity pursuant to the terms of our accounts receivable securitization program.

On August 7, 2014, we issued $300 million aggregate principal amount of 3.750% Senior Secured Notes due 2019 (the “2019 Notes”) and $300 million aggregate principal amount of 4.750% Senior Secured Notes due 2022 (the “2022 Notes”, and together with the 2019 Notes, the “New Senior Secured Notes”). The New Senior Secured Notes were offered only to qualified institutional buyers under Rule 144A and to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act of 1933, as amended (the “Securities Act”). The New Senior Secured Notes have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. Interest is payable on the New Senior Secured Notes on February 1 and August 1 of each year to the holders of record at the close of business on the January 15 and July 15 immediately preceding the related interest payment dates, commencing on February 1, 2015 until the maturity date of August 1, 2019 for the 2019 Notes and August 1, 2022 for the 2022 Notes.

On June 30, 2006, we issued $250 million of senior secured notes which have a 7.125% coupon rate and mature on June 30, 2016 (the “7.125% Notes”). Interest on the 7.125% Notes is payable semiannually in arrears on June 30th and December 30th of each year. In June, 2008, we issued an additional $150 million of 7.125% Notes which formed a single series with the original 7.125% Notes issued in June, 2006. Other than their date of issuance and initial price to the public, the terms of the 7.125% Notes issued in June, 2008 are identical to and trade interchangeably with, the 7.125% Notes which were originally issued in June, 2006.

On July 31, 2014, we redeemed the $250 million, 7.00% senior unsecured notes (the “Unsecured Notes”), which were scheduled to mature on October 1, 2018, at a redemption price equal to 104.56% of the principal amount of the Unsecured Notes resulting in a make-whole premium payment of approximately $11 million. The Unsecured Notes were issued on September 29, 2010 and registered in April, 2011. Interest on the Unsecured Note was payable semiannually in arrears on April 1st and October 1st of each year.

In connection with entering into the previous Credit Agreement on November 15, 2010, and in accordance with the Indenture dated January 20, 2000 governing the rights of our existing notes, we entered into a supplemental indenture pursuant to which our 7.125% Notes (due in 2016) were equally and ratably secured with the lenders under the Credit Agreement with respect to the collateral for so long as the lenders under the Credit Agreement are so secured.

The average amounts outstanding during each of years 2014, 2013 and 2012 under the current and prior Credit Agreements, demand notes and accounts receivable securitization programs was $2.4 billion, $2.9 billion and $2.9 billion, respectively, with corresponding interest rates of 1.8%, 2.2% and 2.9%, respectively, including commitment and facility fees. The maximum amounts outstanding at any month-end were $2.65 billion in 2014, $3.00 billion in 2013 and $3.06 billion in 2012. The effective interest rate on our current and prior Credit Agreements, accounts receivable securitization programs, and demand notes, which includes the respective interest expense, commitment and facility fees, designated interest rate swaps expense and amortization of deferred financing costs and original issue discounts, was 3.2% in 2014, 3.6% in 2013 and 4.5% in 2012.

Our Credit Agreement includes a material adverse change clause that must be represented at each draw. The Credit Agreement contains covenants that include a limitation on sales of assets, mergers, change of ownership, liens and indebtedness, transactions with affiliates, dividends and stock repurchases; and requires compliance with financial covenants including maximum leverage and minimum interest coverage ratios. We are in compliance with all required covenants as of December 31, 2014.

The carrying value of our debt at December 31, 2014 and 2013 was $3.3 billion. The fair values of our debt at December 31, 2014 and 2013 were $3.3 billion and $3.4 billion, respectively. The fair value of our debt was computed based upon quotes received from financial institutions. We consider these to be “level 2” in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with debt instruments.

Aggregate maturities follow:


	(000s)
2015	$	68,319
2016		787,437
2017		90,675
2018		90,882
2019		1,925,923
Later		315,298

Total	$	3,278,534

Common Stock

12 Months Ended

Dec. 31, 2014

Common Stock

5) COMMON STOCK

Dividends

Cash dividends of $0.30 per share ($29.7 million in the aggregate) were declared and paid during 2014, $.20 per share ($19.6 million in the aggregate) were declared and paid during 2013 and $.60 per share ($58.4 million in the aggregate), including a $.40 per share special cash dividend ($38.9 million) were declared and paid during 2012. All classes of our common stock have similar economic rights.

Stock Repurchase Programs

In various prior years, our Board of Directors approved stock repurchase programs authorizing us to purchase shares of our outstanding Class B Common Stock on the open market at prevailing market prices or in negotiated transactions off the market. In conjunction with the new stock repurchase program discussed below, remaining shares available for repurchase pursuant to prior authorizations were cancelled.

In July, 2014, our Board of Directors authorized a new stock repurchase program whereby, from time to time as conditions allow, we may spend up to $400 million to purchase shares of our Class B Common Stock on the open market or in negotiated private transactions. There is no expiration date for our stock repurchase program. Upon approval of the new stock purchase program, our previously announced stock repurchase program was cancelled. The following schedule provides information related to our stock repurchase program for each of the three years ended December 31, 2014. All of the shares repurchased during 2013 and 2012 related to income tax withholding obligations resulting from the exercise of stock options and the vesting of restricted stock grants. No shares were repurchased during 2013 or 2012 pursuant to our publicly announced stock repurchase program. During 2014, 548,192 shares ($58.0 million in the aggregate) were repurchased pursuant to the terms of our recently authorized stock repurchase program and 480,972 shares ($42.7 million in the aggregate) were repurchased in connection with income tax withholding obligations resulting from the exercise of stock options and the vesting of restricted stock grants.


	Additional dollars authorized for repurchase (in thousands)		Total number of shares purchased		Total number of shares cancelled		Average price paid per share for forfeited restricted shares	Total number of shares purchased as part of publicly announced programs		Average price pad per share for shares purchased as part of publicly announced program		Aggregate purchase price paid (in thousands)		Aggregate purchase price paid for shares purchased as part of publicly announced program		Maximum number of shares that may yet be purchased under the program		Maximum number of dollars that may yet be purchased under the program (in thousands)
Balance as of January 1, 2012																	767,704		N/A
2012		—		433,312		—	N/A		—		N/A	$	19,154		N/A		767,704		N/A
2013		—		427,170		—	N/A		—		N/A	$	27,201		N/A		767,704		N/A
2014	$	400,000		1,029,164		767,704	N/A		548,192	$	105.71	$	100,749	$	57,950		N/A	$	342,050

Total for three year period ended December 31, 2014	$	400,000		1,889,646		767,704	N/A		548,192	$	105.71	$	147,104	$	57,950

Stock-based Compensation Plans

At December 31, 2014, we have a number of stock-based employee compensation plans. Pursuant to the FASB’s guidance, we expense the grant-date fair value of stock options and other equity-based compensation pursuant to the straight-line method over the stated vesting period of the award using the Black-Scholes option-pricing model.

Pre-tax compensation costs of $29.2 million during 2014, $25.8 million during 2013, and $20.1 million during 2012 were recognized related to outstanding stock options. In addition, pre-tax compensation costs of $1.9 million during 2014, $2.0 million during 2013 and $2.4 million during 2012 were recognized related to amortization of restricted stock and discounts provided in connection with shares purchased pursuant to our 2005 Employee Stock Purchase Plan.

The expense associated with stock-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, stock-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities and aggregated to $31.1 million in 2014, $27.8 million in 2013 and $22.5 million in 2012. In accordance with ASC 718, excess income tax benefits related to stock-based compensation are classified as cash inflows from financing activities on the Consolidated Statement of Cash Flows. During 2014, 2013 and 2012 we generated $33.9 million, $20.1 million and $16.0 million, respectively, of excess income tax benefits related to stock based compensation which are reflected as cash inflows from financing activities in our Consolidated Statements of Cash Flows, as included herein.

We adopted the 2005 Stock Incentive Plan, as amended in 2008 and 2010, (the “Stock Incentive Plan”) which replaced our Amended and Restated 1992 Stock Option Plan which expired in July of 2005. An aggregate of 23 million shares of Class B Common Stock has been reserved under the Stock Incentive Plan. During 2014, 2013 and 2012, stock options, net of cancellations, of approximately 2.8 million, 2.6 million and 2.6 million, respectively, were granted. The per option weighted-average grant-date fair value of options granted during 2014, 2013 and 2012 was $17.23, $13.33 and $10.73, respectively. Stock options to purchase Class B Common Stock have been granted to our officers, key employees and members of our Board of Directors. All stock options were granted with an exercise price equal to the fair market value on the date of the grant. Options are exercisable ratably over a four-year period beginning one year after the date of the grant. All outstanding options expire five years after the date of the grant. As of December 31, 2014, approximately 3.1 million shares of Class B Common Stock remain available for issuance pursuant to the Stock Incentive Plan.

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model. The following weighted average assumptions were derived from averaging the number of options granted during the most recent five-year period. The weighted-average assumptions reflected below were based upon twenty-one options grants for the five-year period ending December 31, 2014 and eighteen option grants for each of the five-year periods ended December 31, 2013 and 2012.


Year Ended December 31,	2014			2013			2012
Volatility		35	%		36	%		33	%
Interest rate		1	%		1	%		1	%
Expected life (years)		3.4			3.6			3.5
Forfeiture rate		10	%		11	%		10	%
Dividend yield		0.4	%		0.5	%		0.6	%

The risk-free rate is based on the U.S. Treasury zero coupon four year yield in effect at the time of grant. The expected life of the stock options granted was estimated using the historical behavior of employees. Expected volatility was based on historical volatility for a period equal to the stock option’s expected life. Expected dividend yield is based on our dividend yield at the time of grant.

The table below summarizes our stock option activity during each of the last three years:


Outstanding Options	Number of Shares			Average Option Price		Range (High-Low)
Balance, January 1, 2012		7,558,945		$	31.63	$	54.79-$16.22
Granted		2,966,850		$	37.01	$	44.83-$36.95
Exercised		(2,608,007	)	$	23.22	$	46.97-$16.22
Cancelled		(481,550	)	$	38.00	$	46.97-$16.22

Balance, January 1, 2013		7,436,238		$	36.31	$	54.79-$16.22
Granted		2,889,750		$	53.51	$	79.79-$53.38
Exercised		(2,288,666	)	$	32.27	$	54.79-$16.22
Cancelled		(416,364	)	$	43.93	$	53.38-$16.22

Balance, January 1, 2014		7,620,958		$	43.63	$	79.79-$30.32
Granted		2,845,500		$	78.65	$	102.21-$78.17
Exercised		(2,277,469	)	$	38.50	$	73.65-$30.32
Cancelled		(291,538	)	$	55.63	$	78.17-$36.95

Balance, December 31, 2014		7,897,451		$	57.29	$	102.21-$36.95

Outstanding options vested and exercisable as of December 31, 2014		1,412,422		$	43.59	$	79.79-$36.97

The following table provides information about unvested options for the year December 31, 2014:


	Shares			Weighted Average Grant Date Fair Value
Unvested options as of January 1, 2014		5,864,830		$	12.12
Granted		2,845,500		$	17.23
Vested		(1,937,013	)	$	11.90
Cancelled		(288,288	)	$	13.64

Unvested options as of December 31, 2014		6,485,029		$	14.36

The following table provides information regarding all options outstanding at December 31, 2014:


	Options Outstanding		Options Exercisable
Number of options outstanding		7,897,451		1,412,422
Weighted average exercise price	$	57.29	$	43.59
Aggregate intrinsic value as of December 31, 2014	$	426,248,728	$	95,577,868
Weighted average remaining contractual life		2.9		1.8

The total in-the-money value of all stock options exercised during the years ended December 31, 2014, 2013 and 2012 were $112.5 million, $70.9 million and $54.4 million, respectively.

The weighted average remaining contractual life for options outstanding and weighted average exercise price per share for exercisable options at December 31, 2014 were as follows:


Exercise Price	Options Outstanding		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in Years)		Exercisable Options		Weighted Average Exercise Price Per Share		Expected to Vest Options (a)		Weighted Average Exercise Price Per Share
Exercise Price	Shares		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in Years)		Shares		Weighted Average Exercise Price Per Share		Shares		Weighted Average Exercise Price Per Share
$36.95 – $43.46		1,690,463	$	37.00		2.0		465,688	$	37.02		1,100,460	$	36.99
$43.67 – $46.97		1,201,213		43.68		1.0		647,025		43.67		497,938		43.68
$53.38 – $73.65		2,241,625		53.52		3.0		299,209		53.58		1,745,261		53.51
$78.17 – $102.21		2,764,150		78.66		4.2		500		79.79		2,483,140		78.66

Total		7,897,451	$	57.29		2.9		1,412,422	$	43.59		5,826,799	$	60.27

(a)	Assumes a weighted average forfeiture rate of 10.2%.

In addition to the Stock Incentive Plan, we have the following stock incentive and purchase plans: (i) the 2010 Employees’ Restricted Stock Purchase Plan (“2010 Plan”) which allows eligible participants to purchase shares of Class B Common Stock at par value, subject to certain restrictions, and; (ii) a 2005 Employee Stock Purchase Plan which allows eligible employees to purchase shares of Class B Common Stock at a ten percent discount. There were 26,189, 10,000 and 54,127 shares of restricted stock granted pursuant to the 2010 Plan during 2014, 2013 and 2012, respectively, with various ratable vesting periods ranging up to four years from the date of grant. There were 75,303, 90,587 and 117,901 shares issued pursuant to the Employee Stock Purchase Plan during 2014, 2013 and 2012, respectively.

We have reserved 6.0 million shares of Class B Common Stock for issuance under these various plans (excluding terminated plans) and have issued approximately 1.1 million shares, net of cancellations, pursuant to the terms of these plans (excluding terminated plans) as of December 31, 2014. As of December 31, 2014, approximately 4.9 million shares of Class B Common Stock remain available for issuance pursuant to these various plans.

At December 31, 2014, 23,297,420 shares of Class B Common Stock were reserved for issuance upon conversion of shares of Class A, C and D Common Stock outstanding, for issuance upon exercise of options to purchase Class B Common Stock and for issuance of stock under other incentive plans. Class A, C and D Common Stock are convertible on a share for share basis into Class B Common Stock.

Income Taxes

12 Months Ended

Dec. 31, 2014

Income Taxes

6) INCOME TAXES

Components of income tax expense/(benefit) are as follows (amounts in thousands):


	Year Ended December 31,
	2014		2013		2012
Current
Federal	$	248,172	$	256,545	$	254,021
Foreign		4,167		1,655		9,084
State		23,224		28,490		39,076

		275,563		286,690		302,181
Deferred
Federal and foreign		41,583		25,341		(21,408	)
State		7,525		3,278		(6,157	)

		49,108		28,619		(27,565	)

Total	$	324,671	$	315,309	$	274,616

Deferred taxes are required to be classified based on the financial statement classification of the related assets and liabilities which give rise to temporary differences. Deferred taxes result from temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities. The components of deferred taxes are as follows (amounts in thousands):


	Year Ended December 31,
	2014			2013
Deferred income tax assets:
Self-insurance reserves	$	84,915		$	87,483
Compensation accruals		55,788			49,302
State and foreign net operating loss carryforwards and other state and foreign deferred tax assets		60,521			57,204
Other currently non-deductible accrued liabilities		16,739			24,587
Net pension liability—OCI only		11,746			6,390
Doubtful accounts and other reserves		18,428			33,905
Other combined items—OCI only		2,615			9,018

		250,752			267,889
Less: Valuation Allowance		(52,764	)		(46,841	)

Net deferred income tax assets:		197,988			221,048
Deferred income tax liabilities:
Depreciable and amortizable assets		(362,674	)		(337,669	)
Other deferred tax liabilities		(2,963	)		(2,624	)

Net deferred income tax liabilities	$	(167,649	)	$	(119,245	)

There was no material impact of deferred taxes recorded in conjunction with the acquisition of Prominence Health Plan, the Psychiatric Institute of Washington and Cygnet Health Care.

The effective tax rates, as calculated by dividing the provision for income taxes by income before income taxes, were as follows for each of the years ended December 31, 2014, 2013 and 2012 (dollar amounts in thousands):


	2014			2013			2012
Provision for income taxes	$	324,671		$	315,309		$	274,616
Income before income taxes		929,667			869,332			763,663

Effective tax rate		34.9	%		36.3	%		36.0	%

Impacting the effective tax rates during 2014, 2013 and 2012 were favorable discrete tax items of approximately $1 million recorded during each year to adjust the estimated liabilities for uncertain tax positions.

The foreign provision for income taxes is based on foreign pre-tax earnings of $15 million, $6 million, and $38 million in 2014, 2013, and 2012, respectively. The Company’s consolidated financial statements provide for any related tax liability on undistributed earnings that the Company does not intend to be indefinitely reinvested outside the U.S. Certain of the Company’s undistributed international earnings intended to be indefinitely reinvested in operations outside the U.S. have a statutory rate of 21%. As of December 31, 2014, U.S. income taxes have not been provided on a cumulative total of $10 million of such earnings. The amount of unrecognizable deferred tax liability related to these temporary differences is estimated to be approximately $4 million.

A reconciliation between the federal statutory rate and the effective tax rate is as follows:


	Year Ended December 31,
	2014			2013			2012
Federal statutory rate		35.0	%		35.0	%		35.0	%
State taxes, net of federal income tax benefit		2.3			2.5			3.0
Nondeductible transaction costs		—			—			0.2
Divestiture gain		—			0.3			—
Other items		—			0.4			0.1
Impact of income attributable to noncontrolling interests		(2.4	)		(1.9	)		(2.3	)

Effective tax rate		34.9	%		36.3	%		36.0	%

Included in “Other current assets” on our Consolidated Balance Sheet are prepaid federal, foreign, and state income taxes amounting to approximately $17 million and $5 million as of December 31, 2014 and 2013, respectively.

The net deferred tax assets and liabilities are comprised as follows (amounts in thousands):


	Year Ended December 31,
	2014			2013
Current deferred taxes
Assets	$	115,870		$	121,097
Liabilities		(1,305	)		(1,194	)

Total deferred taxes-current		114,565			119,903

Noncurrent deferred taxes
Assets		85,792			103,221
Liabilities		(368,006	)		(342,369	)

Total deferred taxes-noncurrent		(282,214	)		(239,148	)

Total deferred tax liabilities	$	(167,649	)	$	(119,245	)

The assets and liabilities classified as current relate primarily to the allowance for uncollectible patient accounts, compensation-related accruals and the current portion of the temporary differences related to self- insurance reserves. At December 31, 2014, state net operating loss carryforwards (expiring in years 2015 through 2034), and credit carryforwards available to offset future taxable income approximated $1.11 billion representing approximately $54 million in deferred state tax benefit (net of the federal benefit). At December 31, 2014, there were foreign net operating loss carryforwards of approximately $7 million expiring through 2022 representing approximately $3 million in deferred foreign tax benefit.

A valuation allowance is required when it is more likely than not that some portion of the deferred tax assets will not be realized. Based on available evidence, it is more likely than not that certain of our state tax benefits will not be realized. Therefore, valuation allowances of approximately $50 million and $44 million have been reflected as of December 31, 2014 and 2013, respectively. During 2014, the valuation allowance on these state tax benefits increased by approximately $6 million due to additional net operating losses incurred. In addition, valuation allowances of approximately $3 million have been reflected as of December 31, 2014 and 2013 related to foreign net operating losses. There were no significant increases in valuation allowances as a result of the acquisition of Prominence Health Plan, the Psychiatric Institute of Washington and Cygnet Health Care.

We adopted the provisions of Accounting for Uncertainty in Income Taxes effective January 1, 2007. During 2014 and 2013, the estimated liabilities for uncertain tax positions (including accrued interest and penalties) were increased less than $1 million due to tax positions taken in the current and prior years. During 2014, the estimated liabilities for uncertain tax positions (including accrued interest and penalties) were reduced due to the lapse of the statute of limitations resulting in a net income tax benefit of approximately $1 million. The balance at each of December 31, 2014 and 2013, if subsequently recognized, that would favorably affect the effective tax rate and the provision for income taxes is approximately $2 million for each date.

We recognize accrued interest and penalties associated with uncertain tax positions as part of the tax provision. As of December 31, 2014 and 2013, we have accrued interest and penalties of less than $1 million as of each date. The U.S. federal statute of limitations remains open for the 2011 and subsequent years. Foreign and U.S. state and local jurisdictions have statutes of limitations generally ranging for 3 to 4 years. The statute of limitations on certain jurisdictions could expire within the next twelve months. It is reasonably possible that the amount of unrecognized tax benefits will change during the next 12 months, however, it is anticipated that any such change, if it were to occur, would not have a material impact on our results of operations.

The tabular reconciliation of unrecognized tax benefits for the years ended December 31, 2014, 2013 and 2012 is as follows (amounts in thousands).


	As of December 31,
	2014			2013			2012
Balance at January 1,	$	3,369		$	6,824		$	7,403
Additions based on tax positions related to the current year		50			50			200
Additions for tax positions of prior years		195			283			386
Reductions for tax positions of prior years		(1,212	)		(1,260	)		(1,165	)
Settlements		—			(2,528	)		—

Balance at December 31,	$	2,402		$	3,369		$	6,824

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References+ Details

Lease Commitments

12 Months Ended

Dec. 31, 2014

Lease Commitments

7) LEASE COMMITMENTS

Three of our hospital facilities are held under operating leases with Universal Health Realty Income Trust with terms expiring in 2016 (see Note 9 for additional disclosure). We also lease the real property of certain facilities (see Item 2. Properties for additional disclosure).

A summary of property under capital lease follows (amounts in thousands):


	As of December 31,
	2014			2013
Land, buildings and equipment	$	40,782		$	27,636
Less: accumulated amortization		(27,556	)		(27,382	)

	$	13,226		$	254

Future minimum rental payments under lease commitments with a term of more than one year as of December 31, 2014, are as follows (amounts in thousands):


Year	Capital Leases			Operating Leases
	(000s)
2015	$	3,293		$	58,904
2016		3,261			49,043
2017		3,308			31,619
2018		3,322			25,940
2019		3,370			22,229
Later years		22,356			147,288

Total minimum rental	$	38,910		$	335,023

Less: Amount representing interest		(17,310	)

Present value of minimum rental commitments		21,600
Less: Current portion of capital lease obligations		(1,080	)

Long-term portion of capital lease obligations	$	20,520

During 2014, we assumed a capital lease obligation of approximately $16 million in connection with our acquisition of the Psychiatric Institute of Washington, a 124-bed behavioral health care facility located in Washington, D.C. We incurred no additional capital lease obligations during 2013 or 2012. In the ordinary course of business, our facilities routinely lease equipment pursuant to new lease arrangements that will likely result in future lease and rental expense in excess of amounts indicated above.

- Definition

The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.

+ References+ Details

Commitments and Contingencies

12 Months Ended

Dec. 31, 2014

Commitments and Contingencies

8) COMMITMENTS AND CONTINGENCIES

Professional and General Liability, Workers’ Compensation Liability and Property Insurance

Professional and General Liability and Workers Compensation Liability:

Effective November, 2010, excluding certain subsidiaries acquired since 2010 as discussed below, the vast majority of our subsidiaries are self-insured for professional and general liability exposure up to $10 million and $3 million per occurrence, respectively. Our subsidiaries were provided with several excess policies through commercial insurance carriers which provide for coverage in excess of the applicable per occurrence self-insured retention (either $3 million or $10 million) up to $250 million per occurrence and in the aggregate for claims incurred in 2014 and up to $200 million per occurrence and in the aggregate for claims incurred from 2011 through 2013. We remain liable for 10% of the claims paid pursuant to the commercially insured coverage in excess of $10 million up to $60 million per occurrence and in the aggregate.

Since our acquisition of Psychiatric Solutions, Inc. (“PSI”) in November, 2010, the former PSI subsidiaries are self-insured for professional and general liability exposure up to $3 million per occurrence. The nine behavioral health facilities acquired from Ascend Health Corporation (“Ascend”) in October, 2012 have general and professional liability policies through commercial insurance carriers which provide for up to $12 million of aggregate coverage, subject to a $100,000 per occurrence deductible. The 18 facilities acquired from Cygnet Health Care Limited (“Cygnet”), consisting of 16 inpatient behavioral health hospitals and 2 nursing homes, have policies through a commercial insurance carrier located in the United Kingdom that provides for £10 million of professional liability coverage and £25 million of general liability coverage. The facilities acquired from PSI, Ascend and Cygnet, like our other facilities, are also provided excess coverage through commercial insurance carriers for coverage in excess of the underlying commercial policy limitations, as mentioned above.

Our estimated liability for self-insured professional and general liability claims is based on a number of factors including, among other things, the number of asserted claims and reported incidents, estimates of losses for these claims based on recent and historical settlement amounts, estimates of incurred but not reported claims based on historical experience, and estimates of amounts recoverable under our commercial insurance policies. While we continuously monitor these factors, our ultimate liability for professional and general liability claims could change materially from our current estimates due to inherent uncertainties involved in making this estimate. Given our significant self-insured exposure for professional and general liability claims, there can be no assurance that a sharp increase in the number and/or severity of claims asserted against us will not have a material adverse effect on our future results of operations.

As of December 31, 2014, the total accrual for our professional and general liability claims was $193 million, of which $51 million is included in current liabilities. As of December 31, 2013, the total accrual for our professional and general liability claims was $206 million, of which $44 million is included in current liabilities.

We recorded reductions to our professional and general liability self-insurance reserves (relating to prior years) amounting to $20 million during 2014, $81 million during 2013 and $27 million during 2012. The favorable change recorded during 2014 and 2012 resulted from favorable changes in our estimated future claims payments pursuant to a reserve analysis. The favorable change in our estimated future claims payments recorded during 2013, relating to years prior to 2013, were due primarily to: (i) an increased weighting given to company-specific metrics (to 100% from 75%), and decreased general industry metrics (to 0% from 25%), related to projected incidents per exposure, historical claims experience and loss development factors; (ii) historical data which measured the realized favorable impact of medical malpractice tort reform experienced in several states in which we operate, and; (iii) a decrease in claims related to certain higher risk specialties (such as obstetrical) due to a continuation of the company-wide patient safety initiative undertaken during the last several years. As the number of our facilities and our patient volumes have increased, thereby providing for a statistically significant data group, and taking into consideration our long-history of company-specific risk management programs and claims experience, our reserve analyses have included a greater emphasis on our historical professional and general liability experience which has developed favorably as compared to general industry trends.

As of December 31, 2014, the total accrual for our workers’ compensation liability claims was $67 million, of which $32 million is included in current liabilities. As of December 31, 2013, the total accrual for our workers’ compensation liability claims was $64 million, of which $34 million is included in current liabilities. The adjustments recorded during the last three years to our prior year reserves for workers’ compensation claims did not have a material impact on our consolidated results of operations for the years ended December 31, 2014, 2013 or 2012.

Property Insurance:

We have commercial property insurance policies covering catastrophic losses, including windstorm damage, up to a $1 billion policy limit per occurrence, subject to a $250,000 deductible for the majority of our properties (the properties acquired from PSI are subject to a $50,000 deductible). Losses resulting from named windstorms are subject to deductibles between 3% and 5% of the declared total insurable value of the property. In addition, we have commercial property insurance policies covering catastrophic losses resulting from earthquake and flood damage, each subject to aggregated loss limits (as opposed to per occurrence losses). Our earthquake limit is $250 million, subject to a deductible of $250,000, except for facilities located within documented fault zones. Earthquake losses that affect facilities located in fault zones within the United States are subject to a $100 million limit and will have applied deductibles ranging from 1% to 5% of the declared total insurable value of the property. The earthquake limit in Puerto Rico is $25 million, subject to a $25,000 deductible. Non-critical flood losses have either a $250,000 or $500,000 deductible, based upon the location of the facility. Since certain of our facilities have been designated by our insurer as flood prone, we have elected to purchase policies from The National Flood Insurance Program to cover a substantial portion of the applicable deductible. Property insurance for the facilities acquired from Cygnet are provided on an all risk basis up to a £180 million limit that includes coverage for real and personal property as well as business interruption losses.

Legal Proceedings

We are subject to claims and suits in the ordinary course of business, including those arising from care and treatment afforded by our hospitals and are party to litigation, as outlined below.

Office of Inspector General (“OIG”) and Other Government Investigations

In September, 2010, we, along with many other companies in the healthcare industry, received a letter from the United States Department of Justice (“DOJ”) advising of a False Claim Act investigation being conducted in connection with the implantation of implantable cardioverter defibrillators (“ICDs”) from 2003 to 2010 at several of our acute care facilities. The DOJ alleges that ICDs were implanted and billed by our facilities in contravention of a National Coverage Determination regarding these devices. We have established a reserve in connection with this matter which did not have a material impact on our consolidated financial statements.

In February, 2013, the OIG served a subpoena requesting various documents from January, 2008 to the date of the subpoena directed at Universal Health Services, Inc. (“UHS”) concerning it and UHS of Delaware, Inc., and several UHS owned behavioral health facilities including: Keys of Carolina, Old Vineyard Behavioral Health, The Meadows Psychiatric Center, Streamwood Behavioral Health, Hartgrove Hospital, Rock River Academy and Residential Treatment Center, Roxbury Treatment Center, Harbor Point Behavioral Health Center, f/k/a, The Pines Residential Treatment Center, including the Crawford, Brighton and Kempsville campuses, Wekiva Springs Center and River Point Behavioral Health. Prior to receiving this subpoena: (i) the Keys of Carolina and Old Vineyard received notification during the second half of 2012 from the United States Department of Justice of its intent to proceed with an investigation following requests for documents for the period of January, 2007 to the date of the subpoenas from the North Carolina state Attorney General’s Office; (ii) Harbor Point Behavioral Health Center received a subpoena in December, 2012 from the Attorney General of the Commonwealth of Virginia requesting various documents from July, 2006 to the date of the subpoena, and; (iii) The Meadows Psychiatric Center received a subpoena from the OIG in February, 2013 requesting certain documents from 2008 to the date of the subpoena. Unrelated to these matters, the Keys of Carolina was closed and the real property was sold in January, 2013. We were advised that a qui tam action had been filed against Roxbury Treatment Center but the government declined to intervene and the case was dismissed.

In April, 2013, the OIG served facility specific subpoenas on Wekiva Springs Center and River Point Behavioral Health requesting various documents from January, 2005 to the date of the subpoenas. In July, 2013, another subpoena was issued to Wekiva Springs Center and River Point Behavioral Health requesting additional records. In October, 2013, we were advised by the DOJ’s Criminal Frauds Section that they received a referral from the DOJ Civil Division and opened an investigation of River Point Behavioral Health and Wekiva Springs Center. Subsequent subpoenas have since been issued to River Point Behavioral Health and Wekiva Springs Center requesting additional documentation. In April, 2014, the Centers for Medicare and Medicaid Services (“CMS”) instituted a Medicare payment suspension at River Point Behavioral Health in accordance with federal regulations which implemented provisions of the Affordable Care Act regarding suspension of payments during certain investigations. The Florida Agency for Health Care Administration subsequently issued a Medicaid payment suspension for the facility. River Point Behavioral Health submitted a rebuttal statement disputing the basis of the suspension and requesting revocation of the suspension. In response, CMS has continued the payment suspension. River Point Behavioral Health has provided additional information to CMS in an effort to obtain relief from the payment suspension but the suspension remains in effect. In August 2014, we received notification from CMS that, effective September, 2014, the payment suspension was to be continued for another 180 days. We cannot predict if and/or when the facility’s suspended payments will resume. However, if continued for a significant period of time, the payment suspension will likely have a material adverse effect on River Point Behavioral Health’s future results of operations and financial condition. The operating results of River Point Behavioral Health did not have a material impact on our consolidated results of operations for the years ended December 31, 2014 or 2013.

In June, 2013, the OIG served a subpoena on Coastal Harbor Health System in Savannah, Georgia requesting documents from January, 2009 to the date of the subpoena.

In February, 2014, we were notified that the investigation conducted by the Criminal Frauds Section had been expanded to include the National Deaf Academy. In March, 2014, a Civil Investigative Demand (“CID”) was served on the National Deaf Academy requesting documents and information from the facility from January 1, 2008 through the date of the CID. We have been advised by the government that the National Deaf Academy has been added to the facilities which are the subject of the coordinated investigation referenced above.

In March, 2014, CIDs were served on Hartgrove Hospital, Rock River Academy and Streamwood Behavioral Health requesting documents and information from those facilities from January, 2008 through the date of the CID.

In September, 2014, the DOJ Civil Division advised us that they were expanding their investigation to include four additional facilities and were requesting production of documents from these facilities. These facilities are Arbour-HRI Hospital, Behavioral Hospital of Bellaire, St. Simons by the Sea, and Turning Point Care Center.

In December 2014, the DOJ Civil Division requested that Salt Lake Behavioral Health produce documents responsive to the original subpoenas issued in February, 2013.

The DOJ has advised us that the civil aspect of the coordinated investigation in connection with the behavioral health facilities named above is a False Claim Act investigation focused on billings submitted to government payers in relation to services provided at those facilities. At present, we are uncertain as to potential liability and/or financial exposure of the Company and/or named facilities, if any, in connection with these matters.

Matters Relating to Psychiatric Solutions, Inc. (“PSI”):

The following matters pertain to PSI or former PSI facilities (owned by subsidiaries of PSI) which were in existence prior to the acquisition of PSI and for which we have assumed the defense as a result of our acquisition which was completed in November, 2010:

Department of Justice Investigation of Friends Hospital:

In October, 2010, Friends Hospital in Philadelphia, Pennsylvania, received a subpoena from the DOJ requesting certain documents from the facility. The requested documents were collected and provided to the DOJ for review and examination. Another subpoena was issued to the facility in July, 2011 requesting additional documents, which have also been delivered to the DOJ. All documents requested and produced pertained to the operations of the facility while under PSI’s ownership prior to our acquisition. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

Department of Justice Investigation of Riveredge Hospital:

In 2008, Riveredge Hospital in Chicago, Illinois received a subpoena from the DOJ requesting certain information from the facility. Additional requests for documents were also received from the DOJ in 2009 and 2010. The requested documents have been provided to the DOJ. All documents requested and produced pertained to the operations of the facility while under PSI’s ownership prior to our acquisition. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

General:

The healthcare industry is subject to numerous laws and regulations which include, among other things, matters such as government healthcare participation requirements, various licensure, certifications, and accreditations, reimbursement for patient services, and Medicare and Medicaid fraud and abuse. Government action has increased with respect to investigations and/or allegations concerning possible violations of fraud and abuse and false claims statutes and/or regulations by healthcare providers. Currently, and from time to time, some of our facilities are subjected to inquiries and/or actions and receive notices of potential non-compliance of laws and regulations from various federal and state agencies. Providers that are found to have violated these laws and regulations may be excluded from participating in government healthcare programs, subjected to potential licensure, certification, and/or accreditation revocation, subjected to payment suspension, subjected to fines or penalties or required to repay amounts received from the government for previously billed patient services. We monitor all aspects of our business and have developed a comprehensive ethics and compliance program that is designed to meet or exceed applicable federal guidelines and industry standards. Because the law in this area is complex and constantly evolving, governmental investigation or litigation may result in interpretations that are inconsistent with industry practices, including ours. Although we believe our policies, procedures and practices comply with governmental regulations, there is no assurance that we will not be faced with sanctions, fines or penalties in connection with such inquiries or actions, including with respect to the investigations and other matters discussed herein. Even if we were to ultimately prevail, such inquiries and/or actions could have a material adverse effect on us.

The outcome of any current or future litigation or governmental or internal investigations, including the matters described above, cannot be accurately predicted, nor can we predict any resulting penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities. We record accruals for such contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described above because the inherently unpredictable nature of legal proceedings may be exacerbated by various factors, including, but not limited to: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties, or; (vii) there is a wide range of potential outcomes. It is possible that the outcome of these matters could have a material adverse impact on our future results of operations, financial position, cash flows and, potentially, our reputation.

In addition, various suits and claims arising against us in the ordinary course of business are pending. In the opinion of management, the outcome of such claims and litigation will not materially affect our consolidated financial position or results of operations.

In addition to our long-term debt obligations as discussed in Note 4. Long-Term Debt and our operating lease obligations as discussed in Note 7. Lease Commitments, we have various other contractual commitments outstanding as of December 31, 2014 as follows: (i) other combined estimated future purchase obligations of $205 million related to a long-term contract with third-parties consisting primarily of certain revenue cycle data processing services for our acute care facilities ($87 million), expected future costs to be paid to a third-party vendor in connection with the purchase, implementation and on-going operation of an electronic health records application for each of our acute care facilities ($117 million) and estimated minimum liabilities for physician commitments expected to be paid in the future ($2 million); (ii) estimated construction commitment of $151 million made to a third-party for construction of a new acute care hospital located in Henderson, Nevada; (iii) combined estimated future payments of $251 million related to our non-contributory, defined benefit pension plan ($234 million consisting of estimated payments through 2089) and other retirement plan liabilities ($17 million), and; (iv) accrued and unpaid estimated claims expense incurred in connection with our commercial health insurer and self-insured employee benefit plans ($58 million).

- Definition

The entire disclosure for commitments and contingencies.

+ References+ Details

Relationship with Universal Health Realty Income Trust and Related Party Transactions

12 Months Ended

Dec. 31, 2014

Relationship with Universal Health Realty Income Trust and Related Party Transactions

9) RELATIONSHIP WITH UNIVERSAL HEALTH REALTY INCOME TRUST AND RELATED PARTY TRANSACTIONS

Relationship with Universal Health Realty Income Trust:

At December 31, 2014, we held approximately 5.9% of the outstanding shares of Universal Health Realty Income Trust (the “Trust”). We serve as Advisor to the Trust under an annually renewable advisory agreement pursuant to the terms of which we conduct the Trust’s day-to-day affairs, provide administrative services and present investment opportunities. In addition, certain of our officers and directors are also officers and/or directors of the Trust. Management believes that it has the ability to exercise significant influence over the Trust, therefore we account for our investment in the Trust using the equity method of accounting. We earned an advisory fee from the Trust, which is included in net revenues in the accompanying consolidated statements of income, of approximately $2.5 million during 2014, $2.4 million during 2013 and $2.1 million during 2012.

Our pre-tax share of income from the Trust was $3.2 million during 2014, $842,000 during 2013 and $1.2 million during 2012, and is included in net revenues in the accompanying consolidated statements of income for each year. Included in our share of the Trust’s income for 2014 and 2012 was approximately $2.3 million in 2014 and $500,000 in 2012 related to our share of the net favorable impact realized by the Trust in connection with: (i) gains on the sale of medical office buildings (in 2012); (ii) gain on sale of a behavioral health hospital facility (in 2014), and; (iii) gain on fair value recognition resulting from the Trust’s purchase of minority ownership interests in majority owned limited liability companies (in 2014).

The carrying value of our investment in the Trust was $9.3 million and $8.1 million at December 31, 2014 and 2013, respectively, and is included in other assets in the accompanying consolidated balance sheets. The market value of our investment in the Trust was $37.9 million at December 31, 2014 and $31.5 million at December 31, 2013, based on the closing price of the Trust’s stock on the respective dates.

Total rent expense under the operating leases on the four hospital facilities with the Trust (as discussed below) was $16.8 million during 2014, $16.4 million during 2013 and $16.3 million during 2012. In addition, certain of our subsidiaries are tenants in several medical office buildings owned by the Trust or by limited liability companies in which the Trust holds 100% of the ownership interest.

The Trust commenced operations in 1986 by purchasing certain properties from us and immediately leasing the properties back to our respective subsidiaries. Most of the leases were entered into at the time the Trust commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. Each lease also provided for additional or bonus rental, as discussed below. The base rents are paid monthly and the bonus rents are computed and paid on a quarterly basis, based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The leases with our subsidiaries are unconditionally guaranteed by us and are cross-defaulted with one another.

During the third quarter of 2014, we provided notification to the Trust that, upon the December, 2014 expiration of the The Bridgeway’s lease term, we intended to exercise our option to purchase the real property of the facility. On December 31, 2014, we purchased The Bridgeway’s real property (a 103-bed behavioral health facility located in North Little Rock, Arkansas) from the Trust. Pursuant to the terms of the lease, we and the Trust were both required to obtain appraisals of the property to determine its fair market value. Based upon the property appraisals obtained by each party, the purchase price of The Bridgeway’s real property was approximately $17.3 million.

In addition, we recently constructed two free-standing emergency departments (“FEDs”) located in Weslaco and Mission, Texas which were completed and opened during the first quarter of 2015. The Trust purchased one of these FEDs from us in January, 2015 and the other in February, 2015. In conjunction with these sales, wholly-owned subsidiaries of ours, which will operate the FEDs, executed agreements with the Trust to lease the properties for initial terms of 10-years with six, 5-year renewal options. The aggregate construction cost/sales proceeds of these facilities was approximately $12.8 million and the aggregate rent expense paid to the Trust at the commencement of the leases will approximate $900,000 annually.

The table below details the renewal options and terms for each of our three hospital facilities leased from the Trust:

Hospital Name

Type of Facility

Annual
Minimum
Rent

End of Lease Term

Renewal
Term
(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

Pursuant to the terms of the leases with the Trust, we have the option to renew the leases at the lease terms described above by providing notice to the Trust at least 90 days prior to the termination of the then current term. In addition, we have rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. We also have the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at their appraised fair market value as well as purchase any or all of the three leased hospital properties at their appraised fair market value upon one month’s notice should a change of control of the Trust occur.

Other Related Party Transactions:

In December, 2010, our Board of Directors approved the Company’s entering into supplemental life insurance plans and agreements on the lives of our chief executive officer (“CEO”) and his wife. As a result of these agreements, based on actuarial tables and other assumptions, during the life expectancies of the insureds, we would pay approximately $25 million in premiums, and certain trusts owned by our chief executive officer, would pay approximately $8 million in premiums. Based on the projected premiums mentioned above, and assuming the policies remain in effect until the death of the insureds, we will be entitled to receive death benefit proceeds of no less than $33 million representing the $25 million of aggregate premiums paid by us as well as the $8 million of aggregate premiums paid by the trusts. During each of 2014 and 2013 we paid approximately $1.3 million in premium payments and during 2012, we paid approximately $1.4 million in premium payments. These agreements did not have a material effect on our consolidated financial statements or results of operations during 2014, 2013 or 2012.

A member of our Board of Directors and member of the Executive Committee is Of Counsel to the law firm used by us as our principal outside counsel. This Board member is also the trustee of certain trusts for the benefit of our CEO and his family. This law firm also provides personal legal services to our CEO.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References+ Details

Pension Plan

12 Months Ended

Dec. 31, 2014

Pension Plan

10) PENSION PLAN

We maintain contributory and non-contributory retirement plans for eligible employees. Our contributions to the contributory plan amounted to $35.7 million, $29.9 million and $27.3 million in 2014, 2013 and 2012, respectively. The non-contributory plan is a defined benefit pension plan which covers employees of one of our subsidiaries. The benefits are based on years of service and the employee’s highest compensation for any five years of employment. Our funding policy is to contribute annually at least the minimum amount that should be funded in accordance with the provisions of ERISA.

The following table shows the reconciliation of the defined benefit pension plan as of December 31, 2014 and 2013:


	2014			2013
	(000s)
Change in plan assets:
Fair value of plan assets at beginning of year	$	106,469		$	104,074
Actual return (loss) on plan assets		16,470			8,037
Employer contributions		0			0
Benefits paid		(5,605	)		(5,042	)
Administrative expenses		(637	)		(600	)

Fair value of plan assets at end of year	$	116,697		$	106,469
Change in benefit obligation:
Benefit obligation at beginning of year	$	103,558		$	114,529
Service cost		966			1,060
Interest cost		4,986			4,528
Benefits paid		(5,605	)		(5,042	)
Actuarial (gain) loss		23,437			(11,517	)

Benefit obligation at end of year	$	127,342		$	103,558
Amounts recognized in the Consolidated Balance Sheet:
Other non-current assets	$	0		$	2,911
Other non-current liabilities		10,645			0

Total amounts recognized at end of year	$	10,645		$	2,911


	2014			2013			2012
	(000s)
Components of net periodic cost (benefit)
Service cost	$	966		$	1,060		$	1,144
Interest cost		4,985			4,528			4,659
Expected return on plan assets		(7,772	)		(7,601	)		(7,301	)
Recognized actuarial loss		1,107			3,305			4,219

Net periodic cost	$	(714	)	$	1,292		$	2,721


	2014		2013
Measurement Dates
Benefit obligations		12/31/2014		12/31/2013
Fair value of plan assets		12/31/2014		12/31/2013


	2014			2013
Weighted average assumptions as of December 31
Discount rate		3.95	%		4.95	%
Rate of compensation increase		4.00	%		4.00	%


	2014			2013			2012
Weighted-average assumptions for net periodic benefit cost calculations
Discount rate		4.95	%		4.05	%		4.40	%
Expected long-term rate at return on plan assets		7.50	%		7.50	%		8.00	%
Rate of compensation increase		4.00	%		4.00	%		4.00	%

The accumulated benefit obligation was $126.4 million and $102.3 million as of December 31, 2014 and 2013, respectively. As of December 31, 2014, the accumulated benefit obligation exceeded the fair value of plan assets by $9.7 million. As of December 31, 2013, the fair value of plan assets exceeded the accumulated benefit obligation by $4.1 million.

We estimate that there will be a $3.2 million net loss amortized from accumulated other comprehensive income during 2015.

The market values of our pension plan assets at December 31, 2014 and December 31, 2013 by asset category are as follows:


December 31, 2014	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	9,212	$	—	$	9,212	$	—
U.S. Mid Cap		2,852		—		2,852		—
U.S. Small Cap		2,626		—		2,626		—
International Developed		6,181		—		6,181		—
Emerging Markets		4,139		—		4,139		—
Fixed income:
Core Fixed Income		27,062		—		27,062		—
Long Duration Fixed Income		61,718		—		61,718		—
Real Estate:
REIT Fund		2,395		—		2,395		—
Cash/Currency:
Cash Equivalents		512		—		512		—

Total market value	$	116,697	$	—	$	116,697	$	—


December 31, 2013	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	8,600	$	—	$	8,600	$	—
U.S. Mid Cap		2,740		—		2,740		—
U.S. Small Cap		2,725		—		2,725		—
International Developed		6,508		—		6,508		—
Emerging Markets		4,154		—		4,154		—
Fixed income:
Core Fixed Income		23,222		—		23,222		—
Long Duration Fixed Income		55,933		—		55,933		—
Real Estate:
REIT Fund		2,124		—		2,124		—
Cash/Currency:
Cash Equivalents		463		—		463		—

Total market value	$	106,469	$	—	$	106,469	$	—

To develop the expected long-term rate of return on plan assets assumption, we considered the historical returns and the future expectations for returns for each asset class, as well as the target asset allocation of the pension portfolio.

The following table shows expected benefit payments for the years ended December 31, 2014 through 2024 for our defined pension plan. There will be benefit payments under this plan beyond 2024.


Estimated Future Benefit Payments (000s)
2015	$	5,967
2016		6,231
2017		6,449
2018		6,661
2019		6,858
2020-2024		35,959

Total	$	68,125


	2014			2013
Plan Assets
Asset Category
Equity securities		21	%		23	%
Fixed income securities		76	%		74	%
Other		3	%		3	%

Total		100	%		100	%

Investment Policy, Guidelines and Objectives have been established for the defined benefit pension plan. The investment policy is in keeping with the fiduciary requirements under existing federal laws and managed in accordance with the Prudent Investor Rule. Total portfolio risk is regularly evaluated and compared to that of the plan’s policy target allocation and judged on a relative basis over a market cycle. The following asset allocation policy and ranges have been established in accordance with the overall risk and return objectives of the portfolio:


	As of 12/31/14			Permitted Range
Total Equity		21	%		10-30	%
Total Fixed Income		76	%		70-90	%
Other		3	%		0-10	%

In accordance with the investment policy, the portfolio will invest in high quality, large and small capitalization companies traded on national exchanges, and investment grade securities. The investment managers will not write or buy options for speculative purposes; securities may not be margined or sold short. The manager may employ futures or options for the purpose of hedging exposure, and will not purchase unregistered sectors, private placements, partnerships or commodities.

- Definition

The entire disclosure for pension and other postretirement benefits.

+ References+ Details

Segment Reporting

12 Months Ended

Dec. 31, 2014

Segment Reporting

11) SEGMENT REPORTING

Our reportable operating segments consist of acute care hospital services and behavioral health care services. The “Other” segment column below includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design and construction and patient accounting as well as the operating results for our other operating entities including outpatient surgery and radiation centers. The chief operating decision making group for our acute care hospital services and behavioral health care services is comprised of our Chief Executive Officer, the President and the Presidents of each operating segment. The Presidents for each operating segment also manage the profitability of each respective segment’s various facilities. The operating segments are managed separately because each operating segment represents a business unit that offers different types of healthcare services or operates in different healthcare environments. The accounting policies of the operating segments are the same as those described in the summary of significant accounting policies included in this Annual Report on Form 10-K for the year ended December 31, 2014. The corporate overhead allocations, as reflected below, are utilized for internal reporting purposes and are comprised of each period’s projected corporate-level operating expenses (excluding interest expense). The overhead expenses are captured and allocated directly to each segment, to the extent possible, with the non-directly allocated overhead expenses allocated based upon each segment’s respective percentage of total facility-based operating expenses.


2014	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	14,943,102		$	6,689,753			—		$	21,632,855
Gross outpatient revenues	$	8,147,031		$	784,309		$	34,238		$	8,965,578
Total net revenues	$	4,105,090		$	3,945,467		$	14,769		$	8,065,326
Income (loss) before allocation of corporate overhead and income taxes	$	465,328		$	944,068		$	(479,729	)	$	929,667
Allocation of corporate overhead	$	(178,781	)	$	(98,811	)	$	277,592		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	286,547		$	845,257		$	(202,137	)	$	929,667
Total assets	$	3,362,870		$	5,286,960		$	324,613		$	8,974,443


2013	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	13,469,269		$	6,294,046			—		$	19,763,315
Gross outpatient revenues	$	6,828,307		$	744,510		$	40,460		$	7,613,277
Total net revenues	$	3,576,369		$	3,667,967		$	39,486		$	7,283,822
Income (loss) before allocation of corporate overhead and income taxes	$	342,191		$	895,869		$	(368,728	)	$	869,332
Allocation of corporate overhead	$	(184,444	)	$	(89,447	)	$	273,891		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	157,747		$	806,422		$	(94,837	)	$	869,332
Total assets	$	3,125,626		$	4,966,182		$	219,915		$	8,311,723


2012	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	12,406,567		$	5,764,370			—		$	18,170,937
Gross outpatient revenues	$	6,134,615		$	646,177		$	48,183		$	6,828,975
Total net revenues	$	3,461,416		$	3,460,141		$	39,843		$	6,961,400
Income (loss) before allocation of corporate overhead and income taxes	$	337,385		$	838,603		$	(412,325	)	$	763,663
Allocation of corporate overhead	$	(162,056	)	$	(84,597	)	$	246,653		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	175,329		$	754,006		$	(165,672	)	$	763,663
Total assets	$	2,984,169		$	4,979,965		$	236,709		$	8,200,843

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

+ Details

Quarterly Results

12 Months Ended

Dec. 31, 2014

Quarterly Results

12) QUARTERLY RESULTS (unaudited)

The following tables summarize the quarterly financial data for the two years ended December 31, 2014 and 2013:


2014	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,920,166	$	2,019,821	$	2,017,758	$	2,107,581	$	8,065,326
Net income	$	151,852	$	166,614	$	96,038	$	190,492	$	604,996
Less: Net income attributable to noncontrolling interests	$	13,774	$	14,943	$	13,241	$	17,695	$	59,653

Net income attributable to UHS	$	138,078	$	151,671	$	82,797	$	172,797	$	545,343

Earnings per share attributable to UHS-Basic:

Total basic earnings per share	$	1.40	$	1.53	$	0.84	$	1.75	$	5.52

Earnings per share attributable to UHS-Diluted:

Total diluted earnings per share	$	1.38	$	1.51	$	0.82	$	1.71	$	5.42

The 2014 quarterly financial data presented above includes the following:

First Quarter:

•

an unfavorable $8.9 million pre-tax impact ($4.9 million, or $.05 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

•

a favorable $10.1 million pre-tax impact ($6.3 million, or $0.07 per diluted share, net of taxes) resulting from the gain realized on the sale of a non-operating investment.

Second Quarter:

•

an unfavorable $7.1 million pre-tax impact ($3.9 million, or $.04 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications.

Third Quarter:

•

an unfavorable $7.9 million pre-tax impact ($4.5 million, or $.04 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

•

an unfavorable $36.2 million pre-tax impact ($22.7 million, or $0.23 per diluted share, net of taxes) recorded in connection with the costs related to extinguishment of debt resulting primarily from the early redemption of our previously outstanding $250 million, 7.00% senior unsecured notes that were scheduled to mature in 2018 and the repayment of $550 million of borrowings pursuant to the terms of our previously outstanding Term Loan B facility which was scheduled to mature in 2016;

•

an unfavorable $44.0 million pre-tax impact ($27.6 million, or $0.27 per diluted share, net of taxes) incurred in connection with the previously disclosed $65 million settlement of the Garden City matter. This matter was a shareholder class action lawsuit filed in 2009 against PSI and certain of its former officers alleging their violations of federal securities laws and we assumed the defense and liability of this matter as a result of our acquisition of PSI in 2010. This charge is net of approximately $17 million of commercial insurance recoveries that we were entitled to and a previously recorded estimated reserve.

Fourth Quarter:

•

a favorable $13.8 million pre-tax impact ($8.6 million, or $.08 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

•

a favorable $19.7 million pre-tax impact reduction ($11.7 million, or $.12 per diluted share, net of taxes) to our professional and general liability self-insurance reserves relating to years prior to 2014, as discussed in Self-Insured/Other Insurance Risks.


2013	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,831,632	$	1,834,975	$	1,816,369	$	1,800,846	$	7,283,822
Net income	$	129,935	$	167,803	$	123,099	$	133,186	$	554,023
Less: Net income attributable to noncontrolling interests	$	10,151	$	15,962	$	8,512	$	8,665	$	43,290

Net income attributable to UHS	$	119,784	$	151,841	$	114,587	$	124,521	$	510,733

Earnings per share attributable to UHS-Basic:

Total basic earnings per share	$	1.23	$	1.55	$	1.17	$	1.27	$	5.21

Earnings per share attributable to UHS-Diluted:

Total diluted earnings per share	$	1.21	$	1.53	$	1.15	$	1.24	$	5.14

The 2013 quarterly financial data presented above includes the following:

First Quarter:

•

an unfavorable $1.1 million pre-tax impact ($327,000, or $.01 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications.

Second Quarter:

•

an unfavorable $8.9 million pre-tax impact ($4.9 million, or $.05 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

•

a favorable $65.0 million pre-tax impact reduction ($37.8 million, or $.38 per diluted share, net of taxes) to our professional and general liability self-insurance reserves relating to years prior to 2013, as discussed in Self-Insured/Other Insurance Risks.

Third Quarter:

•

a favorable $8.4 million pre-tax impact ($5.1 million, or $.05 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications.

Fourth Quarter:

•

a favorable $19.4 million pre-tax impact ($11.8 million, or $.12 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

•

a favorable $15.6 million pre-tax impact reduction ($9.2 million, or $.09 per diluted share, net of taxes) to our professional and general liability self-insurance reserves relating to years prior to 2013, as discussed in Self-Insured/Other Insurance Risks.

- Definition

The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.

+ References+ Details

Supplemental Condensed Consolidating Financial Information

12 Months Ended

Dec. 31, 2014

Supplemental Condensed Consolidating Financial Information

13) SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

Certain of our senior notes are guaranteed by a group of subsidiaries (the “Guarantors”). The Guarantors, each of which is a 100% directly owned subsidiary of Universal Health Services, Inc., fully and unconditionally guarantee the senior notes on a joint and several basis, subject to certain customary release provisions.

The following financial statements present condensed consolidating financial data for (i) Universal Health Services, Inc. (on a parent company only basis), (ii) the combined Guarantors, (iii) the combined non guarantor subsidiaries (all other subsidiaries), (iv) an elimination column for adjustments to arrive at the information for the parent company, Guarantors, and non guarantors on a consolidated basis, and (v) the parent company and our subsidiaries on a consolidated basis.

Investments in subsidiaries are accounted for by the parent company and the Guarantors using the equity method for this presentation. Results of operations of subsidiaries are therefore classified in the parent company’s and Guarantors’ investment in subsidiaries accounts. The elimination entries set forth in the following condensed consolidating financial statements eliminate distributed and undistributed income of subsidiaries, investments in subsidiaries, and intercompany balances and transactions between the parent, Guarantors, and non guarantors.

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2014

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	6,100,777		$	2,692,752		$	(29,220	)	$	8,764,309
Less: Provision for doubtful accounts		0			471,181			227,802			0			698,983

Net Revenues		0			5,629,596			2,464,950			(29,220	)		8,065,326
Operating charges:
Salaries, wages and benefits		0			2,757,738			1,087,723			0			3,845,461
Other operating expenses		0			1,217,525			592,556			(27,100	)		1,782,981
Supplies expense		0			546,578			349,115			0			895,693
Depreciation and amortization		0			269,490			106,134			0			375,624
Lease and rental expense		0			58,619			37,494			(2,120	)		93,993
EHR incentive income		0			(19,480	)		(8,422	)		0			(27,902	)
Costs related to extinguishment of debt		36,171			0			0			0			36,171

		36,171			4,830,470			2,164,600			(29,220	)		7,002,021

Income from operations		(36,171	)		799,126			300,350			0			1,063,305
Interest expense		127,528			4,516			1,594			0			133,638
Interest (income) expense, affiliate		0			88,246			(88,246	)		0			0
Equity in net income of consolidated affiliates		(646,386	)		(184,385	)		0			830,771			0

Income before income taxes		482,687			890,749			387,002			(830,771	)		929,667
Provision for income taxes		(62,656	)		305,320			82,007			0			324,671

Net income		545,343			585,429			304,995			(830,771	)		604,996
Less: Income attributable to noncontrolling interests		0			0			59,653			0			59,653

Net income attributable to UHS	$	545,343		$	585,429		$	245,342		$	(830,771	)	$	545,343

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2013

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	5,658,699		$	2,780,983		$	(28,644	)	$	8,411,038
Less: Provision for doubtful accounts		0			657,106			470,110			0			1,127,216

Net Revenues		0			5,001,593			2,310,873			(28,644	)		7,283,822
Operating charges:
Salaries, wages and benefits		0			2,573,205			1,031,415			0			3,604,620
Other operating expenses		0			972,170			523,382			(26,808	)		1,468,744
Supplies expense		0			510,078			311,011			0			821,089
Depreciation and amortization		0			236,958			100,214			0			337,172
Lease and rental expense		0			62,518			37,076			(1,836	)		97,758
EHR incentive income		0			(43,027	)		(17,997	)		0			(61,024	)

		0			4,311,902			1,985,101			(28,644	)		6,268,359

Income from operations		0			689,691			325,772			0			1,015,463
Interest expense		139,793			3,365			2,973			0			146,131
Interest (income) expense, affiliate		0			84,640			(84,640	)		0			0
Equity in net income of consolidated affiliates		(597,020	)		(141,004	)		0			738,024			0

Income before income taxes		457,227			742,690			407,439			(738,024	)		869,332
Provision for income taxes		(53,506	)		262,346			106,469			0			315,309

Net income		510,733			480,344			300,970			(738,024	)		554,023
Less: Income attributable to noncontrolling interests		0			0			43,290			0			43,290

Net income attributable to UHS	$	510,733		$	480,344		$	257,680		$	(738,024	)	$	510,733

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	5,152,816		$	2,562,781		$	(27,526	)	$	7,688,071
Less: Provision for doubtful accounts		0			411,538			315,133			0			726,671

Net Revenues		0			4,741,278			2,247,648			(27,526	)		6,961,400
Operating charges:
Salaries, wages and benefits		0			2,452,187			988,730			0			3,440,917
Other operating expenses		0			899,274			502,592			(25,744	)		1,376,122
Supplies expense		0			496,848			302,773			0			799,621
Depreciation and amortization		0			210,867			91,559			0			302,426
Lease and rental expense		0			59,596			37,071			(1,782	)		94,885
Transaction costs		0			5,716			0			0			5,716
EHR incentive income		0			(14,284	)		(15,754	)		0			(30,038	)
Costs related to extinguishment of debt		29,170			0			0			0			29,170

		29,170			4,110,204			1,906,971			(27,526	)		6,018,819

Income from operations		(29,170	)		631,074			340,677			0			942,581
Interest expense		172,467			3,749			2,702			0			178,918
Interest (income) expense, affiliate		0			93,363			(93,363	)		0			0
Equity in net income of consolidated affiliates		(567,906	)		(141,983	)		0			709,889			0

Income before income taxes		366,269			675,945			431,338			(709,889	)		763,663
Provision for income taxes		(77,177	)		237,072			114,721			0			274,616

Net income		443,446			438,873			316,617			(709,889	)		489,047
Less: Income attributable to noncontrolling interests		0			0			45,601			0			45,601

Net income attributable to UHS	$	443,446		$	438,873		$	271,016		$	(709,889	)	$	443,446

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2014

(amounts in thousands)


	Parent			Guarantors			Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	545,343		$	585,429		$	304,995	$	(830,771	)	$	604,996
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		17,668			0			0		0			17,668
Amortization of terminated hedge		(336	)		0			0		0			(336	)
Minimum Pension Liability		(14,270	)		(14,270	)		0		14,270			(14,270	)
Foreign currency translation adjustment		(2,431	)		(2,431	)		0		2,431			(2,431	)

Other comprehensive income before tax		631			(16,701	)		0		16,701			631
Income tax expense related to items of other comprehensive income		1,053			(5,356	)		0		5,356			1,053

Total other comprehensive income, net of tax		(422	)		(11,345	)		0		11,345			(422	)

Comprehensive income		544,921			574,084			304,995		(819,426	)		604,574
Less: Comprehensive income attributable to noncontrolling interests		0			0			59,653		0			59,653

Comprehensive income attributable to UHS	$	544,921		$	574,084		$	245,342	$	(819,426	)	$	544,921

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2013

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	510,733		$	480,344	$	300,970	$	(738,024	)	$	554,023
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		16,963			0		0		0			16,963
Amortization of terminated hedge		(336	)		0		0		0			(336	)
Minimum Pension Liability		14,657			14,657		0		(14,657	)		14,657

Other comprehensive income before tax		31,284			14,657		0		(14,657	)		31,284
Income tax expense related to items of other comprehensive income		11,940			5,670		0		(5,670	)		11,940

Total other comprehensive income, net of tax		19,344			8,987		0		(8,987	)		19,344

Comprehensive income		530,077			489,331		300,970		(747,011	)		573,367
Less: Comprehensive income attributable to noncontrolling interests		0			0		43,290		0			43,290

Comprehensive income attributable to UHS	$	530,077		$	489,331	$	257,680	$	(747,011	)	$	530,077

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2012

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	443,446		$	438,873	$	316,617	$	(709,889	)	$	489,047
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		6,677			0		0		0			6,677
Amortization of terminated hedge		(336	)		0		0		0			(336	)
Minimum Pension Liability		4,986			4,986		0		(4,986	)		4,986

Other comprehensive income before tax		11,327			4,986		0		(4,986	)		11,327
Income tax expense related to items of other comprehensive income		4,306			1,898		0		(1,898	)		4,306

Total other comprehensive income, net of tax		7,021			3,088		0		(3,088	)		7,021

Comprehensive income		450,467			441,961		316,617		(712,977	)		496,068
Less: Comprehensive income attributable to noncontrolling interests		0			0		45,601		0			45,601

Comprehensive income attributable to UHS	$	450,467		$	441,961	$	271,016	$	(712,977	)	$	450,467

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2014

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	21,784		$	10,285		$	0		$	32,069
Accounts receivable, net		0		933,971			348,764			0			1,282,735
Supplies		0		67,847			40,268			0			108,115
Deferred income taxes		113,822		743			0			0			114,565
Other current assets		0		62,431			15,223			0			77,654

Total current assets		113,822		1,086,776			414,540			0			1,615,138

Investments in subsidiaries		7,013,540		1,661,296			0			(8,674,836	)		0
Intercompany receivable		103,808		0			408,682			(512,490	)		0
Intercompany note receivable		0		0			1,222,637			(1,222,637	)		0

Property and equipment		0		4,494,567			1,717,463			0			6,212,030
Less: accumulated depreciation		0		(1,686,192	)		(846,149	)		0			(2,532,341	)

		0		2,808,375			871,314			0			3,679,689

Other assets:
Goodwill		0		2,764,555			526,658			0			3,291,213
Deferred charges		32,379		5,402			2,538			0			40,319
Other		9,601		283,302			55,181			0			348,084

	$	7,273,150	$	8,609,706		$	3,501,550		$	(10,409,963	)	$	8,974,443

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	44,874	$	1,260		$	22,185			0		$	68,319
Accounts payable and accrued liabilities		20,245		1,051,309			41,508			0			1,113,062
Federal and state taxes		1,446		0			0			0			1,446

Total current liabilities		66,565		1,052,569			63,693			0			1,182,827

Intercompany payable		0		512,490			0			(512,490	)		0
Other noncurrent liabilities		1,322		189,456			77,777			0			268,555
Long-term debt		3,187,103		20,212			2,900			0			3,210,215
Intercompany note payable		0		1,222,637			0			(1,222,637	)		0
Deferred income taxes		282,214		0			0			0			282,214
Redeemable noncontrolling interests		0		0			239,552			0			239,552

UHS common stockholders’ equity		3,735,946		5,612,342			3,062,494			(8,674,836	)		3,735,946
Noncontrolling interest		0		0			55,134			0			55,134

Total equity		3,735,946		5,612,342			3,117,628			(8,674,836	)		3,791,080

	$	7,273,150	$	8,609,706		$	3,501,550		$	(10,409,963	)	$	8,974,443

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2013

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	7,990		$	9,248		$	0		$	17,238
Accounts receivable, net		0		799,898			317,063			0			1,116,961
Supplies		0		63,562			38,219			0			101,781
Deferred income taxes		76,719		43,184			0			0			119,903
Other current assets		0		63,786			12,660			0			76,446

Total current assets		76,719		978,420			377,190			0			1,432,329

Investments in subsidiaries		6,378,499		1,476,911			0			(7,855,410	)		0
Intercompany receivable		226,592		0			531,411			(758,003	)		0
Intercompany note receivable		0		0			982,568			(982,568	)		0

Property and equipment		0		4,093,914			1,597,988			0			5,691,902
Less: accumulated depreciation		0		(1,478,758	)		(770,975	)		0			(2,249,733	)

		0		2,615,156			827,013			0			3,442,169

Other assets:
Goodwill		0		2,552,190			496,826			0			3,049,016
Deferred charges		49,866		5,577			2,438			0			57,881
Other		8,411		251,365			70,552			0			330,328

	$	6,740,087	$	7,879,619		$	3,287,998		$	(9,595,981	)	$	8,311,723

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	97,403		916			993			0		$	99,312
Accounts payable and accrued liabilities		28,099		837,354			87,996			0			953,449
Federal and state taxes		4,963		2,164			0			0			7,127

Total current liabilities		130,465		840,434			88,989			0			1,059,888

Intercompany payable		0		758,003			0			(758,003	)		0
Other noncurrent liabilities		7,591		199,104			77,894			0			284,589
Long-term debt		3,168,819		5,337			35,606			0			3,209,762
Intercompany note payable		0		982,568			0			(982,568	)		0
Deferred income taxes		183,233		55,915			0			0			239,148
Redeemable noncontrolling interests		0		0			218,107			0			218,107

UHS common stockholders’ equity		3,249,979		5,038,258			2,817,152			(7,855,410	)		3,249,979
Noncontrolling interest		0		0			50,250			0			50,250

Total equity		3,249,979		5,038,258			2,867,402			(7,855,410	)		3,300,229

	$	6,740,087	$	7,879,619		$	3,287,998		$	(9,595,981	)	$	8,311,723

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2014

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	18,579		$	687,101		$	330,196		$	0	$	1,035,876

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(230,102	)		(161,048	)		0		(391,150	)
Acquisition of property and businesses		0			(422,081	)		(9,305	)		0		(431,386	)
Proceeds received from sale of assets and businesses		0			11,450			3,728			0		15,178
Costs incurred for purchase and development of electronic health records application		0			(13,488	)		0			0		(13,488	)
Increase in insurance subsidiary investments		0			(12,000	)		0			0		(12,000	)

Net cash used in investing activities		0			(666,221	)		(166,625	)		0		(832,846	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(866,748	)		(867	)		(11,514	)		0		(879,129	)
Additional borrowings		830,000			0			0			0		830,000
Financing costs		(14,976	)		0			0			0		(14,976	)
Repurchase of common shares		(100,749	)		0			0			0		(100,749	)
Dividends paid		(29,665	)		0			0			0		(29,665	)
Issuance of common stock		6,863			0			0			0		6,863
Excess income tax benefits related to stock based compensation		33,912			0			0			0		33,912
Profit distributions to noncontrolling interests		0			0			(33,680	)		0		(33,680	)
Changes in intercompany balances with affiliates, net		122,784			(5,444	)		(117,340	)		0		0

Net cash (used in) provided by financing activities		(18,579	)		(6,311	)		(162,534	)		0		(187,424	)

Effect of exchange rate changes on cash and cash equivalents		0			(775	)		0			0		(775	)

Increase in cash and cash equivalents		0			13,794			1,037			0		14,831
Cash and cash equivalents, beginning of period		0			7,990			9,248			0		17,238

Cash and cash equivalents, end of period	$	0		$	21,784		$	10,285		$	0	$	32,069

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2013

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	17,946		$	587,083		$	279,212		$	0	$	884,241

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(269,419	)		(89,074	)		0		(358,493	)
Acquisition of property and businesses		0			(8,094	)		(4,542	)		0		(12,636	)
Proceeds received from sale of assets and businesses		0			7,916			29,566			0		37,482
Costs incurred for purchase and development of electronic health records application		0			(49,811	)		0			0		(49,811	)

Net cash used in investing activities		0			(319,408	)		(64,050	)		0		(383,458	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(429,996	)		(109	)		(10,119	)		0		(440,224	)
Additional borrowings		15,761			0			0			0		15,761
Financing costs		(231	)		0			0			0		(231	)
Repurchase of common shares		(27,201	)		0			0			0		(27,201	)
Dividends paid		(19,621	)		0			0			0		(19,621	)
Issuance of common stock		5,708			0			0			0		5,708
Excess income tax benefits related to stock based compensation		20,121			0			0			0		20,121
Profit distributions to noncontrolling interests		0			0			(61,329	)		0		(61,329	)
Changes in intercompany balances with affiliates, net		417,513			(271,525	)		(145,988	)		0		0

Net cash used in financing activities		(17,946	)		(271,634	)		(217,436	)		0		(507,016	)

Decrease in cash and cash equivalents		0			(3,959	)		(2,274	)		0		(6,233	)
Cash and cash equivalents, beginning of period		0			11,949			11,522			0		23,471

Cash and cash equivalents, end of period	$	0		$	7,990		$	9,248		$	0	$	17,238

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net cash (used in) provided by operating activities	$	(37,648	)	$	594,606		$	242,273		$	0		$	799,231

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(312,190	)		(51,002	)		0			(363,192	)
Acquisition of property and businesses		0			(513,596	)		(14,251	)		0			(527,847	)
Proceeds received from sale of assets and businesses		0			142,667			6,644			0			149,311
Costs incurred for purchase and development of electronic health records application		0			(54,362	)		0			0			(54,362	)
Return of Deposit on terminated purchase agreement		6,500			0			0			0			6,500

Net cash provided by (used in) investing activities		6,500			(737,481	)		(58,609	)		0			(789,590	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(843,002	)		0			(8,258	)		1,613			(849,647	)
Additional borrowings		913,500			1,613			0			(1,613	)		913,500
Financing costs		(8,283	)		0			0			0			(8,283	)
Repurchase of common shares		(19,154	)		0			0			0			(19,154	)
Dividends paid		(58,395	)		0			0			0			(58,395	)
Issuance of common stock		5,435			0			0			0			5,435
Excess income tax benefits related to stock based compensation		16,040			0			0			0			16,040
Profit distributions to noncontrolling interests		0			0			(26,895	)		0			(26,895	)
Changes in intercompany balances with affiliates, net		25,007			119,990			(144,997	)		0			0

Net cash provided by (used in) financing activities		31,148			121,603			(180,150	)		0			(27,399	)

Increase (decrease) in cash and cash equivalents		0			(21,272	)		3,514			0			(17,758	)
Cash and cash equivalents, beginning of period		0			33,221			8,008			0			41,229

Cash and cash equivalents, end of period	$	0		$	11,949		$	11,522		$	0		$	23,471

- Definition

The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.

+ References+ Details

Schedule II-Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2014

Schedule II-Valuation and Qualifying Accounts

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

(amounts in thousands)


Allowance for Doubtful Accounts Receivable:	Balance at beginning of period		Charges to costs and expenses		Acquisitions of business		Write-off of uncollectible accounts			Balance at end of period
Year ended December 31, 2014	$	395,035	$	698,983	$	506	$	(769,876	)	$	324,648

Year ended December 31, 2013	$	311,387	$	1,127,216	$	—	$	(1,043,568	)	$	395,035

Year ended December 31, 2012	$	253,405	$	726,671	$	5,632	$	(674,321	)	$	311,387


Valuation Allowance for Deferred Tax Assets:	Balance at beginning of period		Charges to costs and expenses		Acquisitions of business		Write-offs		Balance at end of period
Year ended December 31, 2014	$	46,841	$	5,923	$	—	$	—	$	52,764

Year ended December 31, 2013	$	44,511	$	2,330	$	—	$	—	$	46,841

Year ended December 31, 2012	$	42,143	$	2,368	$	—	$	—	$	44,511

Business and Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2014

Principles of Consolidation

Revenue Recognition

Charity Care, Uninsured Discounts and Provision for Doubtful Accounts

Uncompensated care (charity care and uninsured discounts):


	(dollar amounts in thousands)
	2014					2013					2012
	Amount		%			Amount		%			Amount		%
Charity care	$	515,435		45	%	$	593,474		59	%	$	778,268		74	%
Uninsured discounts		620,587		55	%		405,296		41	%		267,304		26	%

Total uncompensated care	$	1,136,022		100	%	$	998,770		100	%	$	1,045,572		100	%

The estimated cost of providing uncompensated care:


	(amounts in thousands)
	2014		2013		2012
Estimated cost of providing charity care	$	78,475	$	95,675	$	131,890
Estimated cost of providing uninsured discounts related care		94,484		65,338		45,299

Estimated cost of providing uncompensated care	$	172,959	$	161,013	$	177,189

Concentration of Revenues

Accounting for Medicare and Medicaid Electronic Health Records Incentive Payments

Cash and Cash Equivalents

F) Cash and Cash Equivalents: We consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents.

Property and Equipment

Long-Lived Assets

Goodwill and Intangible Assets

Changes in the carrying amount of goodwill for the two years ended December 31, 2014 were as follows (in thousands):


	Acute Care Services		Behavioral Health Services			Total Consolidated
Balance, January 1, 2013	$	382,696	$	2,654,069		$	3,036,765
Adjustments to goodwill (a)		315		11,936			12,251

Balance, December 31, 2013		383,011		2,666,005			3,049,016
Goodwill acquired during the period		4,088		246,124			250,212
Adjustments to goodwill (b)		0		(8,015	)		(8,015	)

Balance, December 31, 2014	$	387,099	$	2,904,114		$	3,291,213

(a)	The increase in the Behavioral Health Services’ goodwill consists primarily of an amount that was reclassified from other assets.

(b)	The decrease in the Behavioral Health Services’ goodwill consists primarily of foreign currency translation adjustments.

Other Assets

Physician Guarantees and Commitments

Self-Insured Risks

Income Taxes

Other Noncurrent Liabilities

Redeemable Noncontrolling Interests and Noncontrolling Interest

Accumulated Other Comprehensive Income

The amounts recognized in AOCI for the two years ended December 31, 2014 were as follows (in thousands):


	Net Unrealized Gains (Losses) on Effective Cash Flow Hedges			Foreign Currency Translation Adjustment			Minimum Pension Liability			Total AOCI
Balance, January 1, 2013, net of income tax	$	(24,527	)	$	0		$	(19,627	)	$	(44,154	)
2013 activity:
Pretax amount		16,627			0			14,657			31,284
Income tax effect		(6,270	)		0			(5,670	)		(11,940	)

Change, net of income tax		10,357			0			8,987			19,344

Balance, January 1, 2014, net of income tax		(14,170	)		0			(10,640	)		(24,810	)
2014 activity:
Pretax amount		17,332			(2,431	)		(14,270	)		631
Income tax effect		(6,409	)		0			5,356			(1,053	)

Change, net of income tax		10,923			(2,431	)		(8,914	)		(422	)

Balance, December 31, 2014, net of income tax	$	(3,247	)	$	(2,431	)	$	(19,554	)	$	(25,232	)

Accounting for Derivative Financial Investments and Hedging Activities

Stock-Based Compensation

Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:


	Twelve Months Ended December 31,
	2014			2013			2012
Basic and diluted:
Net Income	$	604,996		$	554,023		$	489,047
Less: Net income attributable to noncontrolling interest		(59,653	)		(43,290	)		(45,601	)
Less: Net income attributable to unvested restricted share grants		(236	)		(294	)		(497	)

Net income attributable to UHS—basic and diluted	$	545,107		$	510,439		$	442,949

Basic earnings per share attributable to UHS:
Weighted average number of common shares—basic		98,826			98,033			96,821

Total basic earnings per share	$	5.52		$	5.21		$	4.57

Diluted earnings per share attributable to UHS:
Weighted average number of common shares		98,826			98,033			96,821
Net effect of dilutive stock options and grants based on the treasury stock method		1,718			1,328			890

Weighted average number of common shares and equivalents—diluted		100,544			99,361			97,711

Total diluted earnings per share	$	5.42		$	5.14		$	4.53

Fair Value of Financial Instruments

Use of Estimates

Mergers and Acquisitions

GPO Agreement/Minority Ownership Interest

Provider Taxes

Recent Accounting Standards

Y) Recent Accounting Standards:

Business and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2014

Uncompensated Care


	(dollar amounts in thousands)
	2014					2013					2012
	Amount		%			Amount		%			Amount		%
Charity care	$	515,435		45	%	$	593,474		59	%	$	778,268		74	%
Uninsured discounts		620,587		55	%		405,296		41	%		267,304		26	%

Total uncompensated care	$	1,136,022		100	%	$	998,770		100	%	$	1,045,572		100	%

Estimated Cost of Providing Uncompensated Care


	(amounts in thousands)
	2014		2013		2012
Estimated cost of providing charity care	$	78,475	$	95,675	$	131,890
Estimated cost of providing uninsured discounts related care		94,484		65,338		45,299

Estimated cost of providing uncompensated care	$	172,959	$	161,013	$	177,189

Changes in Carrying Amount of Goodwill

Changes in the carrying amount of goodwill for the two years ended December 31, 2014 were as follows (in thousands):


	Acute Care Services		Behavioral Health Services			Total Consolidated
Balance, January 1, 2013	$	382,696	$	2,654,069		$	3,036,765
Adjustments to goodwill (a)		315		11,936			12,251

Balance, December 31, 2013		383,011		2,666,005			3,049,016
Goodwill acquired during the period		4,088		246,124			250,212
Adjustments to goodwill (b)		0		(8,015	)		(8,015	)

Balance, December 31, 2014	$	387,099	$	2,904,114		$	3,291,213

(a)	The increase in the Behavioral Health Services’ goodwill consists primarily of an amount that was reclassified from other assets.

(b)	The decrease in the Behavioral Health Services’ goodwill consists primarily of foreign currency translation adjustments.

Amounts Recognized in AOCI

The amounts recognized in AOCI for the two years ended December 31, 2014 were as follows (in thousands):


	Net Unrealized Gains (Losses) on Effective Cash Flow Hedges			Foreign Currency Translation Adjustment			Minimum Pension Liability			Total AOCI
Balance, January 1, 2013, net of income tax	$	(24,527	)	$	0		$	(19,627	)	$	(44,154	)
2013 activity:
Pretax amount		16,627			0			14,657			31,284
Income tax effect		(6,270	)		0			(5,670	)		(11,940	)

Change, net of income tax		10,357			0			8,987			19,344

Balance, January 1, 2014, net of income tax		(14,170	)		0			(10,640	)		(24,810	)
2014 activity:
Pretax amount		17,332			(2,431	)		(14,270	)		631
Income tax effect		(6,409	)		0			5,356			(1,053	)

Change, net of income tax		10,923			(2,431	)		(8,914	)		(422	)

Balance, December 31, 2014, net of income tax	$	(3,247	)	$	(2,431	)	$	(19,554	)	$	(25,232	)

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:


	Twelve Months Ended December 31,
	2014			2013			2012
Basic and diluted:
Net Income	$	604,996		$	554,023		$	489,047
Less: Net income attributable to noncontrolling interest		(59,653	)		(43,290	)		(45,601	)
Less: Net income attributable to unvested restricted share grants		(236	)		(294	)		(497	)

Net income attributable to UHS—basic and diluted	$	545,107		$	510,439		$	442,949

Basic earnings per share attributable to UHS:
Weighted average number of common shares—basic		98,826			98,033			96,821

Total basic earnings per share	$	5.52		$	5.21		$	4.57

Diluted earnings per share attributable to UHS:
Weighted average number of common shares		98,826			98,033			96,821
Net effect of dilutive stock options and grants based on the treasury stock method		1,718			1,328			890

Weighted average number of common shares and equivalents—diluted		100,544			99,361			97,711

Total diluted earnings per share	$	5.42		$	5.14		$	4.53

Acquisitions and Divestitures (Tables)

12 Months Ended

Dec. 31, 2014

Aggregate Net Purchase Price Allocation to Assets and Liabilities based on Estimated Fair Values

The aggregate net purchase price of the facilities was allocated to assets and liabilities based on their preliminary estimated fair values as follows:


	Amount (000s)
Working capital, net	$	(41,000	)
Property & equipment		174,000
Goodwill		250,000
Other assets		59,000
Income tax assets, net of deferred tax liabilities		4,000
Debt		(16,000	)
Other		1,000

Cash paid in 2014 for acquisitions	$	431,000


	Amount (000s)
Working capital, net	$	21,000
Property & equipment		60,000
Goodwill		446,000
Other assets		9,000
Income tax assets, net of deferred tax liabilities		(1,000	)
Other liabilities		(7,000	)

Cash paid in 2012 for acquisitions	$	528,000

Results of Operations Reflected as Discontinued Operations


	2013			2012
Net revenues	$	7,813		$	95,226
Income (loss) from discontinued operations, before income taxes		932			(3,472	)
Gain on divestiture		3,080			26,419

Income from discontinued operations, before income tax expense		4,012			22,947
Income tax expense		(1,506	)		(8,688	)

Income from discontinued operations, net of income taxes	$	2,506		$	14,259

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References+ Details

Long-Term Debt (Tables)

12 Months Ended

Dec. 31, 2014

Summary of Long-Term Debt

A summary of long-term debt follows:


	December 31,
	2014			2013
	(amounts in thousands)
Long-term debt:
Notes payable and Mortgages payable (including obligations under capitalized leases of $21,600 in 2014 and $6,633 in 2013) and term loans with varying maturities through 2037; weighted average interest rates of 6.4% in 2014 and 5.9% in 2013 and 2012 (see Note 7 regarding capitalized leases)	$	41,257		$	37,553
Revolving credit and on-demand credit facility		140,500			25,500
Term Loan A, net of unamortized discount of $2,035 in 2014 and $3,340 in 2013		1,761,872			935,308
Term Loan B, net of unamortized discount of $6,473 in 2013		0			543,527
Term Loan A2		0			871,875
Revenue bonds, interest at floating rates of 0.05% at December 31, 2014 and 0.10% at December 31, 2013, with varying maturities through 2015		5,300			5,300
Accounts receivable securitization program		330,000			240,000
3.75% Senior Secured Notes due 2019, net of unamortized discount of $198 in 2014		299,802			0
4.75% Senior Secured Notes due 2022, net of unamortized discount of $204 in 2014		299,796			0
7.125% Senior Secured Notes due 2016, including unamortized net premium of $7 in 2014 and $11 in 2013		400,007			400,011
7.00% Senior Unsecured Notes due 2018		0			250,000

		3,278,534			3,309,074
Less-Amounts due within one year		(68,319	)		(99,312	)

	$	3,210,215		$	3,209,762

Aggregate Maturities

Aggregate maturities follow:


	(000s)
2015	$	68,319
2016		787,437
2017		90,675
2018		90,882
2019		1,925,923
Later		315,298

Total	$	3,278,534

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(e),(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

+ Details

Common Stock (Tables)

12 Months Ended

Dec. 31, 2014

The following schedule provides information related to our stock repurchase program for each of the three years ended December 31, 2014. All of the shares repurchased during 2013 and 2012 related to income tax withholding obligations resulting from the exercise of stock options and the vesting of restricted stock grants. No shares were repurchased during 2013 or 2012 pursuant to our publicly announced stock repurchase program. During 2014, 548,192 shares ($58.0 million in the aggregate) were repurchased pursuant to the terms of our recently authorized stock repurchase program and 480,972 shares ($42.7 million in the aggregate) were repurchased in connection with income tax withholding obligations resulting from the exercise of stock options and the vesting of restricted stock grants.


	Additional dollars authorized for repurchase (in thousands)		Total number of shares purchased		Total number of shares cancelled		Average price paid per share for forfeited restricted shares	Total number of shares purchased as part of publicly announced programs		Average price pad per share for shares purchased as part of publicly announced program		Aggregate purchase price paid (in thousands)		Aggregate purchase price paid for shares purchased as part of publicly announced program		Maximum number of shares that may yet be purchased under the program		Maximum number of dollars that may yet be purchased under the program (in thousands)
Balance as of January 1, 2012																	767,704		N/A
2012		—		433,312		—	N/A		—		N/A	$	19,154		N/A		767,704		N/A
2013		—		427,170		—	N/A		—		N/A	$	27,201		N/A		767,704		N/A
2014	$	400,000		1,029,164		767,704	N/A		548,192	$	105.71	$	100,749	$	57,950		N/A	$	342,050

Total for three year period ended December 31, 2014	$	400,000		1,889,646		767,704	N/A		548,192	$	105.71	$	147,104	$	57,950

Weighted-Average Assumptions Fair Value of Option Grants

The weighted-average assumptions reflected below were based upon twenty-one options grants for the five-year period ending December 31, 2014 and eighteen option grants for each of the five-year periods ended December 31, 2013 and 2012.


Year Ended December 31,	2014			2013			2012
Volatility		35	%		36	%		33	%
Interest rate		1	%		1	%		1	%
Expected life (years)		3.4			3.6			3.5
Forfeiture rate		10	%		11	%		10	%
Dividend yield		0.4	%		0.5	%		0.6	%

Stock Option Activity

The table below summarizes our stock option activity during each of the last three years:


Outstanding Options	Number of Shares			Average Option Price		Range (High-Low)
Balance, January 1, 2012		7,558,945		$	31.63	$	54.79-$16.22
Granted		2,966,850		$	37.01	$	44.83-$36.95
Exercised		(2,608,007	)	$	23.22	$	46.97-$16.22
Cancelled		(481,550	)	$	38.00	$	46.97-$16.22

Balance, January 1, 2013		7,436,238		$	36.31	$	54.79-$16.22
Granted		2,889,750		$	53.51	$	79.79-$53.38
Exercised		(2,288,666	)	$	32.27	$	54.79-$16.22
Cancelled		(416,364	)	$	43.93	$	53.38-$16.22

Balance, January 1, 2014		7,620,958		$	43.63	$	79.79-$30.32
Granted		2,845,500		$	78.65	$	102.21-$78.17
Exercised		(2,277,469	)	$	38.50	$	73.65-$30.32
Cancelled		(291,538	)	$	55.63	$	78.17-$36.95

Balance, December 31, 2014		7,897,451		$	57.29	$	102.21-$36.95

Outstanding options vested and exercisable as of December 31, 2014		1,412,422		$	43.59	$	79.79-$36.97

Information about Unvested Options

The following table provides information about unvested options for the year December 31, 2014:


	Shares			Weighted Average Grant Date Fair Value
Unvested options as of January 1, 2014		5,864,830		$	12.12
Granted		2,845,500		$	17.23
Vested		(1,937,013	)	$	11.90
Cancelled		(288,288	)	$	13.64

Unvested options as of December 31, 2014		6,485,029		$	14.36

Information about all Outstanding Options

The following table provides information regarding all options outstanding at December 31, 2014:


	Options Outstanding		Options Exercisable
Number of options outstanding		7,897,451		1,412,422
Weighted average exercise price	$	57.29	$	43.59
Aggregate intrinsic value as of December 31, 2014	$	426,248,728	$	95,577,868
Weighted average remaining contractual life		2.9		1.8

Weighted Average Remaining Contractual Life for Options Outstanding and Weighted Average Exercise Price Per Share for Exercisable Options

The weighted average remaining contractual life for options outstanding and weighted average exercise price per share for exercisable options at December 31, 2014 were as follows:


Exercise Price	Options Outstanding		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in Years)		Exercisable Options		Weighted Average Exercise Price Per Share		Expected to Vest Options (a)		Weighted Average Exercise Price Per Share
Exercise Price	Shares		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in Years)		Shares		Weighted Average Exercise Price Per Share		Shares		Weighted Average Exercise Price Per Share
$36.95 – $43.46		1,690,463	$	37.00		2.0		465,688	$	37.02		1,100,460	$	36.99
$43.67 – $46.97		1,201,213		43.68		1.0		647,025		43.67		497,938		43.68
$53.38 – $73.65		2,241,625		53.52		3.0		299,209		53.58		1,745,261		53.51
$78.17 – $102.21		2,764,150		78.66		4.2		500		79.79		2,483,140		78.66

Total		7,897,451	$	57.29		2.9		1,412,422	$	43.59		5,826,799	$	60.27

(a)	Assumes a weighted average forfeiture rate of 10.2%.

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2014

Components of Income Tax Expense (Benefit)

Components of income tax expense/(benefit) are as follows (amounts in thousands):


	Year Ended December 31,
	2014		2013		2012
Current
Federal	$	248,172	$	256,545	$	254,021
Foreign		4,167		1,655		9,084
State		23,224		28,490		39,076

		275,563		286,690		302,181
Deferred
Federal and foreign		41,583		25,341		(21,408	)
State		7,525		3,278		(6,157	)

		49,108		28,619		(27,565	)

Total	$	324,671	$	315,309	$	274,616

Components of Deferred Taxes

The components of deferred taxes are as follows (amounts in thousands):


	Year Ended December 31,
	2014			2013
Deferred income tax assets:
Self-insurance reserves	$	84,915		$	87,483
Compensation accruals		55,788			49,302
State and foreign net operating loss carryforwards and other state and foreign deferred tax assets		60,521			57,204
Other currently non-deductible accrued liabilities		16,739			24,587
Net pension liability—OCI only		11,746			6,390
Doubtful accounts and other reserves		18,428			33,905
Other combined items—OCI only		2,615			9,018

		250,752			267,889
Less: Valuation Allowance		(52,764	)		(46,841	)

Net deferred income tax assets:		197,988			221,048
Deferred income tax liabilities:
Depreciable and amortizable assets		(362,674	)		(337,669	)
Other deferred tax liabilities		(2,963	)		(2,624	)

Net deferred income tax liabilities	$	(167,649	)	$	(119,245	)

Effective Tax Rates Calculation


	2014			2013			2012
Provision for income taxes	$	324,671		$	315,309		$	274,616
Income before income taxes		929,667			869,332			763,663

Effective tax rate		34.9	%		36.3	%		36.0	%

Reconciliation Between Federal Statutory Rate and Effective Tax Rate

A reconciliation between the federal statutory rate and the effective tax rate is as follows:


	Year Ended December 31,
	2014			2013			2012
Federal statutory rate		35.0	%		35.0	%		35.0	%
State taxes, net of federal income tax benefit		2.3			2.5			3.0
Nondeductible transaction costs		—			—			0.2
Divestiture gain		—			0.3			—
Other items		—			0.4			0.1
Impact of income attributable to noncontrolling interests		(2.4	)		(1.9	)		(2.3	)

Effective tax rate		34.9	%		36.3	%		36.0	%

Net Deferred Tax Assets and Liabilities

The net deferred tax assets and liabilities are comprised as follows (amounts in thousands):


	Year Ended December 31,
	2014			2013
Current deferred taxes
Assets	$	115,870		$	121,097
Liabilities		(1,305	)		(1,194	)

Total deferred taxes-current		114,565			119,903

Noncurrent deferred taxes
Assets		85,792			103,221
Liabilities		(368,006	)		(342,369	)

Total deferred taxes-noncurrent		(282,214	)		(239,148	)

Total deferred tax liabilities	$	(167,649	)	$	(119,245	)

Reconciliation of Unrecognized Tax Benefits

The tabular reconciliation of unrecognized tax benefits for the years ended December 31, 2014, 2013 and 2012 is as follows (amounts in thousands).


	As of December 31,
	2014			2013			2012
Balance at January 1,	$	3,369		$	6,824		$	7,403
Additions based on tax positions related to the current year		50			50			200
Additions for tax positions of prior years		195			283			386
Reductions for tax positions of prior years		(1,212	)		(1,260	)		(1,165	)
Settlements		—			(2,528	)		—

Balance at December 31,	$	2,402		$	3,369		$	6,824

- Definition

Tabular disclosure of tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities (i.e., uncertain tax positions) and other types of income tax contingencies, including: (1) the policy on classification of interest and penalties; (2) a tabular reconciliation of the total amounts of unrecognized tax benefits at the beginning and end of the period; the total amount(s) of: (3) unrecognized tax benefits that, if recognized, would affect the effective tax rate, and (4) interest and penalties recognized in each of the income statement and balance sheet; (5) for positions for which it is reasonably possible that the total amounts unrecognized will significantly change within 12 months of the reporting date the: (i) nature of the uncertainty, (ii) nature of the event that could occur that would cause the change, and (iii) an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made; and (6) a description of tax years that remain subject to examination by major tax jurisdictions.

+ References+ Details

Lease Commitments (Tables)

12 Months Ended

Dec. 31, 2014

Summary of Property Under Capital Lease

A summary of property under capital lease follows (amounts in thousands):


	As of December 31,
	2014			2013
Land, buildings and equipment	$	40,782		$	27,636
Less: accumulated amortization		(27,556	)		(27,382	)

	$	13,226		$	254

Future Minimum Rental Payments Under Lease Commitments

Future minimum rental payments under lease commitments with a term of more than one year as of December 31, 2014, are as follows (amounts in thousands):


Year	Capital Leases			Operating Leases
	(000s)
2015	$	3,293		$	58,904
2016		3,261			49,043
2017		3,308			31,619
2018		3,322			25,940
2019		3,370			22,229
Later years		22,356			147,288

Total minimum rental	$	38,910		$	335,023

Less: Amount representing interest		(17,310	)

Present value of minimum rental commitments		21,600
Less: Current portion of capital lease obligations		(1,080	)

Long-term portion of capital lease obligations	$	20,520

Relationship with Universal Health Realty Income Trust and Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2014

Remaining Renewal Options and Terms for Each of Four Hospital Facilities Leased from Trust

The table below details the renewal options and terms for each of our three hospital facilities leased from the Trust:

Hospital Name

Type of Facility

Annual
Minimum
Rent

End of Lease Term

Renewal
Term
(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

Pension Plan (Tables)

12 Months Ended

Dec. 31, 2014

Reconciliation of Defined Benefit Pension Plan

The following table shows the reconciliation of the defined benefit pension plan as of December 31, 2014 and 2013:


	2014			2013
	(000s)
Change in plan assets:
Fair value of plan assets at beginning of year	$	106,469		$	104,074
Actual return (loss) on plan assets		16,470			8,037
Employer contributions		0			0
Benefits paid		(5,605	)		(5,042	)
Administrative expenses		(637	)		(600	)

Fair value of plan assets at end of year	$	116,697		$	106,469
Change in benefit obligation:
Benefit obligation at beginning of year	$	103,558		$	114,529
Service cost		966			1,060
Interest cost		4,986			4,528
Benefits paid		(5,605	)		(5,042	)
Actuarial (gain) loss		23,437			(11,517	)

Benefit obligation at end of year	$	127,342		$	103,558
Amounts recognized in the Consolidated Balance Sheet:
Other non-current assets	$	0		$	2,911
Other non-current liabilities		10,645			0

Total amounts recognized at end of year	$	10,645		$	2,911

Components of Net Periodic Pension Cost (Benefit)


	2014			2013			2012
	(000s)
Components of net periodic cost (benefit)
Service cost	$	966		$	1,060		$	1,144
Interest cost		4,985			4,528			4,659
Expected return on plan assets		(7,772	)		(7,601	)		(7,301	)
Recognized actuarial loss		1,107			3,305			4,219

Net periodic cost	$	(714	)	$	1,292		$	2,721

Measurement Dates


	2014		2013
Measurement Dates
Benefit obligations		12/31/2014		12/31/2013
Fair value of plan assets		12/31/2014		12/31/2013

Weighted-average Assumptions for Net Periodic Benefit Cost


	2014			2013
Weighted average assumptions as of December 31
Discount rate		3.95	%		4.95	%
Rate of compensation increase		4.00	%		4.00	%

Weighted Average Assumptions


	2014			2013			2012
Weighted-average assumptions for net periodic benefit cost calculations
Discount rate		4.95	%		4.05	%		4.40	%
Expected long-term rate at return on plan assets		7.50	%		7.50	%		8.00	%
Rate of compensation increase		4.00	%		4.00	%		4.00	%

Market Values of Our Pension Plan Assets

The market values of our pension plan assets at December 31, 2014 and December 31, 2013 by asset category are as follows:


December 31, 2014	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	9,212	$	—	$	9,212	$	—
U.S. Mid Cap		2,852		—		2,852		—
U.S. Small Cap		2,626		—		2,626		—
International Developed		6,181		—		6,181		—
Emerging Markets		4,139		—		4,139		—
Fixed income:
Core Fixed Income		27,062		—		27,062		—
Long Duration Fixed Income		61,718		—		61,718		—
Real Estate:
REIT Fund		2,395		—		2,395		—
Cash/Currency:
Cash Equivalents		512		—		512		—

Total market value	$	116,697	$	—	$	116,697	$	—


December 31, 2013	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	8,600	$	—	$	8,600	$	—
U.S. Mid Cap		2,740		—		2,740		—
U.S. Small Cap		2,725		—		2,725		—
International Developed		6,508		—		6,508		—
Emerging Markets		4,154		—		4,154		—
Fixed income:
Core Fixed Income		23,222		—		23,222		—
Long Duration Fixed Income		55,933		—		55,933		—
Real Estate:
REIT Fund		2,124		—		2,124		—
Cash/Currency:
Cash Equivalents		463		—		463		—

Total market value	$	106,469	$	—	$	106,469	$	—

Estimated Future Benefit

There will be benefit payments under this plan beyond 2024.


Estimated Future Benefit Payments (000s)
2015	$	5,967
2016		6,231
2017		6,449
2018		6,661
2019		6,858
2020-2024		35,959

Total	$	68,125

Plan Assets


	2014			2013
Plan Assets
Asset Category
Equity securities		21	%		23	%
Fixed income securities		76	%		74	%
Other		3	%		3	%

Total		100	%		100	%

Asset Allocation Policy and Ranges Established in accordance with Overall Risk and Return Objectives of Portfolio

The following asset allocation policy and ranges have been established in accordance with the overall risk and return objectives of the portfolio:


	As of 12/31/14			Permitted Range
Total Equity		21	%		10-30	%
Total Fixed Income		76	%		70-90	%
Other		3	%		0-10	%

Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2014

Segment Reporting


2014	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	14,943,102		$	6,689,753			—		$	21,632,855
Gross outpatient revenues	$	8,147,031		$	784,309		$	34,238		$	8,965,578
Total net revenues	$	4,105,090		$	3,945,467		$	14,769		$	8,065,326
Income (loss) before allocation of corporate overhead and income taxes	$	465,328		$	944,068		$	(479,729	)	$	929,667
Allocation of corporate overhead	$	(178,781	)	$	(98,811	)	$	277,592		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	286,547		$	845,257		$	(202,137	)	$	929,667
Total assets	$	3,362,870		$	5,286,960		$	324,613		$	8,974,443


2013	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	13,469,269		$	6,294,046			—		$	19,763,315
Gross outpatient revenues	$	6,828,307		$	744,510		$	40,460		$	7,613,277
Total net revenues	$	3,576,369		$	3,667,967		$	39,486		$	7,283,822
Income (loss) before allocation of corporate overhead and income taxes	$	342,191		$	895,869		$	(368,728	)	$	869,332
Allocation of corporate overhead	$	(184,444	)	$	(89,447	)	$	273,891		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	157,747		$	806,422		$	(94,837	)	$	869,332
Total assets	$	3,125,626		$	4,966,182		$	219,915		$	8,311,723


2012	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	12,406,567		$	5,764,370			—		$	18,170,937
Gross outpatient revenues	$	6,134,615		$	646,177		$	48,183		$	6,828,975
Total net revenues	$	3,461,416		$	3,460,141		$	39,843		$	6,961,400
Income (loss) before allocation of corporate overhead and income taxes	$	337,385		$	838,603		$	(412,325	)	$	763,663
Allocation of corporate overhead	$	(162,056	)	$	(84,597	)	$	246,653		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	175,329		$	754,006		$	(165,672	)	$	763,663
Total assets	$	2,984,169		$	4,979,965		$	236,709		$	8,200,843

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details

Quarterly Results (Tables)

12 Months Ended

Dec. 31, 2014

Summary of Quarterly Financial Data

The following tables summarize the quarterly financial data for the two years ended December 31, 2014 and 2013:


2014	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,920,166	$	2,019,821	$	2,017,758	$	2,107,581	$	8,065,326
Net income	$	151,852	$	166,614	$	96,038	$	190,492	$	604,996
Less: Net income attributable to noncontrolling interests	$	13,774	$	14,943	$	13,241	$	17,695	$	59,653

Net income attributable to UHS	$	138,078	$	151,671	$	82,797	$	172,797	$	545,343

Earnings per share attributable to UHS-Basic:

Total basic earnings per share	$	1.40	$	1.53	$	0.84	$	1.75	$	5.52

Earnings per share attributable to UHS-Diluted:

Total diluted earnings per share	$	1.38	$	1.51	$	0.82	$	1.71	$	5.42


2013	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,831,632	$	1,834,975	$	1,816,369	$	1,800,846	$	7,283,822
Net income	$	129,935	$	167,803	$	123,099	$	133,186	$	554,023
Less: Net income attributable to noncontrolling interests	$	10,151	$	15,962	$	8,512	$	8,665	$	43,290

Net income attributable to UHS	$	119,784	$	151,841	$	114,587	$	124,521	$	510,733

Earnings per share attributable to UHS-Basic:

Total basic earnings per share	$	1.23	$	1.55	$	1.17	$	1.27	$	5.21

Earnings per share attributable to UHS-Diluted:

Total diluted earnings per share	$	1.21	$	1.53	$	1.15	$	1.24	$	5.14

Supplemental Condensed Consolidating Financial Information (Tables)

12 Months Ended

Dec. 31, 2014

Condensed Consolidating Statements of Income

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2014

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	6,100,777		$	2,692,752		$	(29,220	)	$	8,764,309
Less: Provision for doubtful accounts		0			471,181			227,802			0			698,983

Net Revenues		0			5,629,596			2,464,950			(29,220	)		8,065,326
Operating charges:
Salaries, wages and benefits		0			2,757,738			1,087,723			0			3,845,461
Other operating expenses		0			1,217,525			592,556			(27,100	)		1,782,981
Supplies expense		0			546,578			349,115			0			895,693
Depreciation and amortization		0			269,490			106,134			0			375,624
Lease and rental expense		0			58,619			37,494			(2,120	)		93,993
EHR incentive income		0			(19,480	)		(8,422	)		0			(27,902	)
Costs related to extinguishment of debt		36,171			0			0			0			36,171

		36,171			4,830,470			2,164,600			(29,220	)		7,002,021

Income from operations		(36,171	)		799,126			300,350			0			1,063,305
Interest expense		127,528			4,516			1,594			0			133,638
Interest (income) expense, affiliate		0			88,246			(88,246	)		0			0
Equity in net income of consolidated affiliates		(646,386	)		(184,385	)		0			830,771			0

Income before income taxes		482,687			890,749			387,002			(830,771	)		929,667
Provision for income taxes		(62,656	)		305,320			82,007			0			324,671

Net income		545,343			585,429			304,995			(830,771	)		604,996
Less: Income attributable to noncontrolling interests		0			0			59,653			0			59,653

Net income attributable to UHS	$	545,343		$	585,429		$	245,342		$	(830,771	)	$	545,343

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2013

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	5,658,699		$	2,780,983		$	(28,644	)	$	8,411,038
Less: Provision for doubtful accounts		0			657,106			470,110			0			1,127,216

Net Revenues		0			5,001,593			2,310,873			(28,644	)		7,283,822
Operating charges:
Salaries, wages and benefits		0			2,573,205			1,031,415			0			3,604,620
Other operating expenses		0			972,170			523,382			(26,808	)		1,468,744
Supplies expense		0			510,078			311,011			0			821,089
Depreciation and amortization		0			236,958			100,214			0			337,172
Lease and rental expense		0			62,518			37,076			(1,836	)		97,758
EHR incentive income		0			(43,027	)		(17,997	)		0			(61,024	)

		0			4,311,902			1,985,101			(28,644	)		6,268,359

Income from operations		0			689,691			325,772			0			1,015,463
Interest expense		139,793			3,365			2,973			0			146,131
Interest (income) expense, affiliate		0			84,640			(84,640	)		0			0
Equity in net income of consolidated affiliates		(597,020	)		(141,004	)		0			738,024			0

Income before income taxes		457,227			742,690			407,439			(738,024	)		869,332
Provision for income taxes		(53,506	)		262,346			106,469			0			315,309

Net income		510,733			480,344			300,970			(738,024	)		554,023
Less: Income attributable to noncontrolling interests		0			0			43,290			0			43,290

Net income attributable to UHS	$	510,733		$	480,344		$	257,680		$	(738,024	)	$	510,733

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	5,152,816		$	2,562,781		$	(27,526	)	$	7,688,071
Less: Provision for doubtful accounts		0			411,538			315,133			0			726,671

Net Revenues		0			4,741,278			2,247,648			(27,526	)		6,961,400
Operating charges:
Salaries, wages and benefits		0			2,452,187			988,730			0			3,440,917
Other operating expenses		0			899,274			502,592			(25,744	)		1,376,122
Supplies expense		0			496,848			302,773			0			799,621
Depreciation and amortization		0			210,867			91,559			0			302,426
Lease and rental expense		0			59,596			37,071			(1,782	)		94,885
Transaction costs		0			5,716			0			0			5,716
EHR incentive income		0			(14,284	)		(15,754	)		0			(30,038	)
Costs related to extinguishment of debt		29,170			0			0			0			29,170

		29,170			4,110,204			1,906,971			(27,526	)		6,018,819

Income from operations		(29,170	)		631,074			340,677			0			942,581
Interest expense		172,467			3,749			2,702			0			178,918
Interest (income) expense, affiliate		0			93,363			(93,363	)		0			0
Equity in net income of consolidated affiliates		(567,906	)		(141,983	)		0			709,889			0

Income before income taxes		366,269			675,945			431,338			(709,889	)		763,663
Provision for income taxes		(77,177	)		237,072			114,721			0			274,616

Net income		443,446			438,873			316,617			(709,889	)		489,047
Less: Income attributable to noncontrolling interests		0			0			45,601			0			45,601

Net income attributable to UHS	$	443,446		$	438,873		$	271,016		$	(709,889	)	$	443,446

Condensed Consolidating Statements of Comprehensive Income

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2014

(amounts in thousands)


	Parent			Guarantors			Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	545,343		$	585,429		$	304,995	$	(830,771	)	$	604,996
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		17,668			0			0		0			17,668
Amortization of terminated hedge		(336	)		0			0		0			(336	)
Minimum Pension Liability		(14,270	)		(14,270	)		0		14,270			(14,270	)
Foreign currency translation adjustment		(2,431	)		(2,431	)		0		2,431			(2,431	)

Other comprehensive income before tax		631			(16,701	)		0		16,701			631
Income tax expense related to items of other comprehensive income		1,053			(5,356	)		0		5,356			1,053

Total other comprehensive income, net of tax		(422	)		(11,345	)		0		11,345			(422	)

Comprehensive income		544,921			574,084			304,995		(819,426	)		604,574
Less: Comprehensive income attributable to noncontrolling interests		0			0			59,653		0			59,653

Comprehensive income attributable to UHS	$	544,921		$	574,084		$	245,342	$	(819,426	)	$	544,921

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2013

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	510,733		$	480,344	$	300,970	$	(738,024	)	$	554,023
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		16,963			0		0		0			16,963
Amortization of terminated hedge		(336	)		0		0		0			(336	)
Minimum Pension Liability		14,657			14,657		0		(14,657	)		14,657

Other comprehensive income before tax		31,284			14,657		0		(14,657	)		31,284
Income tax expense related to items of other comprehensive income		11,940			5,670		0		(5,670	)		11,940

Total other comprehensive income, net of tax		19,344			8,987		0		(8,987	)		19,344

Comprehensive income		530,077			489,331		300,970		(747,011	)		573,367
Less: Comprehensive income attributable to noncontrolling interests		0			0		43,290		0			43,290

Comprehensive income attributable to UHS	$	530,077		$	489,331	$	257,680	$	(747,011	)	$	530,077

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2012

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	443,446		$	438,873	$	316,617	$	(709,889	)	$	489,047
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		6,677			0		0		0			6,677
Amortization of terminated hedge		(336	)		0		0		0			(336	)
Minimum Pension Liability		4,986			4,986		0		(4,986	)		4,986

Other comprehensive income before tax		11,327			4,986		0		(4,986	)		11,327
Income tax expense related to items of other comprehensive income		4,306			1,898		0		(1,898	)		4,306

Total other comprehensive income, net of tax		7,021			3,088		0		(3,088	)		7,021

Comprehensive income		450,467			441,961		316,617		(712,977	)		496,068
Less: Comprehensive income attributable to noncontrolling interests		0			0		45,601		0			45,601

Comprehensive income attributable to UHS	$	450,467		$	441,961	$	271,016	$	(712,977	)	$	450,467

Condensed Consolidating Balance Sheet

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2014

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	21,784		$	10,285		$	0		$	32,069
Accounts receivable, net		0		933,971			348,764			0			1,282,735
Supplies		0		67,847			40,268			0			108,115
Deferred income taxes		113,822		743			0			0			114,565
Other current assets		0		62,431			15,223			0			77,654

Total current assets		113,822		1,086,776			414,540			0			1,615,138

Investments in subsidiaries		7,013,540		1,661,296			0			(8,674,836	)		0
Intercompany receivable		103,808		0			408,682			(512,490	)		0
Intercompany note receivable		0		0			1,222,637			(1,222,637	)		0

Property and equipment		0		4,494,567			1,717,463			0			6,212,030
Less: accumulated depreciation		0		(1,686,192	)		(846,149	)		0			(2,532,341	)

		0		2,808,375			871,314			0			3,679,689

Other assets:
Goodwill		0		2,764,555			526,658			0			3,291,213
Deferred charges		32,379		5,402			2,538			0			40,319
Other		9,601		283,302			55,181			0			348,084

	$	7,273,150	$	8,609,706		$	3,501,550		$	(10,409,963	)	$	8,974,443

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	44,874	$	1,260		$	22,185			0		$	68,319
Accounts payable and accrued liabilities		20,245		1,051,309			41,508			0			1,113,062
Federal and state taxes		1,446		0			0			0			1,446

Total current liabilities		66,565		1,052,569			63,693			0			1,182,827

Intercompany payable		0		512,490			0			(512,490	)		0
Other noncurrent liabilities		1,322		189,456			77,777			0			268,555
Long-term debt		3,187,103		20,212			2,900			0			3,210,215
Intercompany note payable		0		1,222,637			0			(1,222,637	)		0
Deferred income taxes		282,214		0			0			0			282,214
Redeemable noncontrolling interests		0		0			239,552			0			239,552

UHS common stockholders’ equity		3,735,946		5,612,342			3,062,494			(8,674,836	)		3,735,946
Noncontrolling interest		0		0			55,134			0			55,134

Total equity		3,735,946		5,612,342			3,117,628			(8,674,836	)		3,791,080

	$	7,273,150	$	8,609,706		$	3,501,550		$	(10,409,963	)	$	8,974,443

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2013

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	7,990		$	9,248		$	0		$	17,238
Accounts receivable, net		0		799,898			317,063			0			1,116,961
Supplies		0		63,562			38,219			0			101,781
Deferred income taxes		76,719		43,184			0			0			119,903
Other current assets		0		63,786			12,660			0			76,446

Total current assets		76,719		978,420			377,190			0			1,432,329

Investments in subsidiaries		6,378,499		1,476,911			0			(7,855,410	)		0
Intercompany receivable		226,592		0			531,411			(758,003	)		0
Intercompany note receivable		0		0			982,568			(982,568	)		0

Property and equipment		0		4,093,914			1,597,988			0			5,691,902
Less: accumulated depreciation		0		(1,478,758	)		(770,975	)		0			(2,249,733	)

		0		2,615,156			827,013			0			3,442,169

Other assets:
Goodwill		0		2,552,190			496,826			0			3,049,016
Deferred charges		49,866		5,577			2,438			0			57,881
Other		8,411		251,365			70,552			0			330,328

	$	6,740,087	$	7,879,619		$	3,287,998		$	(9,595,981	)	$	8,311,723

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	97,403		916			993			0		$	99,312
Accounts payable and accrued liabilities		28,099		837,354			87,996			0			953,449
Federal and state taxes		4,963		2,164			0			0			7,127

Total current liabilities		130,465		840,434			88,989			0			1,059,888

Intercompany payable		0		758,003			0			(758,003	)		0
Other noncurrent liabilities		7,591		199,104			77,894			0			284,589
Long-term debt		3,168,819		5,337			35,606			0			3,209,762
Intercompany note payable		0		982,568			0			(982,568	)		0
Deferred income taxes		183,233		55,915			0			0			239,148
Redeemable noncontrolling interests		0		0			218,107			0			218,107

UHS common stockholders’ equity		3,249,979		5,038,258			2,817,152			(7,855,410	)		3,249,979
Noncontrolling interest		0		0			50,250			0			50,250

Total equity		3,249,979		5,038,258			2,867,402			(7,855,410	)		3,300,229

	$	6,740,087	$	7,879,619		$	3,287,998		$	(9,595,981	)	$	8,311,723

Condensed Consolidating Statements of Cash Flows

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2014

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	18,579		$	687,101		$	330,196		$	0	$	1,035,876

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(230,102	)		(161,048	)		0		(391,150	)
Acquisition of property and businesses		0			(422,081	)		(9,305	)		0		(431,386	)
Proceeds received from sale of assets and businesses		0			11,450			3,728			0		15,178
Costs incurred for purchase and development of electronic health records application		0			(13,488	)		0			0		(13,488	)
Increase in insurance subsidiary investments		0			(12,000	)		0			0		(12,000	)

Net cash used in investing activities		0			(666,221	)		(166,625	)		0		(832,846	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(866,748	)		(867	)		(11,514	)		0		(879,129	)
Additional borrowings		830,000			0			0			0		830,000
Financing costs		(14,976	)		0			0			0		(14,976	)
Repurchase of common shares		(100,749	)		0			0			0		(100,749	)
Dividends paid		(29,665	)		0			0			0		(29,665	)
Issuance of common stock		6,863			0			0			0		6,863
Excess income tax benefits related to stock based compensation		33,912			0			0			0		33,912
Profit distributions to noncontrolling interests		0			0			(33,680	)		0		(33,680	)
Changes in intercompany balances with affiliates, net		122,784			(5,444	)		(117,340	)		0		0

Net cash (used in) provided by financing activities		(18,579	)		(6,311	)		(162,534	)		0		(187,424	)

Effect of exchange rate changes on cash and cash equivalents		0			(775	)		0			0		(775	)

Increase in cash and cash equivalents		0			13,794			1,037			0		14,831
Cash and cash equivalents, beginning of period		0			7,990			9,248			0		17,238

Cash and cash equivalents, end of period	$	0		$	21,784		$	10,285		$	0	$	32,069

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2013

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	17,946		$	587,083		$	279,212		$	0	$	884,241

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(269,419	)		(89,074	)		0		(358,493	)
Acquisition of property and businesses		0			(8,094	)		(4,542	)		0		(12,636	)
Proceeds received from sale of assets and businesses		0			7,916			29,566			0		37,482
Costs incurred for purchase and development of electronic health records application		0			(49,811	)		0			0		(49,811	)

Net cash used in investing activities		0			(319,408	)		(64,050	)		0		(383,458	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(429,996	)		(109	)		(10,119	)		0		(440,224	)
Additional borrowings		15,761			0			0			0		15,761
Financing costs		(231	)		0			0			0		(231	)
Repurchase of common shares		(27,201	)		0			0			0		(27,201	)
Dividends paid		(19,621	)		0			0			0		(19,621	)
Issuance of common stock		5,708			0			0			0		5,708
Excess income tax benefits related to stock based compensation		20,121			0			0			0		20,121
Profit distributions to noncontrolling interests		0			0			(61,329	)		0		(61,329	)
Changes in intercompany balances with affiliates, net		417,513			(271,525	)		(145,988	)		0		0

Net cash used in financing activities		(17,946	)		(271,634	)		(217,436	)		0		(507,016	)

Decrease in cash and cash equivalents		0			(3,959	)		(2,274	)		0		(6,233	)
Cash and cash equivalents, beginning of period		0			11,949			11,522			0		23,471

Cash and cash equivalents, end of period	$	0		$	7,990		$	9,248		$	0	$	17,238

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net cash (used in) provided by operating activities	$	(37,648	)	$	594,606		$	242,273		$	0		$	799,231

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(312,190	)		(51,002	)		0			(363,192	)
Acquisition of property and businesses		0			(513,596	)		(14,251	)		0			(527,847	)
Proceeds received from sale of assets and businesses		0			142,667			6,644			0			149,311
Costs incurred for purchase and development of electronic health records application		0			(54,362	)		0			0			(54,362	)
Return of Deposit on terminated purchase agreement		6,500			0			0			0			6,500

Net cash provided by (used in) investing activities		6,500			(737,481	)		(58,609	)		0			(789,590	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(843,002	)		0			(8,258	)		1,613			(849,647	)
Additional borrowings		913,500			1,613			0			(1,613	)		913,500
Financing costs		(8,283	)		0			0			0			(8,283	)
Repurchase of common shares		(19,154	)		0			0			0			(19,154	)
Dividends paid		(58,395	)		0			0			0			(58,395	)
Issuance of common stock		5,435			0			0			0			5,435
Excess income tax benefits related to stock based compensation		16,040			0			0			0			16,040
Profit distributions to noncontrolling interests		0			0			(26,895	)		0			(26,895	)
Changes in intercompany balances with affiliates, net		25,007			119,990			(144,997	)		0			0

Net cash provided by (used in) financing activities		31,148			121,603			(180,150	)		0			(27,399	)

Increase (decrease) in cash and cash equivalents		0			(21,272	)		3,514			0			(17,758	)
Cash and cash equivalents, beginning of period		0			33,221			8,008			0			41,229

Cash and cash equivalents, end of period	$	0		$	11,949		$	11,522		$	0		$	23,471

Business and Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	0 Months Ended	12 Months Ended						0 Months Ended		12 Months Ended										12 Months Ended						12 Months Ended							1 Months Ended	12 Months Ended
	Sep. 01, 2014	Dec. 31, 2014 D Facility	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013 Restricted Stock	Dec. 31, 2014 Acute Care Hospitals	Dec. 31, 2013 Acute Care Hospitals	Jan. 01, 2014 After Modification	Jan. 01, 2014 Before Modification	Dec. 31, 2014 State Medicaid programs	Dec. 31, 2013 State Medicaid programs	Dec. 31, 2012 State Medicaid programs	Dec. 31, 2014 Medicare And Medicaid Net Revenue	Dec. 31, 2013 Medicare And Medicaid Net Revenue	Dec. 31, 2012 Medicare And Medicaid Net Revenue	Dec. 31, 2014 Care Entities Net Revenue	Dec. 31, 2013 Care Entities Net Revenue	Dec. 31, 2012 Care Entities Net Revenue	Dec. 31, 2014 Las Vegas, Nevada Acute Care Facilities	Dec. 31, 2014 Las Vegas, Nevada Net Revenue	Dec. 31, 2013 Las Vegas, Nevada Net Revenue	Dec. 31, 2012 Las Vegas, Nevada Net Revenue	Dec. 31, 2014 Washington, District of Columbia Acute Care Facilities	Dec. 31, 2014 Laredo, Texas Acute Care Facilities	Dec. 31, 2014 Philadelphia, Pennsylvania Behavioral Health Care Facility	Dec. 31, 2014 Illinois D	Dec. 31, 2013 Illinois	Dec. 31, 2014 Texas	Dec. 31, 2013 Texas	Dec. 31, 2014 Texas Uncompensated Care Program	Dec. 31, 2014 Texas Disproportionate Share Hospital Program	Dec. 31, 2014 Texas Delivery System Reform Incentive Pool	Jan. 31, 2015 Texas Subsequent Event Delivery System Reform Incentive Pool	Dec. 31, 2014 Building and Building Improvements Minimum	Dec. 31, 2014 Building and Building Improvements Maximum	Dec. 31, 2014 Equipment Minimum	Dec. 31, 2014 Equipment Maximum
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of revenue													36.00%	38.00%	39.00%	50.00%	49.00%	49.00%		14.00%	14.00%	14.00%
Establishment of partial reserve in the allowance for doubtful accounts for self-pay balances outstanding from the date of discharge, in days		90
Establishment of fully reserve for self-pay balances outstanding from the date of discharge, in days		90
Establishment of fully reserve in the allowance for doubtful accounts for third party liability accounts from the date of discharge, in days		180
Patients treated at hospitals for non elective services gross income less than federal poverty guidelines		400.00%
Percentage of uninsured discount extended for unqualified charity patients								60.00%	30.00%
Net of allowance for doubtful accounts		$ 325,000,000	$ 395,000,000
Provision for doubtful accounts		698,983,000	1,127,216,000	726,671,000		590,000,000	1,020,000,000
Accounts receivable																										44,000,000	49,000,000	102,000,000	62,000,000	45,000,000	33,000,000	24,000,000
Accounts receivable collection																																	24,000,000
Receivables due outstanding in excess of 60 days																										23,000,000	28,000,000
Receivables days in excess																										60
Capitalize interest expense			4,900,000	5,700,000
Property and equipment, useful lives, maximum years																																		20 years	40 years	3 years	15 years
Depreciation expense		314,500,000	285,600,000	270,500,000
Impairment of goodwill or indefinite-lived intangible assets	0		0	0
Other intangible assets, net of accumulated amortization		98,000,000	97,000,000
Amount of estimated future payments related to physician-related contractual commitments		2,000,000	3,000,000
Amount of potential future financial obligations		2,000,000
Acute care facilities with outside owners holding non-controlling minority interest		5
Percentage of non-controlling, minority ownership interests held by outside owners																			28.00%				20.00%	11.00%	20.00%
Redeemable non-controlling interest balances		240,000,000	218,000,000
Non-controlling interest balances		55,000,000	50,000,000
Anti-dilutive weighted average stock options excluded from computation of earnings per share		2,250.0	4,000.0	2,000,000
Restricted stock, vesting period					7 years
Revenue from Medicaid programs		8,764,309,000	8,411,038,000	7,688,071,000						293,000,000	213,000,000	176,000,000
Revenue offset amount										137,000,000	84,000,000	93,000,000
Net aggregate benefit										156,000,000	130,000,000	83,000,000
Net revenues										$ 59,000,000	$ 54,000,000	$ 47,000,000

Summary of Changes in Carrying Amount of Goodwill (Detail) (USD $)
In Thousands, unless otherwise specified

12 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Goodwill [Line Items]

Goodwill, Beginning Balance

$ 3,049,016

$ 3,036,765

Goodwill acquired during the period

250,212

^[1]

Adjustments to goodwill

(8,015)

12,251

^[1]

Goodwill, Ending Balance

3,291,213

3,049,016

Acute Care Services

Goodwill [Line Items]

Goodwill, Beginning Balance

383,011

382,696

Goodwill acquired during the period

4,088

^[1]

Adjustments to goodwill

315

^[1]

Goodwill, Ending Balance

387,099

383,011

Behavioral Health Services

Goodwill [Line Items]

Goodwill, Beginning Balance

2,666,005

2,654,069

Goodwill acquired during the period

246,124

^[1]

Adjustments to goodwill

(8,015)

11,936

^[1]

Goodwill, Ending Balance

$ 2,904,114

$ 2,666,005

[1]	The increase in the Behavioral Health Services' goodwill consists primarily of an amount that was reclassified from other assets.

Amounts Recognized in AOCI (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, beginning balance	$ (14,170)	$ (24,527)
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, Pre tax amount	17,332	16,627
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, Income tax effect	(6,409)	(6,270)
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, Change, net of income tax	10,923	10,357
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, ending balance	(3,247)	(14,170)	(24,527)
Foreign Currency Translation Adjustment, beginning balance	0	0
Foreign Currency Translation Adjustment, Pretax amount	(2,431)	0	0
Foreign Currency Translation Adjustment, Income tax effect	0	0
Foreign Currency Translation Adjustment, Change, net of income tax	(2,431)	0
Foreign Currency Translation Adjustment, ending balance	(2,431)	0	0
Minimum Pension Liability, beginning balance	(10,640)	(19,627)
Minimum Pension Liability, Pre tax amount	(14,270)	14,657
Minimum pension liability, income tax effect	5,356	5,670	1,898
Minimum Pension Liability, Change, net of income tax	(8,914)	8,987
Minimum Pension Liability, ending balance	(19,554)	(10,640)	(19,627)
Total AOCI, beginning balance	(24,810)	(44,154)
Total AOCI, Pre tax amount	631	31,284	11,327
Total AOCI, Income tax effect	(1,053)	(11,940)	(4,306)
Total AOCI, Change, net of income tax	(422)	19,344	7,021
Total AOCI, ending balance	$ (25,232)	$ (24,810)	$ (44,154)

Computation of Basic and Diluted Earnings per Share (Detail) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Basic and diluted:
Net Income									$ 604,996	$ 554,023	$ 489,047
Less: Net income attributable to noncontrolling interest									(59,653)	(43,290)	(45,601)
Less: Net income attributable to unvested restricted share grants									(236)	(294)	(497)
Net income attributable to UHS-basic and diluted									$ 545,107	$ 510,439	$ 442,949
Weighted average number of common shares-basic									98,826	98,033	96,821
Total basic earnings per share	$ 1.75	$ 0.84	$ 1.53	$ 1.40	$ 1.27	$ 1.17	$ 1.55	$ 1.23	$ 5.52	$ 5.21	$ 4.57
Weighted average number of common shares									98,826	98,033	96,821
Net effect of dilutive stock options and grants based on the treasury stock method									1,718	1,328	890
Weighted average number of common shares and equivalents-diluted									100,544	99,361	97,711
Total diluted earnings per share	$ 1.71	$ 0.82	$ 1.51	$ 1.38	$ 1.24	$ 1.15	$ 1.53	$ 1.21	$ 5.42	$ 5.14	$ 4.53

Acquisitions and Divestitures - Additional Information (Detail) (USD $)	12 Months Ended						12 Months Ended			3 Months Ended	12 Months Ended		3 Months Ended	12 Months Ended				1 Months Ended	3 Months Ended	12 Months Ended	3 Months Ended				12 Months Ended
	Dec. 31, 2014 Facility	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012 Auburn Regional Medical Center	Dec. 31, 2012 2012 Divestiture of Assets and Businesses	Dec. 31, 2012 2012 Divestiture of Assets and Businesses Peak Behavioral Health Services Bed	Dec. 31, 2012 2012 Divestiture of Assets and Businesses Hospital San Juan Capestrano Bed	Dec. 31, 2012 2012 Divestiture of Assets and Businesses Auburn Regional Medical Center Bed	Dec. 31, 2012 2012 Divestiture of Assets and Businesses Behavioral Health Care Facility Facility	Jun. 30, 2013 Two Thousand Thirteen Divestiture of Assets and Businesses Peak Behavioral Health Services	Dec. 31, 2013 Two Thousand Thirteen Divestiture of Assets and Businesses Peak Behavioral Health Services	Dec. 31, 2013 2013 Acquisitions of Assets and Businesses	Dec. 31, 2012 2012 Acquisitions of Assets and Businesses	Dec. 31, 2012 2012 Acquisitions of Assets and Businesses	Dec. 31, 2012 2012 Acquisitions of Assets and Businesses Ascend Health Corporation	Dec. 31, 2012 2012 Acquisitions of Assets and Businesses Physician Practices and Various Real Property	Dec. 31, 2014 2014 Acquisitions of Assets and Businesses	Nov. 30, 2010 Cygnet Health Care Limited Facility	Sep. 30, 2014 Cygnet Health Care Limited Bed Hospital Facility	Dec. 31, 2014 Cygnet Health Care Limited	Jun. 30, 2014 Psychiatric Institute Bed	Mar. 31, 2014 Palo Verde Behavioral Health Bed	Dec. 31, 2014 The Bridgeway Bed	Dec. 31, 2014 Cygnet Hospital-Harrow Bed	Feb. 28, 2015 Cygnet Hospital-Taunton Scenario, Forecast Bed
Business Acquisition [Line Items]
Number of beds																			723		124	48	103	44	46
Acquisition, cash paid												$ 13,000,000		$ 528,000,000	$ 503,000,000	$ 25,000,000	$ 431,000,000
Number of facilities																		18	17
Number of hospitals	3																		15
Number of nursing homes																		2	2
Net revenues													42,000,000							175,000,000
Pro forma net revenues												7,620,000,000		7,110,000,000			8,280,000,000
Pro forma net income attributable to UHS												522,000,000		464,000,000			558,000,000
Pro forma net income attributable to UHS per diluted share												$ 5.25		$ 4.74			$ 5.55
Aggregate cash proceeds from divestiture of businesses	15,000,000
Net cash proceeds from divestiture of assets and businesses					149,000,000		50,000,000	93,000,000	6,000,000	24,000,000	37,000,000
Aggregate pre-tax net gain on the divestiture		$ 3,080,000	$ 26,419,000	$ 26,000,000						$ 3,000,000	$ 3,000,000
Number of acute care hospital beds included in acquisition							108	159
Number of non-operating behavioral health facilities									2
Number of beds						104

Aggregate Net Purchase Price Allocation to Assets and Liabilities based on Estimated Fair Values (Detail) (USD $) In Thousands, unless otherwise specified				12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012 2012 Acquisitions of Assets and Businesses	Dec. 31, 2014 2014 Acquisitions of Assets and Businesses
Business Acquisition [Line Items]
Working capital, net				$ 21,000	$ (41,000)
Property & equipment				60,000	174,000
Goodwill	3,291,213	3,049,016	3,036,765	446,000	250,000
Other assets				9,000	59,000
Income tax assets, net of deferred tax liabilities				(1,000)	4,000
Debt					(16,000)
Other				(7,000)	1,000
Cash paid in 2012 for acquisitions				$ 528,000	$ 431,000

Results of Operations Reflected as Discontinued Operations (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Acquisitions And Discontinued Operations [Line Items]
Net revenues	$ 7,813	$ 95,226
Income (loss) from discontinued operations, before income taxes	932	(3,472)
Gain on divestiture	3,080	26,419
Income from discontinued operations, before income tax expense	4,012	22,947
Income tax expense	(1,506)	(8,688)
Income from discontinued operations, net of income taxes	$ 2,506	$ 14,259

- Definition

Overall income (loss) from a disposal group that is classified as a component of the entity, before income tax, reported as a separate component of income before extraordinary items. Includes the following (before income tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References+ Details

- Definition

Tax effect allocated to a disposal group that is classified as a component of the entity reported as a separate component of income before extraordinary items. Includes the tax effects of the following: income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References+ Details

- Definition

Amount of income (loss) from a disposal group, net of income tax before extraordinary items allocable to noncontrolling interests. Includes, net of tax, income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References+ Details

Financial Instruments - Additional Information (Detail) (USD $)	12 Months Ended												12 Months Ended
	Dec. 31, 2011	Dec. 31, 2011 Forward Starting Interest Rate Swaps Derivative	Dec. 31, 2010 Forward Starting Interest Rate Swaps Derivative	Dec. 31, 2010 Two Point Three Eight Percent Forward Starting Interest Rate Swaps	Dec. 31, 2014 Interest Rate Swap	Dec. 31, 2013 Interest Rate Swap	Dec. 31, 2013 Interest Rate Swap Other Current Liabilities	Dec. 31, 2013 Interest Rate Swap Other Noncurrent Liabilities	Dec. 31, 2014 Fair Value Hedge	Dec. 31, 2013 Fair Value Hedge	Dec. 31, 2012 Fair Value Hedge	Dec. 31, 2011 One Point Nine One Percent Forward Starting Interest Rate Swaps	Dec. 31, 2011 One Point Three Two Percent Forward Starting Interest Rate Swaps	Dec. 31, 2011 One Point Nine Six Percent Forward Starting Interest Rate Swaps	Dec. 31, 2011 Two Point Five Zero Percent Forward Starting Interest Rate Swaps	Dec. 31, 2011 Cash Flow Hedging Interest Rate Cap from December Twenty Eleven to December Twenty Twelve	Dec. 31, 2011 Cash Flow Hedging Interest Rate Cap from December Twenty Twelve to December Twenty Thirteen	Dec. 31, 2011 Cash Flow Hedging Forward Starting Interest Rate Swaps	Dec. 31, 2010 Cash Flow Hedging Two Point Three Eight Percent Forward Starting Interest Rate Swaps	Dec. 31, 2011 Cash Flow Hedging One Point Nine One Percent Forward Starting Interest Rate Swaps	Dec. 31, 2011 Cash Flow Hedging One Point Three Two Percent Forward Starting Interest Rate Swaps	Dec. 31, 2011 Cash Flow Hedging One Point Nine Six Percent Forward Starting Interest Rate Swaps	Dec. 31, 2011 Cash Flow Hedging Two Point Five Zero Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Fair value of hedges outstanding									$ 0	$ 0	$ 0
Number of additional forward starting interest rate swaps		6	4
Notional amount of interest rate cash flow hedges																450,000,000	400,000,000	425,000,000	600,000,000	225,000,000	75,000,000	25,000,000	100,000,000
Maturity date of interest rate cash flow hedges	Dec. 01, 2013			May 01, 2015									Dec. 01, 2012	Dec. 01, 2013	Dec. 01, 2014
Fixed rate payable on interest rate swap				2.38%									1.32%	1.96%	2.50%
Average fixed rate payable on interest rate swap												1.91%
Derivative cap interest rate	7.00%
Premium paid on interest rate cap	740,000
Fair value of our interest rate swaps, liability					$ 6,000,000	$ 24,000,000	$ 19,000,000	$ 5,000,000

Summary of Long-Term Debt (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Accounts receivable securitization program	$ 330,000,000
Long-term debt	3,278,534,000	3,309,074,000
Less-Amounts due within one year	(68,319,000)	(99,312,000)
Long-term debt, net	3,210,215,000	3,209,762,000
Notes Payable And Mortgages Payable
Debt Instrument [Line Items]
Notes payable and Mortgages payable (including obligations under capitalized leases of $21,600 in 2014 and $6,633 in 2013) and term loans with varying maturities through 2037; weighted average interest rates of 6.4% in 2014 and 5.9% in 2013 and 2012 (see Note 7 regarding capitalized leases)	41,257,000	37,553,000
Revolving Credit And Demand Notes
Debt Instrument [Line Items]
Line of credit facility amount outstanding	140,500,000	25,500,000
Term Loan A
Debt Instrument [Line Items]
Line of credit facility amount outstanding	1,761,872,000	935,308,000
Term Loan B Facility
Debt Instrument [Line Items]
Line of credit facility amount outstanding	0	543,527,000
Term Loan- A2
Debt Instrument [Line Items]
Line of credit facility amount outstanding	0	871,875,000
Revenue Bonds
Debt Instrument [Line Items]
Revenue bonds, interest at floating rates of 0.05% at December 31, 2014 and 0.1% at December 31, 2013, with varying maturities through 2015	5,300,000	5,300,000
Accounts Receivable Securitization Program
Debt Instrument [Line Items]
Accounts receivable securitization program	330,000,000	240,000,000
3.750% Senior Secured Notes due 2019
Debt Instrument [Line Items]
Senior Notes	299,802,000	0
4.750% Senior Secured Notes due 2022
Debt Instrument [Line Items]
Senior Notes	299,796,000	0
7.125% Senior Secured Notes due 2016
Debt Instrument [Line Items]
Senior Notes	400,007,000	400,011,000
7.00% Senior Unsecured Notes due 2018
Debt Instrument [Line Items]
Senior Notes	$ 0	$ 250,000,000

- Definition

The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.

+ References+ Details

- Definition

Carrying amount of long-term debt, net of unamortized discount or premium, including current and noncurrent amounts. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.

+ References+ Details

Summary of Long-Term Debt (Parenthetical) (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Notes Payable And Mortgages Payable
Debt Instrument [Line Items]
Obligations under capitalized leases	$ 21,600	$ 6,633
Weighted average interest	6.40%	5.90%
Term Loans With Varying Maturities
Debt Instrument [Line Items]
Debt instruments, maturity date	2037
Term Loan A
Debt Instrument [Line Items]
Unamortized discount	2,035	3,340
Term Loan B Facility
Debt Instrument [Line Items]
Unamortized discount	0	6,473
Revenue Bonds
Debt Instrument [Line Items]
Interest at floating rates	0.05%	0.10%
Debt instruments, maturity date	2015
3.750% Senior Secured Notes due 2019
Debt Instrument [Line Items]
Debt instruments, maturity date	2019
Senior notes, interest rate	3.75%
Unamortized discount	198
4.750% Senior Secured Notes due 2022
Debt Instrument [Line Items]
Debt instruments, maturity date	2022
Senior notes, interest rate	4.75%
Unamortized discount	204
7.125% Senior Secured Notes due 2016
Debt Instrument [Line Items]
Debt instruments, maturity date	2016
Senior notes, interest rate	7.125%
Unamortized net premium	$ 7	$ 11
7.00% Senior Unsecured Notes due 2018
Debt Instrument [Line Items]
Debt instruments, maturity date	2018
Senior notes, interest rate	7.00%

Long-Term Debt - Additional Information (Detail) (USD $)	12 Months Ended					0 Months Ended	12 Months Ended																			12 Months Ended			12 Months Ended		0 Months Ended	12 Months Ended		12 Months Ended						0 Months Ended						0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014 Term Loan A Quarterly installment payments commence in the fourth quarter of 2014 through September, 2016	Dec. 31, 2014 Term Loan A Quarterly installment payments after September, 2016	Aug. 07, 2014 Term Loan B Facility	Dec. 31, 2014 Term Loan-A and Term Loan A2 facilities	Dec. 31, 2013 Term Loan-A and Term Loan A2 facilities	Dec. 31, 2014 New Senior Secured Notes	Dec. 31, 2014 ABR-based loans	Dec. 31, 2014 Revolving Credit Facility	Dec. 31, 2014 Revolving Credit Facility One Month Eurodollar Rate Plus Index Based Loans Minimum	Dec. 31, 2014 Revolving Credit Facility One Month Eurodollar Rate Plus Index Based Loans Maximum	Dec. 31, 2014 Revolving Credit Facility One Two Three Six Month Eurodollar Rate Plus Index Based Loans Minimum	Dec. 31, 2014 Revolving Credit Facility One Two Three Six Month Eurodollar Rate Plus Index Based Loans Maximum	Dec. 31, 2014 Term Loan A	Dec. 31, 2013 Term Loan A	Dec. 31, 2014 Term Loan A One Month Eurodollar Rate Plus Index Based Loans Minimum	Dec. 31, 2014 Term Loan A One Month Eurodollar Rate Plus Index Based Loans Maximum	Dec. 31, 2014 Term Loan A One Two Three Six Month Eurodollar Rate Plus Index Based Loans Minimum	Dec. 31, 2014 Term Loan A One Two Three Six Month Eurodollar Rate Plus Index Based Loans Maximum	Dec. 31, 2014 Short Term on Demand Credit Facility Revolving Credit Facility	Dec. 31, 2014 Letter of Credit Revolving Credit Facility	Dec. 31, 2014 Accounts Receivable Securitization Facility	Aug. 07, 2014 3.750% Senior Secured Notes due 2019	Dec. 31, 2014 3.750% Senior Secured Notes due 2019 New Senior Secured Notes	Aug. 07, 2014 3.750% Senior Secured Notes due 2019 New Senior Secured Notes	Aug. 07, 2014 4.750% Senior Secured Notes due 2022	Dec. 31, 2014 4.750% Senior Secured Notes due 2022 New Senior Secured Notes	Aug. 07, 2014 4.750% Senior Secured Notes due 2022 New Senior Secured Notes	Jul. 31, 2014 7.00% Senior Unsecured Notes	Dec. 31, 2014 7.00% Senior Unsecured Notes	Jul. 31, 2014 7.00% Senior Unsecured Notes	Dec. 31, 2014 Senior Notes 7.125%	Jun. 30, 2008 Senior Notes 7.125%	Jun. 30, 2006 Senior Notes 7.125%	Dec. 31, 2014 Credit Agreement And Securitization	Dec. 31, 2013 Credit Agreement And Securitization	Dec. 31, 2012 Credit Agreement And Securitization	Aug. 07, 2014 Amendment of Credit Facility	Aug. 01, 2014 Amendment of Credit Facility	Oct. 31, 2013 Amendment of Credit Facility	Aug. 07, 2014 Amendment of Credit Facility Revolving Credit Facility	Dec. 31, 2014 Amendment of Credit Facility Term Loan A	Aug. 07, 2014 Amendment of Credit Facility Term Loan A	Aug. 01, 2014 Amendment of Credit Facility Accounts Receivable Securitization Facility
Debt Instrument [Line Items]
Line of credit facility, starting date																																								Aug. 07, 2014						Aug. 01, 2014
Line of credit facility, maturity month																																								2019-08
Line of credit facility, borrowing capacity											$ 800,000,000												$ 125,000,000																				$ 800,000,000		$ 1,775,000,000
Line of credit facility amount outstanding											140,000,000					1,761,872,000	935,308,000					500,000																						1,764,000,000
Reduction of long-term debt	879,129,000	440,224,000	849,647,000			550,000,000																									250,000,000	250,000,000
Line of credit facility, maturity year						2016
Accounts receivable securitization program credit facility, borrowing capacity																																									360,000,000	275,000,000
Line of credit facility, maturity date																																														Oct. 31, 2016
Senior notes, issued																									300,000,000		300,000,000	300,000,000		300,000,000						250,000,000
Senior notes, interest rate																									3.75%		3.75%	4.75%		4.75%		7.00%	7.00%			7.125%
Debt instrument redemption, date																															Jul. 31, 2014	Jul. 31, 2014
Unsecured notes make-whole redemption price																															104.56%
Costs related to extinguishment of debt	36,171,000	0	29,170,000
Write-off deferred charges																																20,000,000
Original issue discount on the extinguished debt																2,035,000	3,340,000															5,000,000
Write-off deferred charges, original issue discount and make-whole premiums paid																															11,000,000	11,000,000
Rate adjustment to weighted average federal funds rate for credit facility borrowings	0.50%
Rate adjustment to one month Eurodollar rate on credit facility borrowings	1.00%
Consolidated leverage ratio												0.50%	1.25%	1.50%	2.25%			0.50%	1.25%	1.50%	2.25%
Current applicable margins										0.50%	1.50%					1.50%
Line of credit facility, available borrowing capacity											640,000,000
Letters of credit, outstanding											20,000,000
Scheduled principal payments made				11,000,000	22,000,000		36,000,000	72,000,000
Accounts receivable securitization program credit facility, amount outstanding	330,000,000
Accounts receivable securitization program, additional capacity																								30,000,000
Senior notes, repayment terms									Interest is payable on the New Senior Secured Notes on February 1 and August 1 of each year																									Interest on the 7.125% Notes is payable semiannually in arrears on June 30th and December 30th of each year
Senior notes, interest payment, commencement date									Feb. 01, 2015
Senior notes, maturity date																										Aug. 01, 2019			Aug. 01, 2022			Oct. 01, 2018		Jun. 30, 2016
Line of credit facility additional borrowing capacity																																			150,000,000
Average amounts outstanding under Credit Agreement, Prior Credit Agreement, demand notes and accounts receivable securitization programs																																					2,400,000,000	2,900,000,000	2,900,000,000
Effective interest rate	3.20%	3.60%	4.50%																																		1.80%	2.20%	2.90%
Maximum amounts outstanding at any month-end																																					2,650,000,000	3,000,000,000	3,060,000,000
Long-term debt	3,210,215,000	3,209,762,000
Fair value of debt	$ 3,300,000,000	$ 3,400,000,000

Aggregate Maturities (Detail) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Long Term Debt Maturities Repayments Of Principal [Line Items]
2015	$ 68,319	$ 99,312
2016	787,437
2017	90,675
2018	90,882
2019	1,925,923
Later	315,298
Long-term debt	$ 3,278,534	$ 3,309,074

- Definition

+ References+ Details

Common Stock - Additional Information (Detail) (USD $)	12 Months Ended
Common Stock - Additional Information (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jul. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividends declared and paid, per share	$ 0.30	$ 0.20	$ 0.60
Dividends declared and paid	$ 29,700,000	$ 19,600,000	$ 58,400,000
Stock repurchase programs authorized to purchase, value	400,000,000			400,000,000
Stock repurchased, value	100,749,000	27,201,000	19,154,000
Compensation cost recognized	31,092,000	27,783,000	22,518,000
Excess tax benefit from share based compensation	33,912,000	20,121,000	16,040,000
Stock options granted during period (net of cancellations)	2,845,500	2,889,750	2,966,850
Total in-the-money value of all stock options exercised during the year	112,500,000	70,900,000	54,400,000
Stock issued during period, net of cancellations	1,100,000
Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted during period (net of cancellations)	2.8	2.6	2.6
Weighted-average grant date fair value of option granted	$ 17.23	$ 13.33	$ 10.73
Common Stock remain available for issuance	3,100,000
2005 Employees' Restricted Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized	75,303	90,587	117,901
Common Stock remain available for issuance	4,900,000
Stock issued under employee stock purchase plan	26,189	10,000	54,127
Percentage of discount provided to eligible employees for purchase of shares under employee stock purchase plan	10.00%
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized, pre-tax charge	29,200,000	25,800,000	20,100,000
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized, after-tax	1,900,000	2,000,000	2,400,000
Stock Repurchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchased, shares	548,192
Stock repurchased, value	57,950,000
Income Tax Withholding Obligations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchased, shares	480,972
Stock repurchased, value	42,700,000
Special Cash Dividend
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividends declared and paid, per share			$ 0.40
Dividends declared and paid			$ 38,900,000
Class B
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved	6,000,000
Issuance upon conversion of shares	23,297,420
Class B \| Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved	23,000,000

Schedule of Information Related to Stock Repurchase Programs (Detail) (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended				12 Months Ended		12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jul. 31, 2014	Dec. 31, 2014 Stock Repurchase Program	Dec. 31, 2011 Stock Repurchase Programs Twenty Eleven	Dec. 31, 2012 Stock Repurchase Programs Twenty Twelve	Dec. 31, 2013 Stock Repurchase Programs Twenty Thirteen	Dec. 31, 2014 Stock Repurchase Programs Twenty Fourteen	Dec. 31, 2014 Stock Repurchase Programs Twenty Fourteen Stock Repurchase Program
Class of Stock [Line Items]
Additional dollars authorized for repurchase	$ 400,000			$ 400,000					$ 400,000
Total number of shares purchased	1,889,646						433,312	427,170	1,029,164
Total number of shares cancelled	767,704								767,704
Total number of shares purchased as part of publicly announced programs					548,192					548,192
Average price pad per share for shares purchased as part of publicly announced program					$ 105.71					$ 105.71
Aggregate purchase price paid	147,104						19,154	27,201	100,749
Aggregate purchase price paid for shares purchased as part of publicly announced program	100,749	27,201	19,154		57,950					57,950
Maximum number of shares that may yet be purchased under the program						767,704	767,704	767,704
Maximum number of dollars that may yet be purchased under the program									$ 342,050

Assumptions Used in Black-Scholes Model to Determine Fair Value for Stock Option Awards Granted (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	35.00%	36.00%	33.00%
Interest rate	1.00%	1.00%	1.00%
Expected life (years)	3 years 4 months 24 days	3 years 7 months 6 days	3 years 6 months
Forfeiture rate	10.00%	11.00%	10.00%
Dividend yield	0.40%	0.50%	0.60%

Summary of Option Activities (Detail) (USD $)	12 Months Ended
Summary of Option Activities (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Option, Number of shares, beginning balance	7,620,958	7,436,238	7,558,945
Granted, Number of Shares	2,845,500	2,889,750	2,966,850
Exercised, Number of Shares	(2,277,469)	(2,288,666)	(2,608,007)
Cancelled, Number of Shares	(291,538)	(416,364)	(481,550)
Outstanding Option, Number of shares, ending balance	7,897,451	7,620,958	7,436,238
Outstanding Option, Average Option Price, beginning balance	$ 43.63	$ 36.31	$ 31.63
Outstanding options vested and exercisable, Number of Shares	1,412,422
Granted, Average Option Price	$ 78.65	$ 53.51	$ 37.01
Exercised, Average Option Price	$ 38.50	$ 32.27	$ 23.22
Cancelled, Average Option Price	$ 55.63	$ 43.93	$ 38.00
Outstanding Option, Average Option Price, ending balance	$ 57.29	$ 43.63	$ 36.31
Outstanding options vested and exercisable, Average option price	$ 43.59
54.79 -$16.22
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High		$ 54.79	$ 54.79
Range, Low		$ 16.22	$ 16.22
44.83 -$36.95
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High			$ 44.83
Range, Low			$ 36.95
46.97 -$16.22
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High			$ 46.97
Range, Low			$ 16.22
79.79 -$53.38
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High		$ 79.79
Range, Low		$ 53.38
53.38 -$16.22
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High		$ 53.38
Range, Low		$ 16.22
79.79-$30.32
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High		$ 79.79
Range, Low		$ 30.32
102.21-$78.17
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	$ 102.21
Range, Low	$ 78.17
73.65-$30.32
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	$ 73.65
Range, Low	$ 30.32
78.17-$36.95
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	$ 78.17
Range, Low	$ 36.95
102.21-$36.95
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	$ 102.21
Range, Low	$ 36.95
79.79-$36.97
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	$ 79.79
Range, Low	$ 36.97

Schedule of Information about Unvested Options (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested options, Shares, beginning balance	5,864,830
Granted, Shares	2,845,500
Vested, Shares	(1,937,013)
Cancelled, Shares	(288,288)
Unvested options, Shares, ending balance	6,485,029
Unvested options, Weighted Average Grant Date Fair Value Per Share, beginning balance	$ 12.12
Granted, Weighted Average Grant Date Fair Value Per Share	$ 17.23
Vested, Weighted Average Grant Date Fair Value Per Share	$ 11.90
Canceled, Weighted Average Grant Date Fair Value Per Share	$ 13.64
Unvested options, Weighted Average Grant Date Fair Value Per Share, ending balance	$ 14.36

Schedule of Information about All Outstanding Options (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number, Options Outstanding	7,897,451	7,620,958	7,436,238	7,558,945
Weighted average exercise price, Options Outstanding	$ 57.29	$ 43.63	$ 36.31	$ 31.63
Aggregate intrinsic value, Options Outstanding	$ 426,248,728
Weighted average remaining contractual life, Options Outstanding	2 years 10 months 24 days
Number, Options Exercisable	1,412,422
Weighted Average Exercise Price, Options Exercisable	$ 43.59
Aggregate intrinsic value, Options Exercisable	$ 95,577,868
Weighted average remaining contractual life, Options Exercisable	1 year 9 months 18 days

Schedule of Weighted Average Remaining Contractual Life for Options Outstanding and Weighted Average Exercise Price Per Share for Exercisable Options (Detail) (USD $)

12 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Options Outstanding, Shares

7,897,451

7,620,958

7,436,238

7,558,945

Options Outstanding, Weighted Average Exercise Price Per Share

$ 57.29

$ 43.63

$ 36.31

$ 31.63

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

2 years 10 months 24 days

Exercisable Options, Shares

1,412,422

Weighted average exercise price per share, Options Exercisable

$ 43.59

Expected to Vest Options , Shares

5,826,799

^[1]

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 60.27

Range One

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Range, Low

$ (36.95)

Range, High

$ 43.46

Options Outstanding, Shares

1,690,463

Options Outstanding, Weighted Average Exercise Price Per Share

$ 37.00

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

2 years

Exercisable Options, Shares

465,688

Weighted average exercise price per share, Options Exercisable

$ 37.02

Expected to Vest Options , Shares

1,100,460

^[1]

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 36.99

Range Two

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Range, Low

$ (43.67)

Range, High

$ 46.97

Options Outstanding, Shares

1,201,213

Options Outstanding, Weighted Average Exercise Price Per Share

$ 43.68

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

2 years

Exercisable Options, Shares

647,025

Weighted average exercise price per share, Options Exercisable

$ 43.67

Expected to Vest Options , Shares

497,938

^[1]

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 43.68

Range Three

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Range, Low

$ (53.38)

Range, High

$ 73.65

Options Outstanding, Shares

2,241,625

Options Outstanding, Weighted Average Exercise Price Per Share

$ 53.52

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

3 years

Exercisable Options, Shares

299,209

Weighted average exercise price per share, Options Exercisable

$ 53.58

Expected to Vest Options , Shares

1,745,261

^[1]

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 53.51

Range Four

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Range, Low

$ (78.17)

Range, High

$ 102.21

Options Outstanding, Shares

2,764,150

Options Outstanding, Weighted Average Exercise Price Per Share

$ 78.66

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

4 years 2 months 12 days

Exercisable Options, Shares

500

Weighted average exercise price per share, Options Exercisable

$ 79.79

Expected to Vest Options , Shares

2,483,140

^[1]

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 78.66

[1]	Assumes a weighted average forfeiture rate of 10.2%.

Components of Income Tax Expense Benefit (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Components Of Income Tax Expense Benefit [Line Items]
Current, Federal	$ 248,172	$ 256,545	$ 254,021
Current, Foreign	4,167	1,655	9,084
Current, State	23,224	28,490	39,076
Current, Total	275,563	286,690	302,181
Deferred, Federal and foreign	41,583	25,341	(21,408)
Deferred, State	7,525	3,278	(6,157)
Deferred, Total	49,108	28,619	(27,565)
Provision for income taxes	$ 324,671	$ 315,309	$ 274,616

- Definition

Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.

+ References+ Details

- Definition

Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.

+ References+ Details

- Definition

Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.

+ References+ Details

- Definition

Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.

+ References+ Details

- Definition

Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.

+ References+ Details

Components of Deferred Taxes (Detail) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Schedule of Components of Deferred Tax Provision [Line Items]
Self-insurance reserves	$ 84,915	$ 87,483
Compensation accruals	55,788	49,302
State and foreign net operating loss carryforwards and other state and foreign deferred tax assets	60,521	57,204
Other currently non-deductible accrued liabilities	16,739	24,587
Net pension liability-OCI only	11,746	6,390
Doubtful accounts and other reserves	18,428	33,905
Other combined items-OCI only	2,615	9,018
Deferred income tax assets, Gross	250,752	267,889
Less: Valuation Allowance	(52,764)	(46,841)
Net deferred income tax assets:	197,988	221,048
Depreciable and amortizable assets	(362,674)	(337,669)
Other deferred tax liabilities	(2,963)	(2,624)
Net deferred income tax liabilities	$ (167,649)	$ (119,245)

Effective Tax Rates Calculation (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Schedule Of Effective Tax Rates Line Items
Provision for income taxes	$ 324,671	$ 315,309	$ 274,616
Income before income taxes	$ 929,667	$ 869,332	$ 763,663
Effective tax rate	34.90%	36.30%	36.00%

Income Taxes - Additional Information (Detail) (USD $)	12 Months Ended
Income Taxes - Additional Information (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Taxes [Line Items]
Favorable discrete tax items	$ 1,000,000	$ 1,000,000	$ 1,000,000
Foreign pre-tax earnings	15,000,000	6,000,000	38,000,000
Effective income tax rate, foreign	21.00%
Undistributed foreign earnings	10,000,000
Unrecognizable deferred tax liability related to foreign earnings	4,000,000
Deferred federal and state tax benefit	17,000,000	5,000,000
Future taxable income, amount	1,110,000,000
Deferred state tax benefit (net of the federal benefit)	7,525,000	3,278,000	(6,157,000)
Net operating losses	60,521,000	57,204,000
Deferred foreign tax benefit	3,000,000
Valuation allowances	52,764,000	46,841,000
Increase in estimated liabilities for uncertain tax positions	1,000,000	1,000,000
Decrease in estimated liabilities for uncertain tax positions due to the lapse of the statute of limitations	1,000,000
Impact of unrecognized tax benefits if recognized	2,000,000	2,000,000
Jurisdictions statutes of limitations expiration period	12 months
Period of expiration of the statute of limitations for certain jurisdictions	Within the next twelve months
Allowance in relation to state tax benefit
Income Taxes [Line Items]
Valuation allowances	50,000,000	44,000,000
Net Operating Losses
Income Taxes [Line Items]
Increase in valuation allowance	6,000,000
Foreign Net Operating Losses
Income Taxes [Line Items]
Increase in valuation allowance	3,000,000	3,000,000
Maximum
Income Taxes [Line Items]
Accrued interest and penalties	1,000,000	1,000,000
Foreign and U.S. state and local jurisdictions have statutes of limitations, in years	4 years
Minimum
Income Taxes [Line Items]
Foreign and U.S. state and local jurisdictions have statutes of limitations, in years	3 years
State and Local Jurisdiction
Income Taxes [Line Items]
Deferred state tax benefit (net of the federal benefit)	54,000,000
Foreign Tax Authority
Income Taxes [Line Items]
Net operating losses	$ 7,000,000

Reconciliation between Federal Statutory Rate and Effective Tax Rate (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Reconciliation of Statutory Federal Tax Rate [Line Items]
Federal statutory rate	35.00%	35.00%	35.00%
State taxes, net of federal income tax benefit	2.30%	2.50%	3.00%
Nondeductible transaction costs			0.20%
Divestiture gain		0.30%
Other items		0.40%	0.10%
Impact of income attributable to noncontrolling interests	(2.40%)	(1.90%)	(2.30%)
Effective tax rate	34.90%	36.30%	36.00%

Net Deferred Tax Assets and Liabilities (Detail) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Deferred Tax Assets And Liabilities [Line Items]
Current deferred taxes, Assets	$ 115,870	$ 121,097
Current deferred taxes, Liabilities	(1,305)	(1,194)
Total deferred taxes-current	114,565	119,903
Noncurrent deferred taxes, Assets	85,792	103,221
Noncurrent deferred taxes, Liabilities	(368,006)	(342,369)
Total deferred taxes-noncurrent	(282,214)	(239,148)
Net deferred income tax liabilities	$ (167,649)	$ (119,245)

- Definition

Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed within one year or operating cycle, if longer.

+ References+ Details

- Definition

Amount after allocation of valuation allowances of noncurrent deferred tax asset attributable to deductible temporary differences and carryforwards. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).

+ References+ Details

- Definition

Amount of deferred tax liability attributable to taxable temporary differences, net of deferred tax asset attributable to deductible temporary differences and carryforwards net of valuation allowances expected to be realized or consumed within one year or operating cycle, if longer.

+ References+ Details

Reconciliation of Unrecognized Tax Benefits (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Reconciliation of Unrecognized Tax Benefits [Line Items]
Balance at January 1,	$ 3,369	$ 6,824	$ 7,403
Additions based on tax positions related to the current year	50	50	200
Additions for tax positions of prior years	195	283	386
Reductions for tax positions of prior years	(1,212)	(1,260)	(1,165)
Settlements		(2,528)
Balance at December 31,	$ 2,402	$ 3,369	$ 6,824

Summary of Property under Capital Lease (Detail) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Capital Leased Assets [Line Items]
Land, buildings and equipment	$ 40,782	$ 27,636
Less: accumulated amortization	(27,556)	(27,382)
Property under capital lease, Total	$ 13,226	$ 254

Future Minimum Rental Payments under Lease Commitments (Detail) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014
Future Minimum Payments Under Non-Cancelable Operating Leases With Initial Terms Of One-Year Or More [Line Items]
Capital Leases, 2015	$ 3,293
Capital Leases, 2016	3,261
Capital Leases, 2017	3,308
Capital Leases, 2018	3,322
Capital Leases, 2019	3,370
Capital Leases, Later years	22,356
Capital Leases, Total minimum rental	38,910
Less: Amount representing interest	(17,310)
Present value of minimum rental commitments	21,600
Less: Current portion of capital lease obligations	(1,080)
Long-term portion of capital lease obligations	20,520
Operating Leases, 2015	58,904
Operating Leases, 2016	49,043
Operating Leases, 2017	31,619
Operating Leases, 2018	25,940
Operating Leases, 2019	22,229
Operating Leases, Later years	147,288
Operating Leases, Total minimum rental	$ 335,023

Commitments and Contingencies - Additional Information (Detail)	1 Months Ended			1 Months Ended	3 Months Ended	12 Months Ended																												12 Months Ended
	Aug. 31, 2014	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)	Nov. 30, 2010 Cygnet Health Care Limited Facility Patient	Sep. 30, 2014 Cygnet Health Care Limited Facility	Dec. 31, 2014 Cygnet Health Care Limited GBP (£)	Nov. 30, 2010 Professional Liability Cygnet Health Care Limited GBP (£)	Nov. 30, 2010 General Liability Cygnet Health Care Limited GBP (£)	Dec. 31, 2014 Location 2 USD ($)	Dec. 31, 2014 Location 1 USD ($)	Dec. 31, 2014 Wind Storms Maximum USD ($)	Dec. 31, 2014 Wind Storms Minimum	Dec. 31, 2014 Earthquake USD ($)	Dec. 31, 2014 Earthquake Maximum USD ($)	Dec. 31, 2014 Earthquake UNITED STATES Maximum USD ($)	Dec. 31, 2014 Earthquake UNITED STATES Minimum	Dec. 31, 2014 Earthquake PUERTO RICO USD ($)	Dec. 31, 2014 Flood Location 2 USD ($)	Dec. 31, 2014 Flood Location 1 USD ($)	Nov. 30, 2010 Subsidiaries Professional Liability Maximum USD ($)	Nov. 30, 2010 Subsidiaries General Liability Maximum USD ($)	Dec. 31, 2014 Subsidiaries General and Professional Liability Insurance Policies	Dec. 31, 2014 Subsidiaries General and Professional Liability Insurance Policies Maximum USD ($)	Dec. 31, 2013 Subsidiaries General and Professional Liability Insurance Policies Maximum USD ($)	Dec. 31, 2014 Subsidiaries General and Professional Liability Insurance Policies Minimum USD ($)	Dec. 31, 2014 Psychiatric Solutions Inc General and Professional Liability Insurance Policies Maximum USD ($)	Oct. 31, 2012 Behavioral Health Facilities Acquired from Ascend Health Corporation General and Professional Liability Insurance Policies USD ($)	Dec. 31, 2014 Revenue Cycle Data Processing Services USD ($)	Dec. 31, 2014 Electronic Health Records Application USD ($)	Dec. 31, 2014 Estimated Minimum Liabilities For Physician Commitments USD ($)	Dec. 31, 2014 Construction Commitment USD ($)	Dec. 31, 2014 Related to Certain Equipment USD ($)	Dec. 31, 2014 Commercial Health Insurer and Self-insured Employee Benefit Plans USD ($)	Dec. 31, 2014 Professional And General Liability Psi Subsidiaries USD ($)	Dec. 31, 2013 Professional And General Liability Psi Subsidiaries USD ($)	Dec. 31, 2012 Professional And General Liability Psi Subsidiaries USD ($)	Dec. 31, 2011 Professional And General Liability Psi Subsidiaries
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability		$ 193,000,000	$ 206,000,000				£ 10,000,000	£ 25,000,000												$ 10,000,000	$ 3,000,000					$ 3,000,000	$ 12,000,000
Purchased several excess policies through commercial insurance carriers per occurrence																							250,000,000	200,000,000
Percentage of liability for claims paid under commercially insured coverage																						10.00%
Liability for claims paid under commercially insured coverage																							60,000,000		10,000,000
Minimum Insurance Deductible									250,000	50,000			250,000														100,000
Number of patients				16
Number of facilities				18	17
Number of nursing homes				2	2
Self-insured for professional and general liability, current		51,000,000	44,000,000
Reduction in professional and general liability self-insurance reserves relating to prior years																																		20,000,000	81,000,000	27,000,000
Weighting given to company-specific metrics																																				100.00%	75.00%
General industry metrics																																				0.00%	25.00%
Compensation liability claims		67,000,000	64,000,000
Compensation and related benefits		32,000,000	34,000,000
Commercial property insurance policies covering catastrophic losses											1,000,000,000			250,000,000	100,000,000		25,000,000
Percentage of insurance deductible											5.00%	3.00%			5.00%	1.00%
Maximum insurance deductible																	25,000	250,000	500,000
Property insurance						180,000,000
Payment suspension period increased	180 days
Combined estimated future purchase obligations		205,000,000																										87,000,000	117,000,000	2,000,000	151,000,000	251,000,000	58,000,000
Defined benefit pension plan estimated payments through 2089		234,000,000
Other retirement plan liabilities		$ 17,000,000

Relationship with Universal Health Realty Income Trust and Related Party Transactions - Additional Information (Detail) (USD $)		12 Months Ended					12 Months Ended		12 Months Ended				3 Months Ended
	Dec. 31, 2014 D Y	Dec. 31, 2014 Chief Executive Officer	Dec. 31, 2013 Chief Executive Officer	Dec. 31, 2012 Chief Executive Officer	Dec. 31, 2014 Chief Executive Officer Trust Owned by Chief Executive Officer	Dec. 31, 2014 Minimum Y	Dec. 31, 2014 Minimum Chief Executive Officer	Dec. 31, 2014 Maximum Y	Dec. 31, 2014 Relationship with Universal Health Realty Income Trust	Dec. 31, 2013 Relationship with Universal Health Realty Income Trust	Dec. 31, 2012 Relationship with Universal Health Realty Income Trust	Sep. 30, 2014 Relationship with Universal Health Realty Income Trust	Mar. 31, 2015 Relationship with Universal Health Realty Income Trust Scenario, Forecast	Mar. 31, 2015 Relationship with Universal Health Realty Income Trust Scenario, Forecast Texas Facility
Related Party Transaction [Line Items]
Trust outstanding shares held, percentage									5.90%
Advisory fee earned									$ 2,500,000	$ 2,400,000	$ 2,100,000
Pre-tax share of income from the Trust									3,200,000	842,000	1,200,000
Share of gain on fair value recognition included in the share of trust									2,300,000		500,000
Carrying value of investment in Trust									9,300,000	8,100,000
Market value of investment in Trust									37,900,000	31,500,000
Rent expense under operating leases									16,800,000	16,400,000	16,300,000
Non-controlling ownership interests by subsidiaries									100.00%
Lease initial terms						13		15
Lease renewal period, years	5
Estimated purchase price of The Bridgeway's real property												17,300,000
Number of free-standing emergency departments to be acquired														2
Aggregate construction cost/sales proceeds													12,800,000
Aggregate rent expense paid													900,000
Notice period on renewal of lease	90
Period of rights of refusal to leased facilities	180
Estimated payments to acquire life insurance policies		25,000,000			8,000,000
Estimated death benefit proceeds							33,000,000
Payments to acquire life insurance policies		$ 1,300,000	$ 1,300,000	$ 1,400,000

Remaining Renewal Options and Terms for Hospital Facilities Leased from Trust (Detail) (USD $)

12 Months Ended

Dec. 31, 2014

McAllen Medical Center

Property Subject to or Available for Operating Lease [Line Items]

Acute Care

$ 5,485,000

2016-12

15 years

^[1]

Wellington Regional Medical Center

Property Subject to or Available for Operating Lease [Line Items]

Acute Care

3,030,000

2016-12

15 years

^[2]

Southwest Healthcare System, Inland Valley Campus

Property Subject to or Available for Operating Lease [Line Items]

Acute Care

$ 2,648,000

2016-12

15 years

^[2]

[1]	We have three 5-year renewal options at existing lease rates (through 2031).
[2]	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

Remaining Renewal Options and Terms for Hospital Facilities Leased from Trust (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2014 RenewalOptions
McAllen Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at existing lease rates	3
Renewal options term at existing lease rates	5 years
Wellington Regional Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at existing lease rates	1
Renewal options term at existing lease rates	5 years
Number of renewal options at fair market lease rates	2
Renewal options term at fair market lease rates	5 years
Southwest Healthcare System, Inland Valley Campus
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at existing lease rates	1
Renewal options term at existing lease rates	5 years
Number of renewal options at fair market lease rates	2
Renewal options term at fair market lease rates	5 years
Maximum \| McAllen Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at existing lease rates expiration year	2031
Maximum \| Wellington Regional Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at existing lease rates expiration year	2021
Renewal options at fair market value lease rates expiration year	2031
Maximum \| Southwest Healthcare System, Inland Valley Campus
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at existing lease rates expiration year	2021
Renewal options at fair market value lease rates expiration year	2031
Minimum \| Wellington Regional Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at fair market value lease rates expiration year	2022
Minimum \| Southwest Healthcare System, Inland Valley Campus
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at fair market value lease rates expiration year	2022

Pension Plan - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Defined Benefit Plan Disclosure [Line Items]
Amount of contributions to contributory plan	$ 35.7	$ 29.9	$ 27.3
Accumulated benefit obligation	126.4	102.3
Fair value of plan assets exceeded accumulated benefit obligation	9.7	4.1
Estimated net loss that will be amortized from accumulated other comprehensive income over the next fiscal year	$ 3.2

Schedule of Reconciliation of Defined Benefit Pension Plan (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets at beginning of year	$ 106,469	$ 104,074
Actual return (loss) on plan assets	16,470	8,037
Employer contributions	0	0
Benefits paid	(5,605)	(5,042)
Administrative expenses	(637)	(600)
Fair value of plan assets at end of year	116,697	106,469	104,074
Benefit obligation at beginning of year	103,558	114,529
Service cost	966	1,060	1,144
Interest cost	4,986	4,528
Benefits paid	(5,605)	(5,042)
Actuarial (gain) loss	23,437	(11,517)
Benefit obligation at end of year	127,342	103,558	114,529
Other non-current assets	0	2,911
Other non-current liabilities	10,645	0
Total amounts recognized at end of year	$ 10,645	$ 2,911

Components of Net Periodic Pension Cost Benefit (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 966	$ 1,060	$ 1,144
Interest cost	4,986	4,528
Expected return on plan assets	(7,772)	(7,601)	(7,301)
Recognized actuarial loss	1,107	3,305	4,219
Net periodic cost	(714)	1,292	2,721
Components of net periodic cost (benefit)
Defined Benefit Plan Disclosure [Line Items]
Interest cost	$ 4,985	$ 4,528	$ 4,659

Schedule of Weighted Average Assumptions (Detail)	12 Months Ended
Schedule of Weighted Average Assumptions (Detail)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Schedule of Postemployment Benefits Weighted Average Assumptions [Line Items]
Discount rate	3.95%	4.95%
Rate of compensation increase	4.00%	4.00%
Discount rate	4.95%	4.05%	4.40%
Expected long-term rate at return on plan assets	7.50%	7.50%	8.00%
Rate of compensation increase	4.00%	4.00%	4.00%

Schedule of Market Values of Pension Plan Assets (Detail) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 116,697	$ 106,469	$ 104,074
Equity Securities \| U.S. Large Cap
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	9,212	8,600
Equity Securities \| U.S. Mid Cap
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,852	2,740
Equity Securities \| U.S. Small Cap
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,626	2,725
Equity Securities \| International Developed
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6,181	6,508
Equity Securities \| Emerging Markets
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	4,139	4,154
Fixed Income Securities \| Core Fixed Income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	27,062	23,222
Fixed Income Securities \| Long Duration Fixed Income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	61,718	55,933
Fixed income securities \| REIT Fund
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,395	2,124
Cash \| Cash Equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	512	463
Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	116,697	106,469
Fair Value, Inputs, Level 2 \| Equity Securities \| U.S. Large Cap
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	9,212	8,600
Fair Value, Inputs, Level 2 \| Equity Securities \| U.S. Mid Cap
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,852	2,740
Fair Value, Inputs, Level 2 \| Equity Securities \| U.S. Small Cap
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,626	2,725
Fair Value, Inputs, Level 2 \| Equity Securities \| International Developed
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6,181	6,508
Fair Value, Inputs, Level 2 \| Equity Securities \| Emerging Markets
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	4,139	4,154
Fair Value, Inputs, Level 2 \| Fixed Income Securities \| Core Fixed Income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	27,062	23,222
Fair Value, Inputs, Level 2 \| Fixed Income Securities \| Long Duration Fixed Income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	61,718	55,933
Fair Value, Inputs, Level 2 \| Fixed income securities \| REIT Fund
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,395	2,124
Fair Value, Inputs, Level 2 \| Cash \| Cash Equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 512	$ 463

Schedule of Estimated Future Benefit Payments (Detail) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014
Defined Benefit Plan Disclosure [Line Items]
2015	$ 5,967
2016	6,231
2017	6,449
2018	6,661
2019	6,858
2020-2024	35,959
Total	$ 68,125

Schedule of Plan Assets Category (Detail)	12 Months Ended
Schedule of Plan Assets Category (Detail)	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]
Total	100.00%	100.00%
Equity Securities
Defined Benefit Plan Disclosure [Line Items]
Asset Allocation	21.00%	23.00%
Fixed income securities
Defined Benefit Plan Disclosure [Line Items]
Asset Allocation	76.00%	74.00%
Other
Defined Benefit Plan Disclosure [Line Items]
Asset Allocation	3.00%	3.00%

Schedule of Asset Allocation Policy and Ranges for Overall Risk and Return Objectives of Portfolio (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Equity Funds
Defined Benefit Plan Disclosure [Line Items]
Assets allocation	21.00%
Permitted Range, minimum	10.00%
Permitted Range, maximum	30.00%
Fixed Income Funds
Defined Benefit Plan Disclosure [Line Items]
Assets allocation	76.00%
Permitted Range, minimum	70.00%
Permitted Range, maximum	90.00%
Other
Defined Benefit Plan Disclosure [Line Items]
Assets allocation	3.00%	3.00%
Permitted Range, minimum	0.00%
Permitted Range, maximum	10.00%

Segment Reporting (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]
Gross inpatient revenues									$ 21,632,855	$ 19,763,315	$ 18,170,937
Gross outpatient revenues									8,965,578	7,613,277	6,828,975
Total net revenues	2,107,581	2,017,758	2,019,821	1,920,166	1,800,846	1,816,369	1,834,975	1,831,632	8,065,326	7,283,822	6,961,400
Income (loss) before allocation of corporate overhead and income taxes									929,667	869,332	763,663
Allocation of corporate overhead									0	0	0
Income (loss) after allocation of corporate overhead and before income taxes									929,667	869,332	763,663
Total assets	8,974,443				8,311,723				8,974,443	8,311,723	8,200,843
Acute Care Hospital Services
Segment Reporting Information [Line Items]
Gross inpatient revenues									14,943,102	13,469,269	12,406,567
Gross outpatient revenues									8,147,031	6,828,307	6,134,615
Total net revenues									4,105,090	3,576,369	3,461,416
Income (loss) before allocation of corporate overhead and income taxes									465,328	342,191	337,385
Allocation of corporate overhead									(178,781)	(184,444)	(162,056)
Income (loss) after allocation of corporate overhead and before income taxes									286,547	157,747	175,329
Total assets	3,362,870				3,125,626				3,362,870	3,125,626	2,984,169
Behavioral Health Services
Segment Reporting Information [Line Items]
Gross inpatient revenues									6,689,753	6,294,046	5,764,370
Gross outpatient revenues									784,309	744,510	646,177
Total net revenues									3,945,467	3,667,967	3,460,141
Income (loss) before allocation of corporate overhead and income taxes									944,068	895,869	838,603
Allocation of corporate overhead									(98,811)	(89,447)	(84,597)
Income (loss) after allocation of corporate overhead and before income taxes									845,257	806,422	754,006
Total assets	5,286,960				4,966,182				5,286,960	4,966,182	4,979,965
Other
Segment Reporting Information [Line Items]
Gross outpatient revenues									34,238	40,460	48,183
Total net revenues									14,769	39,486	39,843
Income (loss) before allocation of corporate overhead and income taxes									(479,729)	(368,728)	(412,325)
Allocation of corporate overhead									277,592	273,891	246,653
Income (loss) after allocation of corporate overhead and before income taxes									(202,137)	(94,837)	(165,672)
Total assets	$ 324,613				$ 219,915				$ 324,613	$ 219,915	$ 236,709

Quarterly Results (Detail) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Quarterly Financial Data [Line Items]
Net revenues	$ 2,107,581	$ 2,017,758	$ 2,019,821	$ 1,920,166	$ 1,800,846	$ 1,816,369	$ 1,834,975	$ 1,831,632	$ 8,065,326	$ 7,283,822	$ 6,961,400
Net income	190,492	96,038	166,614	151,852	133,186	123,099	167,803	129,935	604,996	554,023	489,047
Less: Net income attributable to noncontrolling interests	17,695	13,241	14,943	13,774	8,665	8,512	15,962	10,151	59,653	43,290	45,601
Net income attributable to UHS	$ 172,797	$ 82,797	$ 151,671	$ 138,078	$ 124,521	$ 114,587	$ 151,841	$ 119,784	$ 545,343	$ 510,733	$ 443,446
Total basic earnings per share	$ 1.75	$ 0.84	$ 1.53	$ 1.40	$ 1.27	$ 1.17	$ 1.55	$ 1.23	$ 5.52	$ 5.21	$ 4.57
Total diluted earnings per share	$ 1.71	$ 0.82	$ 1.51	$ 1.38	$ 1.24	$ 1.15	$ 1.53	$ 1.21	$ 5.42	$ 5.14	$ 4.53

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References+ Details

Quarterly Results - Additional Information (Detail) (USD $)	3 Months Ended
	Sep. 30, 2014 Implementation of EHR applications	Jun. 30, 2014 Implementation of EHR applications	Mar. 31, 2014 Implementation of EHR applications	Jun. 30, 2013 Implementation of EHR applications	Mar. 31, 2013 Implementation of EHR applications	Dec. 31, 2014 EHR applications	Dec. 31, 2013 EHR applications	Sep. 30, 2013 EHR applications	Mar. 31, 2014 Resulting from the gain realized on the sale of a non-operating investment	Sep. 30, 2014 Related to extinguishment of debt from the early redemption of previously outstanding $250 million 7.00% senior unsecured notes and the repayment of $550 million of previously outstanding Term Loan B facility	Sep. 30, 2014 Incurred in connection with the previously disclosed $65 million settlement of the Garden City matter	Dec. 31, 2014 Professional and general liability self-insurance reserves	Dec. 31, 2013 Professional and general liability self-insurance reserves	Jun. 30, 2013 Professional and general liability self-insurance reserves
Quarterly Financial Information [Line Items]
Unfavorable pre-tax reduction	$ 7,900,000	$ 7,100,000	$ 8,900,000	$ 8,900,000	$ 1,100,000					$ 36,200,000	$ 44,000,000
Unfavorable after-tax reduction	4,500,000	3,900,000	4,900,000	4,900,000	327,000					22,700,000	27,600,000
Tax reduction per diluted share	$ 0.04	$ 0.04	$ 0.05	$ 0.05	$ 0.01	$ 0.08	$ 0.12	$ 0.05	$ 0.07	$ 0.23	$ 0.27	$ 0.12	$ 0.09	$ 0.38
Favorable pre-tax reduction						13,800,000	19,400,000	8,400,000	10,100,000			19,700,000	15,600,000	65,000,000
Favorable after-tax reduction						$ 8,600,000	$ 11,800,000	$ 5,100,000	$ 6,300,000			$ 11,700,000	$ 9,200,000	$ 37,800,000

Supplemental Condensed Consolidating Statements of Income (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts									$ 8,764,309	$ 8,411,038	$ 7,688,071
Less: Provision for doubtful accounts									698,983	1,127,216	726,671
Net revenues	2,107,581	2,017,758	2,019,821	1,920,166	1,800,846	1,816,369	1,834,975	1,831,632	8,065,326	7,283,822	6,961,400
Operating charges:
Salaries, wages and benefits									3,845,461	3,604,620	3,440,917
Other operating expenses									1,782,981	1,468,744	1,376,122
Supplies expense									895,693	821,089	799,621
Depreciation and amortization									375,624	337,172	302,426
Lease and rental expense									93,993	97,758	94,885
Transaction costs									0	0	5,716
EHR incentive income									(27,902)	(61,024)	(30,038)
Costs related to extinguishment of debt									36,171	0	29,170
Operating expenses									7,002,021	6,268,359	6,018,819
Income from operations									1,063,305	1,015,463	942,581
Interest expense									133,638	146,131	178,918
Interest (income) expense, affiliate									0	0	0
Equity in net income of consolidated affiliates									0	0	0
Income before income taxes									929,667	869,332	763,663
Provision for income taxes									324,671	315,309	274,616
Net income	190,492	96,038	166,614	151,852	133,186	123,099	167,803	129,935	604,996	554,023	489,047
Less: Income attributable to noncontrolling interests	17,695	13,241	14,943	13,774	8,665	8,512	15,962	10,151	59,653	43,290	45,601
Net income attributable to UHS	172,797	82,797	151,671	138,078	124,521	114,587	151,841	119,784	545,343	510,733	443,446
Parent
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts									0	0	0
Less: Provision for doubtful accounts									0	0	0
Net revenues									0	0	0
Operating charges:
Salaries, wages and benefits									0	0	0
Other operating expenses									0	0	0
Supplies expense									0	0	0
Depreciation and amortization									0	0	0
Lease and rental expense									0	0	0
Transaction costs											0
EHR incentive income									0	0	0
Costs related to extinguishment of debt									36,171		29,170
Operating expenses									36,171	0	29,170
Income from operations									(36,171)	0	(29,170)
Interest expense									127,528	139,793	172,467
Interest (income) expense, affiliate									0	0	0
Equity in net income of consolidated affiliates									(646,386)	(597,020)	(567,906)
Income before income taxes									482,687	457,227	366,269
Provision for income taxes									(62,656)	(53,506)	(77,177)
Net income									545,343	510,733	443,446
Less: Income attributable to noncontrolling interests									0	0	0
Net income attributable to UHS									545,343	510,733	443,446
Guarantors
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts									6,100,777	5,658,699	5,152,816
Less: Provision for doubtful accounts									471,181	657,106	411,538
Net revenues									5,629,596	5,001,593	4,741,278
Operating charges:
Salaries, wages and benefits									2,757,738	2,573,205	2,452,187
Other operating expenses									1,217,525	972,170	899,274
Supplies expense									546,578	510,078	496,848
Depreciation and amortization									269,490	236,958	210,867
Lease and rental expense									58,619	62,518	59,596
Transaction costs											5,716
EHR incentive income									(19,480)	(43,027)	(14,284)
Costs related to extinguishment of debt									0		0
Operating expenses									4,830,470	4,311,902	4,110,204
Income from operations									799,126	689,691	631,074
Interest expense									4,516	3,365	3,749
Interest (income) expense, affiliate									88,246	84,640	93,363
Equity in net income of consolidated affiliates									(184,385)	(141,004)	(141,983)
Income before income taxes									890,749	742,690	675,945
Provision for income taxes									305,320	262,346	237,072
Net income									585,429	480,344	438,873
Less: Income attributable to noncontrolling interests									0	0	0
Net income attributable to UHS									585,429	480,344	438,873
Non Guarantors
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts									2,692,752	2,780,983	2,562,781
Less: Provision for doubtful accounts									227,802	470,110	315,133
Net revenues									2,464,950	2,310,873	2,247,648
Operating charges:
Salaries, wages and benefits									1,087,723	1,031,415	988,730
Other operating expenses									592,556	523,382	502,592
Supplies expense									349,115	311,011	302,773
Depreciation and amortization									106,134	100,214	91,559
Lease and rental expense									37,494	37,076	37,071
Transaction costs											0
EHR incentive income									(8,422)	(17,997)	(15,754)
Costs related to extinguishment of debt									0		0
Operating expenses									2,164,600	1,985,101	1,906,971
Income from operations									300,350	325,772	340,677
Interest expense									1,594	2,973	2,702
Interest (income) expense, affiliate									(88,246)	(84,640)	(93,363)
Equity in net income of consolidated affiliates									0	0	0
Income before income taxes									387,002	407,439	431,338
Provision for income taxes									82,007	106,469	114,721
Net income									304,995	300,970	316,617
Less: Income attributable to noncontrolling interests									59,653	43,290	45,601
Net income attributable to UHS									245,342	257,680	271,016
Consolidating Adjustments
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts									(29,220)	(28,644)	(27,526)
Less: Provision for doubtful accounts									0	0	0
Net revenues									(29,220)	(28,644)	(27,526)
Operating charges:
Salaries, wages and benefits									0	0	0
Other operating expenses									(27,100)	(26,808)	(25,744)
Supplies expense									0	0	0
Depreciation and amortization									0	0	0
Lease and rental expense									(2,120)	(1,836)	(1,782)
Transaction costs											0
EHR incentive income									0	0	0
Costs related to extinguishment of debt									0		0
Operating expenses									(29,220)	(28,644)	(27,526)
Income from operations									0	0	0
Interest expense									0	0	0
Interest (income) expense, affiliate									0	0	0
Equity in net income of consolidated affiliates									830,771	738,024	709,889
Income before income taxes									(830,771)	(738,024)	(709,889)
Provision for income taxes									0	0	0
Net income									(830,771)	(738,024)	(709,889)
Less: Income attributable to noncontrolling interests									0	0	0
Net income attributable to UHS									$ (830,771)	$ (738,024)	$ (709,889)

Supplemental Condensed Consolidating Comprehensive Income (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Condensed Statement of Income Captions [Line Items]
Net income	$ 190,492	$ 96,038	$ 166,614	$ 151,852	$ 133,186	$ 123,099	$ 167,803	$ 129,935	$ 604,996	$ 554,023	$ 489,047
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges									17,668	16,963	6,677
Amortization of terminated hedge									(336)	(336)	(336)
Minimum pension liability									(14,270)	14,657	4,986
Foreign currency translation adjustment									(2,431)	0	0
Other comprehensive income (loss) before tax									631	31,284	11,327
Income tax (benefit) expense related to items of other comprehensive income									1,053	11,940	4,306
Total other comprehensive income, net of tax									(422)	19,344	7,021
Comprehensive income									604,574	573,367	496,068
Less: Comprehensive income attributable to noncontrolling interests									59,653	43,290	45,601
Comprehensive income attributable to UHS									544,921	530,077	450,467
Consolidating Adjustments
Condensed Statement of Income Captions [Line Items]
Net income									(830,771)	(738,024)	(709,889)
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges									0	0	0
Amortization of terminated hedge									0	0	0
Minimum pension liability									14,270	(14,657)	(4,986)
Foreign currency translation adjustment									2,431
Other comprehensive income (loss) before tax									16,701	(14,657)	(4,986)
Income tax (benefit) expense related to items of other comprehensive income									5,356	(5,670)	(1,898)
Total other comprehensive income, net of tax									11,345	(8,987)	(3,088)
Comprehensive income									(819,426)	(747,011)	(712,977)
Less: Comprehensive income attributable to noncontrolling interests									0	0	0
Comprehensive income attributable to UHS									(819,426)	(747,011)	(712,977)
Parent
Condensed Statement of Income Captions [Line Items]
Net income									545,343	510,733	443,446
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges									17,668	16,963	6,677
Amortization of terminated hedge									(336)	(336)	(336)
Minimum pension liability									(14,270)	14,657	4,986
Foreign currency translation adjustment									(2,431)
Other comprehensive income (loss) before tax									631	31,284	11,327
Income tax (benefit) expense related to items of other comprehensive income									1,053	11,940	4,306
Total other comprehensive income, net of tax									(422)	19,344	7,021
Comprehensive income									544,921	530,077	450,467
Less: Comprehensive income attributable to noncontrolling interests									0	0	0
Comprehensive income attributable to UHS									544,921	530,077	450,467
Guarantors
Condensed Statement of Income Captions [Line Items]
Net income									585,429	480,344	438,873
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges									0	0	0
Amortization of terminated hedge									0	0	0
Minimum pension liability									(14,270)	14,657	4,986
Foreign currency translation adjustment									(2,431)
Other comprehensive income (loss) before tax									(16,701)	14,657	4,986
Income tax (benefit) expense related to items of other comprehensive income									(5,356)	5,670	1,898
Total other comprehensive income, net of tax									(11,345)	8,987	3,088
Comprehensive income									574,084	489,331	441,961
Less: Comprehensive income attributable to noncontrolling interests									0	0	0
Comprehensive income attributable to UHS									574,084	489,331	441,961
Non Guarantors
Condensed Statement of Income Captions [Line Items]
Net income									304,995	300,970	316,617
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges									0	0	0
Amortization of terminated hedge									0	0	0
Minimum pension liability									0	0	0
Foreign currency translation adjustment									0
Other comprehensive income (loss) before tax									0	0	0
Income tax (benefit) expense related to items of other comprehensive income									0	0	0
Total other comprehensive income, net of tax									0	0	0
Comprehensive income									304,995	300,970	316,617
Less: Comprehensive income attributable to noncontrolling interests									59,653	43,290	45,601
Comprehensive income attributable to UHS									$ 245,342	$ 257,680	$ 271,016

Supplemental Condensed Consolidating Balance Sheet (Detail) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 32,069	$ 17,238	$ 23,471	$ 41,229
Accounts receivable, net	1,282,735	1,116,961
Supplies	108,115	101,781
Deferred income taxes	114,565	119,903
Other current assets	77,654	76,446
Total current assets	1,615,138	1,432,329
Investments in subsidiaries	0	0
Intercompany receivable	0	0
Intercompany note receivable	0	0
Property and equipment	6,212,030	5,691,902
Less: accumulated depreciation	(2,532,341)	(2,249,733)
Property, Plant and Equipment, Net	3,679,689	3,442,169
Other assets:
Goodwill	3,291,213	3,049,016	3,036,765
Deferred charges	40,319	57,881
Other	348,084	330,328
Total assets	8,974,443	8,311,723	8,200,843
Current liabilities:
Current maturities of long-term debt	68,319	99,312
Accounts payable and accrued liabilities	1,113,062	953,449
Federal and state taxes	1,446	7,127
Total current liabilities	1,182,827	1,059,888
Intercompany payable	0	0
Other noncurrent liabilities	268,555	284,589
Long-term debt	3,210,215	3,209,762
Intercompany note payable	0	0
Deferred income taxes	282,214	239,148
Redeemable noncontrolling interests	239,552	218,107
UHS common stockholders' equity	3,735,946	3,249,979
Noncontrolling interest	55,134	50,250
Total equity	3,791,080	3,300,229	2,765,949	2,347,118
Liabilities and Equity, Total	8,974,443	8,311,723
Consolidating Adjustments
Current assets:
Cash and cash equivalents	0	0	0
Accounts receivable, net	0	0
Supplies	0	0
Deferred income taxes	0	0
Other current assets	0	0
Total current assets	0	0
Investments in subsidiaries	(8,674,836)	(7,855,410)
Intercompany receivable	(512,490)	(758,003)
Intercompany note receivable	(1,222,637)	(982,568)
Property and equipment	0	0
Less: accumulated depreciation	0	0
Property, Plant and Equipment, Net	0	0
Other assets:
Goodwill	0	0
Deferred charges	0	0
Other	0	0
Total assets	(10,409,963)	(9,595,981)
Current liabilities:
Current maturities of long-term debt	0	0
Accounts payable and accrued liabilities	0	0
Federal and state taxes	0	0
Total current liabilities	0	0
Intercompany payable	(512,490)	(758,003)
Other noncurrent liabilities	0	0
Long-term debt	0	0
Intercompany note payable	(1,222,637)	(982,568)
Deferred income taxes	0	0
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	(8,674,836)	(7,855,410)
Noncontrolling interest	0	0
Total equity	(8,674,836)	(7,855,410)
Liabilities and Equity, Total	(10,409,963)	(9,595,981)
Parent
Current assets:
Cash and cash equivalents	0	0	0
Accounts receivable, net	0	0
Supplies	0	0
Deferred income taxes	113,822	76,719
Other current assets	0	0
Total current assets	113,822	76,719
Investments in subsidiaries	7,013,540	6,378,499
Intercompany receivable	103,808	226,592
Intercompany note receivable	0	0
Property and equipment	0	0
Less: accumulated depreciation	0	0
Property, Plant and Equipment, Net	0	0
Other assets:
Goodwill	0	0
Deferred charges	32,379	49,866
Other	9,601	8,411
Total assets	7,273,150	6,740,087
Current liabilities:
Current maturities of long-term debt	44,874	97,403
Accounts payable and accrued liabilities	20,245	28,099
Federal and state taxes	1,446	4,963
Total current liabilities	66,565	130,465
Intercompany payable	0	0
Other noncurrent liabilities	1,322	7,591
Long-term debt	3,187,103	3,168,819
Intercompany note payable	0	0
Deferred income taxes	282,214	183,233
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	3,735,946	3,249,979
Noncontrolling interest	0	0
Total equity	3,735,946	3,249,979
Liabilities and Equity, Total	7,273,150	6,740,087
Guarantors
Current assets:
Cash and cash equivalents	21,784	7,990	11,949
Accounts receivable, net	933,971	799,898
Supplies	67,847	63,562
Deferred income taxes	743	43,184
Other current assets	62,431	63,786
Total current assets	1,086,776	978,420
Investments in subsidiaries	1,661,296	1,476,911
Intercompany receivable	0	0
Intercompany note receivable	0	0
Property and equipment	4,494,567	4,093,914
Less: accumulated depreciation	(1,686,192)	(1,478,758)
Property, Plant and Equipment, Net	2,808,375	2,615,156
Other assets:
Goodwill	2,764,555	2,552,190
Deferred charges	5,402	5,577
Other	283,302	251,365
Total assets	8,609,706	7,879,619
Current liabilities:
Current maturities of long-term debt	1,260	916
Accounts payable and accrued liabilities	1,051,309	837,354
Federal and state taxes	0	2,164
Total current liabilities	1,052,569	840,434
Intercompany payable	512,490	758,003
Other noncurrent liabilities	189,456	199,104
Long-term debt	20,212	5,337
Intercompany note payable	1,222,637	982,568
Deferred income taxes	0	55,915
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	5,612,342	5,038,258
Noncontrolling interest	0	0
Total equity	5,612,342	5,038,258
Liabilities and Equity, Total	8,609,706	7,879,619
Non Guarantors
Current assets:
Cash and cash equivalents	10,285	9,248	11,522
Accounts receivable, net	348,764	317,063
Supplies	40,268	38,219
Deferred income taxes	0	0
Other current assets	15,223	12,660
Total current assets	414,540	377,190
Investments in subsidiaries	0	0
Intercompany receivable	408,682	531,411
Intercompany note receivable	1,222,637	982,568
Property and equipment	1,717,463	1,597,988
Less: accumulated depreciation	(846,149)	(770,975)
Property, Plant and Equipment, Net	871,314	827,013
Other assets:
Goodwill	526,658	496,826
Deferred charges	2,538	2,438
Other	55,181	70,552
Total assets	3,501,550	3,287,998
Current liabilities:
Current maturities of long-term debt	22,185	993
Accounts payable and accrued liabilities	41,508	87,996
Federal and state taxes	0	0
Total current liabilities	63,693	88,989
Intercompany payable	0	0
Other noncurrent liabilities	77,777	77,894
Long-term debt	2,900	35,606
Intercompany note payable	0	0
Deferred income taxes	0	0
Redeemable noncontrolling interests	239,552	218,107
UHS common stockholders' equity	3,062,494	2,817,152
Noncontrolling interest	55,134	50,250
Total equity	3,117,628	2,867,402
Liabilities and Equity, Total	$ 3,501,550	$ 3,287,998

Supplemental Condensed Consolidating Statements of Cash flows (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	$ 1,035,876	$ 884,241	$ 799,231
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(391,150)	(358,493)	(363,192)
Acquisition of property and businesses	(431,386)	(12,636)	(527,847)
Proceeds received from sale of assets and businesses	15,178	37,482	149,311
Costs incurred for purchase and development of electronic health records application	(13,488)	(49,811)	(54,362)
Increase in insurance subsidiary investments	(12,000)	0	0
Return of Deposit on terminated purchase agreement	0	0	6,500
Net cash provided by (used in) investing activities	(832,846)	(383,458)	(789,590)
Cash Flows from Financing Activities:
Reduction of long-term debt	(879,129)	(440,224)	(849,647)
Additional borrowings	830,000	15,761	913,500
Financing costs	(14,976)	(231)	(8,283)
Repurchase of common shares	(100,749)	(27,201)	(19,154)
Dividends paid	(29,665)	(19,621)	(58,395)
Issuance of common stock	6,863	5,708	5,435
Excess income tax benefits related to stock based compensation	33,912	20,121	16,040
Profit distributions to noncontrolling interests	(33,680)	(61,329)	(26,895)
Changes in intercompany balances with affiliates, net	0	0	0
Net cash (used in) provided by financing activities	(187,424)	(507,016)	(27,399)
Effect of exchange rate changes on cash and cash equivalents	(775)	0	0
Decrease in cash and cash equivalents	14,831	(6,233)	(17,758)
Cash and cash equivalents, beginning of period	17,238	23,471	41,229
Cash and cash equivalents, end of period	32,069	17,238	23,471
Consolidating Adjustments
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0	0
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	0	0	0
Acquisition of property and businesses	0	0	0
Proceeds received from sale of assets and businesses	0	0	0
Costs incurred for purchase and development of electronic health records application	0	0	0
Increase in insurance subsidiary investments	0
Return of Deposit on terminated purchase agreement			0
Net cash provided by (used in) investing activities	0	0	0
Cash Flows from Financing Activities:
Reduction of long-term debt	0	0	1,613
Additional borrowings	0	0	(1,613)
Financing costs	0	0	0
Repurchase of common shares	0	0	0
Dividends paid	0	0	0
Issuance of common stock	0	0	0
Excess income tax benefits related to stock based compensation	0	0	0
Profit distributions to noncontrolling interests	0	0	0
Changes in intercompany balances with affiliates, net	0	0	0
Net cash (used in) provided by financing activities	0	0	0
Effect of exchange rate changes on cash and cash equivalents	0
Decrease in cash and cash equivalents	0	0	0
Cash and cash equivalents, beginning of period	0	0	0
Cash and cash equivalents, end of period	0	0	0
Parent
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	18,579	17,946	(37,648)
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	0	0	0
Acquisition of property and businesses	0	0	0
Proceeds received from sale of assets and businesses	0	0	0
Costs incurred for purchase and development of electronic health records application	0	0	0
Increase in insurance subsidiary investments	0
Return of Deposit on terminated purchase agreement			6,500
Net cash provided by (used in) investing activities	0	0	6,500
Cash Flows from Financing Activities:
Reduction of long-term debt	(866,748)	(429,996)	(843,002)
Additional borrowings	830,000	15,761	913,500
Financing costs	(14,976)	(231)	(8,283)
Repurchase of common shares	(100,749)	(27,201)	(19,154)
Dividends paid	(29,665)	(19,621)	(58,395)
Issuance of common stock	6,863	5,708	5,435
Excess income tax benefits related to stock based compensation	33,912	20,121	16,040
Profit distributions to noncontrolling interests	0	0	0
Changes in intercompany balances with affiliates, net	122,784	417,513	25,007
Net cash (used in) provided by financing activities	(18,579)	(17,946)	31,148
Effect of exchange rate changes on cash and cash equivalents	0
Decrease in cash and cash equivalents	0	0	0
Cash and cash equivalents, beginning of period	0	0	0
Cash and cash equivalents, end of period	0	0	0
Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	687,101	587,083	594,606
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(230,102)	(269,419)	(312,190)
Acquisition of property and businesses	(422,081)	(8,094)	(513,596)
Proceeds received from sale of assets and businesses	11,450	7,916	142,667
Costs incurred for purchase and development of electronic health records application	(13,488)	(49,811)	(54,362)
Increase in insurance subsidiary investments	(12,000)
Return of Deposit on terminated purchase agreement			0
Net cash provided by (used in) investing activities	(666,221)	(319,408)	(737,481)
Cash Flows from Financing Activities:
Reduction of long-term debt	(867)	(109)	0
Additional borrowings	0	0	1,613
Financing costs	0	0	0
Repurchase of common shares	0	0	0
Dividends paid	0	0	0
Issuance of common stock	0	0	0
Excess income tax benefits related to stock based compensation	0	0	0
Profit distributions to noncontrolling interests	0	0	0
Changes in intercompany balances with affiliates, net	(5,444)	(271,525)	119,990
Net cash (used in) provided by financing activities	(6,311)	(271,634)	121,603
Effect of exchange rate changes on cash and cash equivalents	(775)
Decrease in cash and cash equivalents	13,794	(3,959)	(21,272)
Cash and cash equivalents, beginning of period	7,990	11,949	33,221
Cash and cash equivalents, end of period	21,784	7,990	11,949
Non Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	330,196	279,212	242,273
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(161,048)	(89,074)	(51,002)
Acquisition of property and businesses	(9,305)	(4,542)	(14,251)
Proceeds received from sale of assets and businesses	3,728	29,566	6,644
Costs incurred for purchase and development of electronic health records application	0	0	0
Increase in insurance subsidiary investments	0
Return of Deposit on terminated purchase agreement			0
Net cash provided by (used in) investing activities	(166,625)	(64,050)	(58,609)
Cash Flows from Financing Activities:
Reduction of long-term debt	(11,514)	(10,119)	(8,258)
Additional borrowings	0	0	0
Financing costs	0	0	0
Repurchase of common shares	0	0	0
Dividends paid	0	0	0
Issuance of common stock	0	0	0
Excess income tax benefits related to stock based compensation	0	0	0
Profit distributions to noncontrolling interests	(33,680)	(61,329)	(26,895)
Changes in intercompany balances with affiliates, net	(117,340)	(145,988)	(144,997)
Net cash (used in) provided by financing activities	(162,534)	(217,436)	(180,150)
Effect of exchange rate changes on cash and cash equivalents	0
Decrease in cash and cash equivalents	1,037	(2,274)	3,514
Cash and cash equivalents, beginning of period	9,248	11,522	8,008
Cash and cash equivalents, end of period	$ 10,285	$ 9,248	$ 11,522

Valuation and Qualifying Accounts (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Allowance for Doubtful Accounts Receivable
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at beginning of period	$ 395,035	$ 311,387	$ 253,405
Charges to costs and expenses	698,983	1,127,216	726,671
Acquisitions of business	506		5,632
Write-off of uncollectible accounts	(769,876)	(1,043,568)	(674,321)
Balance at end of period	324,648	395,035	311,387
Valuation Allowance for Deferred Tax Assets
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at beginning of period	46,841	44,511	42,143
Charges to costs and expenses	5,923	2,330	2,368
Balance at end of period	$ 52,764	$ 46,841	$ 44,511

Schedule of Weighted Average Remaining Contractual Life for Options Outstanding and Weighted Average Exercise Price Per Share for Exercisable Options (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average forfeiture rate	10.20%

Schedule of Measurement Dates (Detail)	12 Months Ended
Schedule of Measurement Dates (Detail)	Dec. 31, 2014	Dec. 31, 2013
Benefit Obligation
Defined Benefit Plan Disclosure [Line Items]
Measurement Dates	12/31/2014	12/31/2013
Fair Value Of Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Measurement Dates	12/31/2014	12/31/2013

Supplemental Condensed Consolidating Financial Information - Additional Information (Detail) (Guarantors)	Dec. 31, 2014
Guarantors
Supplementary Information [Line Items]
Percentage of ownership interests	100.00%